export const stocks = [["Armada Acquisition Corp. I","Armada Acquisition Corp. I does not have significant operations.It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or related business combination with one or more businesses in the financial technology industry.The company was incorporated in 2020 and is based in Philadelphia, Pennsylvania.","United States","2020","Aug 13, 2021","Shell Companies","Financials","2","Stephen P. Herbert","1760 Market Street, Suite 602Philadelphia, Pennsylvania 19103United States","(215) 543-6886","armadaacq.com","AACI","NASDAQ","USD","0001844817",null,"US04208V1035","85-3810850","6770",{"Chief Executive Officer and Chairman":"Stephen P. Herbert","President, Treasurer, Secretary and Director":"Douglas M. Lurio Esq."},"94.86M","n/a","-634,410",null,"-0.02","n/a","n/a","n/a","n/a","10,110","11.78","11.60","11.52 - 11.78","10.12 - 12.53","0.01","n/a","n/a","n/a"],["Agilent Technologies, Inc.","Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide.The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab.The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.The Diagnostics and Genomics segment focuses on genomics, nucleic acid contract manufacturing and research and development, pathology, companion diagnostics, reagent partnership, and biomolecular analysis businesses.The Agilent CrossLab segment provides GC and LC columns, sample preparation products, custom chemistries, and laboratory instrument supplies; and offers services portfolio, including repairs, parts, maintenance, installations, training, compliance support, software as a service, asset management, and consulting services.The company markets its products through direct sales, distributors, resellers, manufacturer's representatives, and electronic commerce.Agilent Technologies, Inc. was incorporated in 1999 and is headquartered in Santa Clara, California.","United States","1999","Nov 18, 1999","Diagnostics & Research","Healthcare","18,100","Robert W. McMahon","5301 Stevens Creek BlvdSanta Clara, California 95051United States","(408) 345-8886","agilent.com","A","NYSE","USD","0001090872",null,"US00846U1016","77-0518772","3826",{"Chief Executive Officer, President and Director":"Michael R. McMullen","Senior Vice President, Chief Financial Officer and Interim President of Diagnostics and Genomics Group":"Robert W. McMahon","Chief Operating Officer":"Padraig McDonnell","Senior Vice President and President of Order Fulfillment and Supply Chain":"Henrik Ancher-Jensen","Principal Accounting Officer, Vice President and Corporate Controller":"Rodney Gonsalves","Senior Vice President and Chief Information Officer":"John Kohl","Vice President, Interim General Counsel and Secretary":"P. Diana Chiu","Senior Vice President of Human Resources and Global Communications":"Dominique P. Grau","Senior Vice President of Strategy and Corporate Development":"Allison Ballmer","MD of UK and Ireland Operations and Vice President of Human Resources - Europe":"Yvonne Mackie"},"40.87B","6.74B","1.24B",null,"4.19","33.28","25.16","$0.94 (0.68%)","Apr 1, 2024","890,109","139.69","137.52","138.41 - 140.95","96.80 - 151.58","1.12","Buy","140.41 (+0.69%)","May 21, 2024"],["ATA Creativity Global","ATA Creativity Global, together with its subsidiaries, provides educational services to individual students through its training center network in China and internationally.Its educational services include portfolio training, research-based learning, overseas study counselling, in-school art classes through cooperation with high schools and training organizations, foreign language training services, in-school art classes, junior art education, and other related educational services to its students.The company also offers online courses for students. It provides its services through partnership with sales channels, internet and mobile advertisement, word of mouth referral, and marketing events and activities.The company was formerly known as ATA Inc. and changed its name to ATA Creativity Global in September 2019.ATA Creativity Global was founded in 1999 and is headquartered in Hefei, China.","China","1999",null,"Education & Training Services","Consumer Staples","581","Xiaofeng  Ma","Rm. 507, Bldg. 3, Binhuzhuoyuecheng, Wenhuakechuangyuan, Huayuan Blvd. 365Baohe, Hefei, Anhui, F4 230051China","8610-6518-1133","ir.atai.net.cn","AACG","NASDAQ","USD","0001420529",null,"US00211V1061",null,"8200",{"President and Director":"Jun Zhang","Chief Financial Officer":"Ruobai Sima","Co-Founder, Chairman and Chief Executive Officer":"Xiaofeng Ma","Co-Founder and Consultant":"Lin Wang","General Counsel":"Haichang Xiong","Advisor":"Amy Tung"},"28.53M","31.26M","-4.75M",null,"-0.15","n/a","n/a","n/a","n/a","12,039","0.890","0.934","0.863 - 0.937","0.790 - 1.890","0.97","n/a","n/a","May 13, 2024"],["Ares Acquisition Corporation II","Ares Acquisition Corporation II does not have significant operations.It focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses.Ares Acquisition Corporation II was incorporated in 2021 and is based in New York, New York.","United States","2021","Apr 21, 2023","Shell Companies","Financials","4","David B. Kaplan","C/o Ares Management Llc, 245 Park Avenue, 42nd FloorNew York, New York 10167United States","310-201-4100","Visit Website","AACT","NYSE","USD","0001853138",null,"KYG330331045",null,"6770",{"Co-Chairman and Chief Executive Officer":"David B. Kaplan","Chief Financial Officer":"Jarrod Morgan Phillips","Chief Operating Officer":"Allyson Satin","Executive Vice President of Strategy":"Peter Ogilvie"},"663.75M","n/a","n/a",null,"n/a","n/a","n/a","n/a","n/a","12,213","10.62","10.63","10.62 - 10.64","10.10 - 10.76","n/a","n/a","n/a","n/a"],["Alcoa Corporation","Alcoa Corporation, together with its subsidiaries, produces and sells bauxite, alumina, and aluminum products in the United States, Spain, Australia, Iceland, Norway, Brazil, Canada, and internationally.The company operates through two segments, Alumina and Aluminum. It engages in bauxite mining operations; and processes bauxite into alumina and sells it to customers who process it into industrial chemical products, as well as aluminum smelting and casting businesses.The company offers primary aluminum in the form of alloy ingot or value-add ingot to customers that produce products for the transportation, building and construction, packaging, wire, and other industrial markets; and flat-rolled aluminum in the form of sheet, which is sold primarily to customers that produce beverage and food cans.In addition, it owns hydro power plants that generates and sells electricity in the wholesale market to traders, large industrial consumers, distribution companies, and other generation companies.The company was formerly known as Alcoa Upstream Corporation and changed its name to Alcoa Corporation in October 2016.The company was founded in 1886 and is headquartered in Pittsburgh, Pennsylvania.","United States","1888","Nov 1, 2016","Aluminum","Materials","13,600","William F. Oplinger","201 Isabella Street, Suite 500Pittsburgh, Pennsylvania 15212United States","412-315-2900","alcoa.com","AA","NYSE","USD","0001675149",null,"US0138721065","81-1789115","3334",{"President, Chief Executive Officer and Director":"William F. Oplinger","Executive Vice President and Chief Financial Officer":"Molly S. Beerman","Executive Vice President and General Counsel":"Andrew J.A Hastings","Executive Vice President and Chief Human Resources Officer":"Tammi A. Jones","Executive Vice President and Chief Commercial Officer":"Renato Bacchi","Executive Vice President and Chief Operating Officer":"Matthew T. Reed","Senior Vice President, Controller and Principal Accounting Officer":"Renee Henry","Vice President of Investor Relations":"James Dwyer","Senior Vice President of Tax":"Heather Hudak","Executive Vice President and Chief External Affairs Officer":"Nicol Gagstetter"},"6.60B","10.48B","-672.00M",null,"-3.76","n/a","35.70","$0.40 (1.09%)","Mar 4, 2024","5,376,928","36.70","35.94","36.25 - 37.20","23.07 - 38.20","2.49","Hold","35.29 (-4.03%)","Apr 17, 2024"],["African Agriculture Holdings Inc.","African Agriculture Holdings Inc., a food security company, engages in operating a commercial-scale alfalfa farm on the African continent.The company is based in New York, New York. African Agriculture Holdings Inc. operates as a subsidiary of Global Commodities & Investments Ltd.","United States","2017",null,"Farm Products","Consumer Staples","85","Michael  Rhodes","445 Park Avenue, Ninth FloorNew York, New York 10022United States","(212) 745-1164","africanagriculture.com","AAGR","NASDAQ","USD","0001848898",null,"US00792J1007",null,"0100",{"Chairman and Chief Strategy Officer":"Alan Kessler","Chief Financial Officer":"Harry Green","Chief Executive Officer and Secretary":"Michael Rhodes","Chief Operating Officer":"Edward Meiring","Chief Technical Officer":"Kiran Peethambaran Shylaja","Chief Operating Officer of Senegal Operations":"Javier Orellana","Head of Logistics and Technology Integration":"Elad Harzahav"},"20.20M","1.82M","-43.06M",null,"-1.21","n/a","n/a","n/a","n/a","90,500","0.361","0.373","0.330 - 0.373","0.290 - 11.391","-0.85","n/a","n/a","May 15, 2024"],["Aadi Bioscience, Inc.","Aadi Bioscience, Inc., a biopharmaceutical company, engages in developing and commercializing precision therapies for genetically defined cancers with alterations in mTOR pathway genes.Its lead drug product candidate comprises FYARRO, a form of sirolimus protein-bound particles for injectable suspension for the treatment in adult patients with advanced unresectable or metastatic malignant PEComa.The company is also involved in evaluating FYARRO in cancers, including indications targeting specific genomic alterations that activate the mTOR pathway.Aadi Bioscience, Inc. was incorporated in 2007 and is headquartered in Pacific Palisades, California.","United States","2011",null,"Biotechnology","Healthcare","89","Stephen M. Rodin J.D.","17383 Sunset Avenue, Suite A250Pacific Palisades, California 90272United States","424-473-8055","aadibio.com","AADI","NASDAQ","USD","0001422142",null,"US00032Q1040","61-1547850","2834",{"Founder, Secretary and Executive Chairman":"Dr. Neil P. Desai Ph.D.","Chief Medical Officer":"Dr. Loretta M. Itri F.A.C.P., M.D.","President, Chief Executive Officer and Director":"David J. Lennon Ph.D.","Chief Financial Officer, Treasurer, Investor Relations and Corporate Communications":"Scott M. Giacobello CPA","Senior Vice President of Legal and General Counsel":"Stephen M. Rodin J.D.","Senior Vice President of Human Resources and Chief Human Resources Officer":"Raymond G. Steitz","Chief Quality Officer and Senior Vice President of Manufacturing Operations":"Bryan Ball"},"52.05M","24.35M","-65.77M",null,"-2.44","n/a","n/a","n/a","n/a","90,575","2.060","2.020","2.020 - 2.130","1.550 - 8.600","0.30","Buy","5.00 (+135.85%)","May 8, 2024"],["American Airlines Group Inc.","American Airlines Group Inc., through its subsidiaries, operates as a network air carrier.The company provides scheduled air transportation services for passengers and cargo through its hubs in Charlotte, Chicago, Dallas/Fort Worth, Los Angeles, Miami, New York, Philadelphia, Phoenix, and Washington, D.C., as well as through partner gateways in London, Doha, Madrid, Seattle/Tacoma, Sydney, and Tokyo.It operates a mainline fleet of 965 aircraft. The company was formerly known as AMR Corporation and changed its name to American Airlines Group Inc. in December 2013.American Airlines Group Inc. was founded in 1926 and is headquartered in Fort Worth, Texas.","United States","1930",null,"Airlines","Industrials","132,100","Robert D. Isom Jr.","1 Skyview DriveFort Worth, Texas 76155United States","(682) 278-9000","aa.com","AAL","NASDAQ","USD","0000006201",null,"US02376R1023","75-1825172","4512",{"Chief Executive Officer, President and Director":"Robert D. Isom Jr.","Executive Vice President and Chief Operating Officer":"David G. Seymour","Chief Strategy Officer and Vice Chair":"Stephen L. Johnson","Executive Vice President and Chief Financial Officer":"Devon E. May","Executive Vice President and Chief Digital and Information Officer":"Ganesh Jayaram","Managing Director of Investor Relations":"Scott Long","Executive Vice President and Chief Legal Officer":"Priya R. Aiyar","Senior Vice President and Chief Communications and Marketing Officer":"Ronald J. Defeo","Senior Vice President and Chief People Officer":"Mecole Brown","Executive Vice President and Chief Commercial Officer":"Vasu S. Raja"},"9.09B","53.17B","500.00M",null,"0.62","22.34","5.15","n/a","n/a","21,184,834","14.00","13.86","13.72 - 14.07","10.86 - 19.08","1.57","Buy","17.93 (+29.46%)","Apr 25, 2024"],["Altisource Asset Management Corporation","AAMC has historically been an asset management company that provides portfolio management and corporate governance services to investment vehicles but given the sale and discontinuance of certain operations the Company is in the process of repositioning itself.Additional information is available at www.altisourceamc.com.","United States","2012",null,"Mortgage Finance","Financials","13","Ms. Sarah  Maynard","5100 Tamarind ReefChristiansted, VI 00820Virgin Islands, U.S.","(340) 692-1055","altisourceamc.com","AAMC","NYSEAMERICAN","USD","0001555074",null,"VI02153X1080","66-0783125","6500",{"Chief Executive Officer and Chairman":"William Charles Erbey","Chief Financial Officer and Corporate Secretary":"Richard G. Roddick CPA","Director of Human Resources and Administration":"Sarah Maynard","Senior Manager of Underwriting":"Thresa Daftan"},"8.20M","3.17M","-32.55M",null,"-11.12","n/a","n/a","n/a","n/a","2,331","3.060","3.220","3.010 - 3.210","2.610 - 60.882","1.44","n/a","n/a","May 13, 2024"],["The Aaron's Company, Inc.","The Aaron's Company, Inc. provides lease-to-own and retail purchase solutions.It operates through Aaron's Business and BrandsMart segments. The company engages in direct-to-consumer sales and lease solution of furniture, appliances, electronics, computers, and other home products through company-operated and franchised stores in the United States and Canada, as well as its e-commerce platforms, including aarons.com and brandsmartusa.com.It also manufactures and supplies upholstered furniture. The company sells its products under the Aaron's, BrandsMart U.S.A., BrandsMart Leasing, and Woodhaven Furniture Industries brands.The company was formerly known as Aaron's SpinCo, Inc. The Aaron's Company, Inc. was founded in 1955 and is based in Atlanta, Georgia.","United States","1955",null,"Rental & Leasing Services","Industrials","9,071","Douglas A. Lindsay","400 Galleria Parkway Se, Suite 300Atlanta, Georgia 30339-3182United States","678-402-3000","aarons.com","AAN","NYSE","USD","0001821393",null,"US00258W1080",null,"7359",{"Chief Executive Officer and Director":"Douglas A. Lindsay","President":"Stephen W. Olsen","Executive Vice President and Chief Financial Officer":"C. Kelly Wall","EVice President, General Counsel, Secretary, Chief Compliance Officer and Chief Corporate Affairs Officer":"Rachel G. George","Executive Vice President and Chief Operating Officer of Lease-to-Own":"Russell S. Falkenstein","Principal Accounting Officer, Vice President and Corporate Controller":"Douglass L. Noe","Vice President of Corporate Communications and Investor Relations":"Michael P. Dickerson","Senior Director of Corporate Affairs":"Keith Hancock"},"218.82M","2.14B","2.82M",null,"0.09","77.22","109.23","$0.50 (7.19%)","Mar 13, 2024","128,668","6.93","6.79","6.88 - 7.05","6.69 - 16.16","1.31","Buy","10.33 (+48.63%)","May 6, 2024"],["Atlantic American Corporation","Atlantic American Corporation, through its subsidiaries, provides life and health, and property and casualty insurance products in the United States.It operates through American Southern and Bankers Fidelity segments. The company offers property and casualty insurance products, including commercial automobile insurance coverage for state governments, local municipalities, and other motor pools and fleets; general liability; and inland marine insurance products.It also provides surety bond coverage for subdivision construction; school bus contracts; and performance and payment bonds.In addition, the company offers individual and group whole life insurance products; Medicare supplement insurance products; and other accident and health insurance products comprising various individual and group policies for the payment of standard benefits for the treatment of diagnosed cancer and other critical illnesses, as well as various other products, such as short-term nursing facility care, accident only, hospital indemnity, and disability coverages.It markets its products through independent agents and brokers. The company was founded in 1937 and is based in Atlanta, Georgia.Atlantic American Corporation is a subsidiary of Atlantic American / Delta Group.","United States","1968",null,"Insurance - Life","Financials","154","Hilton Hatchett Howell Jr.","4370 Peachtree Rd NeAtlanta, Georgia 30319United States","(404) 266-5500","atlam.com","AAME","NASDAQ","USD","0000008177",null,"US0482091008","58-1027114","6311",{"Chairman of the Board, President and Chief Executive Officer":"Hilton Hatchett Howell Jr.","Vice President, Chief Financial Officer and Corporate Secretary":"Jeffrey Ross Franklin CPA","Chief Information Officer and Vice President":"John Dunbar","Vice President of Human Resources":"Barbara B. Snyder","Executive Vice President":"Ricky David Burns","Vice President and Controller":"Casey Brant Hudson"},"38.36M","186.79M","-570,000",null,"-0.03","n/a","n/a","$0.04 (2.13%)","Apr 11, 2024","1,720","1.980","1.930","1.870 - 1.980","1.490 - 3.000","0.33","n/a","n/a","Jun 28, 2024"],["AAON, Inc.","AAON, Inc., together with its subsidiaries, engages in engineering, manufacturing, marketing, and selling air conditioning and heating equipment in the United States and Canada.The company operates through three segments: AAON Oklahoma, AAON Coil Products, and BASX. It offers rooftop units, data center cooling solutions, cleanroom systems, chillers, packaged outdoor mechanical rooms, air handling units, makeup air units, energy recovery units, condensing units, geothermal/water-source heat pumps, coils, and controls.The company markets and sells its products to retail, manufacturing, educational, lodging, supermarket, data centers, medical and pharmaceutical, and other commercial industries.It sells its products through a network of independent manufacturer representative organizations and internal sales force, as well as online.The company was incorporated in 1987 and is based in Tulsa, Oklahoma.","United States","1988",null,"Building Products & Equipment","Industrials","3,856","Gary D. Fields","2425 South Yukon Ave.Tulsa, Oklahoma 74107United States","(918) 583-2266","aaon.com","AAON","NASDAQ","USD","0000824142",null,"US0003602069","87-0448736","3585",{"Chief Executive Officer and Director":"Gary D. Fields","Founder, Consultant and Director":"Norman H. Asbjornson","Vice President of Finance, Chief Financial Officer and Treasurer":"Rebecca A. Thompson","Vice President and Executive VP of AAON Oklahoma":"Stephen E. Wakefield","Vice President and President of AAON Coil Products":"Gordon D. Wichman","President and Chief Operating Officer":"Matthew Tobolski Ph.D., SE","Chief Accounting Officer":"Christopher Douglas Eason","Chief Information Officer":"Xerxes Gazder","Vice President of Administration":"Casey R. Kidwell","Director of Investor Relations":"Joseph Logan Mondillo C.F.A."},"6.44B","1.16B","179.83M",null,"2.15","36.52","33.79","$0.32 (0.41%)","Mar 15, 2024","2,031,732","87.00","90.89","76.67 - 87.23","52.24 - 96.34","0.91","Buy","n/a","May 2, 2024"],["Advance Auto Parts, Inc.","Advance Auto Parts, Inc. provides automotive replacement parts, accessories, batteries, and maintenance items for domestic and imported cars, vans, sport utility vehicles, and light and heavy duty trucks.The company offers battery accessories; belts and hoses; brakes and brake pads; chassis and climate control parts; clutches and drive shafts; engines and engine parts; exhaust systems and parts; hub assemblies; ignition components and wires; radiators and cooling parts; starters and alternators; and steering and alignment parts.It also offers air conditioning chemicals and accessories; air fresheners; antifreeze and washer fluids; electrical wires and fuses; electronics; floor mats, seat covers, and interior accessories; hand and specialty tools; lighting products; performance parts; sealants, adhesives, and compounds; tire repair accessories; vent shades, mirrors and exterior accessories; washes, waxes and cleaning supplies; and wiper blades.In addition, the company offers air filters; fuel and oil additives; fuel filters; grease and lubricants; motor oils; oil filters, part cleaners and treatments; and transmission fluids for engine maintenance.Further, it offers battery and wiper installation; engine light scanning and checking; electrical system testing, including batteries, starters, and alternators; oil and battery recycling; and loaner tool program services.Additionally, the company sells its products through its website. It serves professional installers and do-it-yourself customers.The company operates stores under the Advance Auto Parts and Carquest names, as well as branches under the Worldpac name.The company has stores in the United States, Puerto Rico, the U.S. Virgin Islands, and Canada; and independently owned Carquest branded stores in Mexico and various Caribbean Islands.Advance Auto Parts, Inc. was founded in 1929 and is based in Raleigh, North Carolina.","United States","1929",null,"Specialty Retail","Consumer Discretionary","69,000","Shane M. O'Kelly","4200 Six Forks RoadRaleigh, North Carolina 27609United States","(540) 362-4911","advanceautoparts.com","AAP","NYSE","USD","0001158449",null,"US00751Y1064","54-2049910","5531",{"Executive Vice President of Professional":"Robert B. Cushing","Executive Vice President of U.S. Stores and Independents":"Herman L. Word Jr.","President, Chief Executive Officer and Director":"Shane M. O'Kelly","Co-Founder and Chief Executive Officer of Regis Human Resources":"Carlos A. Saladrigas CPA","Executive Vice President and Chief Financial Officer":"Ryan Grimsland","Senior Vice President, Controller and Chief Accounting Officer":"Elizabeth E. Dreyer CPA","Executive Vice President and Chief Technology Officer":"Sri R. Donthi","Senior Vice President of Communications, Investor Relations, and Community Affairs":"Elisabeth L. Eisleben","Executive Vice President, General Counsel and Corporate Secretary":"Tammy Moss Finley","Executive Vice President of Human Resources and CHRO":"Kristen Soler"},"4.55B","11.29B","29.74M",null,"0.50","152.62","20.10","$1.00 (1.31%)","Apr 11, 2024","654,452","75.85","74.92","75.71 - 77.39","47.73 - 127.31","1.20","Hold","64.71 (-15.2%)","May 29, 2024"],["Apple Inc","Apple Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.The company offers iPhone, a line of smartphones; Mac, a line of personal computers; iPad, a line of multi-purpose tablets; and wearables, home, and accessories comprising AirPods, Apple TV, Apple Watch, Beats products, and HomePod.It also provides AppleCare support and cloud services; and operates various platforms, including the App Store that allow customers to discover and download applications and digital content, such as books, music, video, games, and podcasts.In addition, the company offers various services, such as Apple Arcade, a game subscription service; Apple Fitness+, a personalized fitness service; Apple Music, which offers users a curated listening experience with on-demand radio stations; Apple News+, a subscription news and magazine service; Apple TV+, which offers exclusive original content; Apple Card, a co-branded credit card; and Apple Pay, a cashless payment service, as well as licenses its intellectual property.The company serves consumers, and small and mid-sized businesses; and the education, enterprise, and government markets.It distributes third-party applications for its products through the App Store. The company also sells its products through its retail and online stores, and direct sales force; and third-party cellular network carriers, wholesalers, retailers, and resellers.Apple Inc. was founded in 1976 and is headquartered in Cupertino, California.","United States","1977","Dec 12, 1980","Consumer Electronics","Technology","161,000","Timothy D. Cook","One Apple Park WayCupertino, California 95014United States","(408) 996-1010","apple.com","AAPL","NASDAQ","USD","0000320193",null,"US0378331005","94-2404110","3571",{"Chief Executive Officer and Director":"Timothy D. Cook","Chief Financial Officer and Senior Vice President":"Luca Maestri","Chief Operating Officer":"Jeffrey E. Williams","Senior Vice President, General Counsel and Secretary":"Katherine L. Adams","Senior Vice President of Retail":"Deirdre O'Brien","Senior Director of Corporate Accounting":"Chris Kondo","Chief Technology Officer":"James Wilson","Director of Investor Relations":"Suhasini Chandramouli","Senior Vice President of Worldwide Marketing":"Greg Joswiak","Head of Corporate Development":"Adrian Perica"},"2.83T","381.62B","100.39B",null,"6.43","28.52","26.26","$1.00 (0.55%)","May 10, 2024","157,741,757","186.65","173.03","182.66 - 187.00","164.08 - 199.62","1.28","Buy","204.00 (+11.24%)","May 2, 2024"],["American Battery Technology Company","American Battery Technology Company operates as a battery materials company.The company explores for resources of battery metals, such as such as lithium, nickel, cobalt, and manganese; and develops and commercializes technologies for the extraction of battery metals, as well as commercializes integrated process for the recycling of lithium-ion batteries.The company was formerly known as American Battery Metals Corporation. American Battery Technology Company was incorporated in 2011 and is headquartered in Reno, Nevada.","United States","2011",null,"Other Industrial Metals & Mining","Materials","54","Ryan Mitchell Melsert","100 Washington Street, Suite 100Reno, Nevada 89503United States","775-473-4744","americanbatterytechnology.com","ABAT","NASDAQ","USD","0001576873",null,"US02451V3096","33-1227980","1400",{"Chief Executive Officer, Chief Technology Officer and Director":"Ryan Mitchell Melsert","Chief Financial Officer":"Jesse Samuel Deutsch","Chief Operating Officer":"Andres Meza","Chief Resource Officer":"Scott H. Jolcover A.A.","Director of Investor Relations":"Anthony Young","General Counsel and Board Secretary":"Bret Meich","Chief Geologist and Consultant":"Gregory Kuzma","Head of Resources":"Ross Leisinger","Head of Policy":"Doug Hamilton"},"75.43M","n/a","-29.23M",null,"-0.69","n/a","n/a","n/a","n/a","500,105","1.360","1.360","1.320 - 1.400","1.210 - 14.100","1.35","n/a","n/a","n/a"],["Applied Optoelectronics, Inc.","Applied Optoelectronics, Inc. designs, manufactures, and sells fiber-optic networking products in the United States, Taiwan, and China.It offers optical modules, optical filters, lasers, laser components, subassemblies, transmitters and transceivers, turn-key equipment, headend, node, distribution equipment, and amplifiers.The company sells its products to internet data center operators, cable television, telecom equipment manufacturers, fiber-to-the-home, and internet service providers through its direct and indirect sales channels.Applied Optoelectronics, Inc. was incorporated in 1997 and is headquartered in Sugar Land, Texas.","United States","1997","Sep 26, 2013","Communication Equipment","Technology","2,149","Dr. Chih-Hsiang  Lin Ph.D.","13139 Jess Pirtle BlvdSugar Land, Texas 77478United States","281-295-1800","ao-inc.com","AAOI","NASDAQ","USD","0001158114",null,"US03823U1025","76-0533927","3674",{"Founder, Chairman of the Board, President and Chief Executive Officer":"Dr. Chih-Hsiang Lin Ph.D.","Chief Financial Officer and Chief Strategy Officer":"Dr. Stefan J. Murry Ph.D.","Senior Vice President, Chief Legal and Compliance Officer and Secretary":"David C. Kuo","Senior Vice President and North America General Manager":"Dr. Hung-Lun Chang","Senior Vice President and Asia General Manager":"Shu-Hua Yeh","Investor Relations":"Lindsay Grant Savarese","Senior Vice President and GM of Broadband Access":"Todd McCrum","Vice President of Finance and Controller":"Jessica Hung"},"425.07M","217.65M","-56.05M",null,"-1.75","n/a","84.03","n/a","n/a","1,805,267","10.60","10.35","10.54 - 11.45","1.60 - 24.75","2.05","Buy","20.00 (+80.67%)","May 9, 2024"],["American Assets Trust, Inc.","American Assets Trust, Inc. is a full service, vertically integrated and self-administered real estate investment trust (REIT), headquartered in San Diego, California.The company has over 55 years of experience in acquiring, improving, developing and managing premier office, retail, and residential properties throughout the United States in some of the nation's most dynamic, high-barrier-to-entry markets primarily in Southern California, Northern California, Washington, Oregon, Texas and Hawaii.The company's office portfolio comprises approximately 4.1 million rentable square feet, and its retail portfolio comprises approximately 3.1 million rentable square feet.In addition, the company owns one mixed-use property (including approximately 94,000 rentable square feet of retail space and a 369-room all-suite hotel) and 2,110 multifamily units.In 2011, the company was formed to succeed to the real estate business of American Assets, Inc., a privately held corporation founded in 1967 and, as such, has significant experience, long-standing relationships and extensive knowledge of its core markets, submarkets and asset classes.","United States","1967","Jan 13, 2011","REIT - Diversified","Real Estate","228","Ernest Sylvan Rady","3420 Carmel Mountain Road, Suite 100San Diego, California 92121United States","(858) 350-2600","americanassetstrust.com","AAT","NYSE","USD","0001500217",null,"US0240131047",null,"6798",{"Chairman and Chief Executive Officer":"Ernest Sylvan Rady","President. Chief Operating Officer and Secretary":"Adam Wyll","Executive Vice President, Treasurer and Chief Financial Officer":"Robert F. Barton","Senior Vice President of Construction and Development":"Jerry Gammieri","Senior Vice President of Retail Properties":"Christopher E. Sullivan","Senior Vice President of Office Properties":"Steve Center"},"1.31B","444.11M","53.50M",null,"0.90","23.96","26.68","$1.34 (6.22%)","Jun 6, 2024","178,101","21.92","21.56","21.24 - 22.08","17.15 - 23.92","1.28","Hold","22.00 (+2.04%)","Apr 30, 2024"],["AbbVie Inc.","AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals worldwide.The company offers Humira, an injection for autoimmune and intestinal Behçet's diseases, and pyoderma gangrenosum; Skyrizi to treat moderate to severe plaque psoriasis, psoriatic disease, and Crohn's disease; Rinvoq to treat rheumatoid and psoriatic arthritis, ankylosing spondylitis, atopic dermatitis, axial spondyloarthropathy, ulcerative colitis, and Crohn's disease; Imbruvica for the treatment of adult patients with blood cancers; Epkinly to treat lymphoma; Elahere to treat cancer; and Venclexta/Venclyxto to treat blood cancers.It also provides facial injectables, plastics and regenerative medicine, body contouring, and skincare products; botox therapeutic; Vraylar for depressive disorder; Duopa and Duodopa to treat advanced Parkinson's disease; Ubrelvy for the acute treatment of migraine in adults; and Qulipta for episodic and chronic migraine.In addition, the company offers Ozurdex for eye diseases; Lumigan/Ganfort and Alphagan/Combigan for the reduction of elevated intraocular pressure in patients with open angle glaucoma or ocular hypertension; Restasis to increase tear production; and other eye care products.Further, it provides Mavyret/Maviret to treat chronic hepatitis C virus genotype 1-6 infection; Creon, a pancreatic enzyme therapy; Lupron to treat advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; and Synthroid for hypothyroidism.It has collaborations with Calico Life Sciences LLC; REGENXBIO Inc.; Janssen Biotech, Inc.; and Genentech, Inc., as well as collaboration with Tentarix Biotherapeutics, LP to develop conditionally-active and multi-specific biologics for oncology and immunology.The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.","United States",null,null,"Drug Manufacturers - General","Healthcare","50,000","Richard A. Gonzalez","1 North Waukegan RoadNorth Chicago, Illinois 60064United States","(847) 932-7900","abbvie.com","ABBV","NYSE","USD","0001551152",null,"US00287Y1091","32-0375147","2834",{"Chairman and Chief Executive Officer":"Richard A. Gonzalez","President and Chief Operating Officer":"Robert A. Michael","Executive Vice President and Chief Financial Officer":"Scott T. Reents","Executive Vice President and Chief Operating Officer":"Dr. Azita Saleki-Gerhardt Ph.D.","Executive Vice President and Chief Commercial Officer":"Jeffrey Ryan Stewart","Senior Vice President and Chief Scientific Officer of Global Research":"Dr. Thomas J. Hudson M.D.","Senior Vice President of Investor Relations":"Elizabeth Shea","Executive Vice President, General Counsel and Secretary":"Perry C. Siatis","Senior Vice President, Chief Ethics, Compliance Officer and Allergan Aesthetic Legal":"Sanjay Narayan","Executive Vice President and Chief Human Resources Officer":"Timothy J. Richmond"},"290.01B","54.40B","5.99B",null,"3.37","48.60","16.70","$6.20 (3.79%)","Apr 12, 2024","3,983,972","161.16","160.81","160.74 - 164.25","130.96 - 182.89","0.56","Buy","182.18 (+11.23%)","Apr 26, 2024"],["Abeona Therapeutics Inc.","Abeona Therapeutics Inc., a clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening diseases.Its lead clinical program is EB-101, an autologous, engineered cell therapy that is in Phase III clinical trial for recessive dystrophic epidermolysis bullosa.The company develops ABO-503 for the treatment of X-linked retinoschisis; ABO-504 for the treatment of stargardt disease; and ABO-505 for the treatment of autosomal dominant optic atrophy.In addition, it is developing AAV-based gene therapy through its AIM vector platform programs. The company was formerly known as PlasmaTech Biopharmaceuticals, Inc. and changed its name to Abeona Therapeutics Inc. in June 2015.Abeona Therapeutics Inc. is headquartered in Cleveland, Ohio.","United States",null,"Sep 19, 1980","Biotechnology","Healthcare","84","Dr. Vishwas  Seshadri M.B.A., Ph.D.","6555 Carnegie Ave, 4th FloorCleveland, Ohio 44103United States","646-813-4701","abeonatherapeutics.com","ABEO","NASDAQ","USD","0000318306",null,"US00289Y2063","83-0221517","2834",{"President, Chief Executive Officer and Director":"Dr. Vishwas Seshadri M.B.A., Ph.D.","Chief Financial Officer":"Joseph Walter Vazzano CPA","Senior Vice President and General Counsel":"Dr. Brendan M. O'Malley J.D., Ph.D.","Senior Vice President, Chief Technology Officer and CSO":"Brian Kevany Ph.D.","Vice President of Investor Relations and Corporate Communications":"Gregory Gin","Vice President of Human Resources":"Alison Hardgrove","Vice President and Head of Quality":"Jon Voss","Chief Medical Officer":"Dmitriy Grachev M.D., Ph.D.","Senior Vice President, Chief Commercial Officer and Head of Business Development":"Dr. Madhav Vasanthavada M.B.A., Ph.D.","Senior Vice President of Regulatory Affairs":"Carl Denny"},"125.83M","3.50M","-54.19M",null,"-2.53","n/a","n/a","n/a","n/a","2,683,582","4.350","4.070","4.340 - 5.110","2.830 - 9.010","1.48","Strong Buy","28.00 (+508.7%)","May 13, 2024"],["Asbury Automotive Group, Inc.","Asbury Automotive Group, Inc., together with its subsidiaries, operates as an automotive retailer in the United States.It offers a range of automotive products and services, including new and used vehicles; and vehicle repair and maintenance services, replacement parts, and collision repair services.The company also provides finance and insurance products, including arranging vehicle financing through third parties; and aftermarket products, such as extended service contracts, guaranteed asset protection debt cancellation, prepaid maintenance, and disability and accident insurance.Asbury Automotive Group, Inc. was founded in 1996 and is based in Duluth, Georgia.","United States","1996",null,"Auto & Truck Dealerships","Consumer Discretionary","15,000","David W. Hult","2905 Premiere Parkway Nw, Suite 300Duluth, Georgia 30097United States","770-418-8200","asburyauto.com","ABG","NYSE","USD","0001144980",null,"US0434361046","01-0609375","5500",{"President, Chief Executive Officer and Director":"David W. Hult","Senior Vice President and Chief Financial Officer":"Michael D. Welch","Senior Vice President of Operations":"Daniel Clara","Senior Vice President, Chief Legal Officer and Secretary":"George A. Villasana","Senior Vice President and Chief Human Resources Officer":"Jed M. Milstein","Vice President, Chief Accounting Officer and Controller":"Nathan Edward Briesemeister","Chief Information Officer and Vice President":"Barry Cohen","Senior Vice President of Strategy and Innovation":"Miran Maric","Vice President- Corporate FP&A and Treasurer":"Karen Reid"},"4.31B","15.42B","568.20M",null,"27.57","7.75","6.65","n/a","n/a","177,682","211.91","208.45","211.03 - 215.30","178.40 - 256.39","1.16","Hold","208.33 (-2.54%)","Apr 25, 2024"],["ARCA biopharma, Inc.","ARCA biopharma, Inc., a clinical stage biopharmaceutical company, engages in the development and commercialization of targeted therapies for cardiovascular diseases.Its lead product candidate is Gencaro, a pharmacogenetically-targeted beta-adrenergic receptor antagonist that has completed Phase IIb trial for the treatment of atrial fibrillation in patients with heart failure.It is developing Recombinant Nematode Anticoagulant Protein c2, a protein therapeutic that is in Phase IIb clinical trial for the treatment for COVID-19.The company has a collaboration agreement with LabCorp to develop genetic test for GENETIC-AF clinical trial.ARCA biopharma, Inc. is headquartered in Westminster, Colorado.","United States",null,null,"Biotechnology","Healthcare","4","Thomas A. Keuer","10170 Church Ranch Way, Suite 100Westminster, Colorado 80021United States","(720) 940-2200","arcabio.com","ABIO","NASDAQ","USD","0000907654",null,"US00211Y5069","36-3855489","2835",{"Co-Founder, President, Chief Executive Officer and Director":"Dr. Michael R. Bristow M.D., Ph.D.","Chief Financial Officer, Treasurer and Company Secretary":"C. Jeffrey Dekker CPA","Chief Operating Officer":"Thomas A. Keuer"},"47.29M","n/a","-6.00M",null,"-0.42","n/a","n/a","n/a","n/a","16,801","3.300","3.260","3.250 - 3.460","1.560 - 3.880","1.21","n/a","n/a","Apr 25, 2024"],["Abacus Life, Inc.","Abacus Life, Inc. operates as an alternative asset manager specializing in life insurance products.It purchases life insurance policies from consumers seeking liquidity and manages policies over time via trading, holding, and/or servicing.The company was founded in 2004 and is based in Orlando, Florida.","United States","2004",null,"Insurance - Life","Financials","102","Todd  McNealy","2101 Park Center Drive, Suite 200Orlando, Florida 32835United States","(800) 561-4148","abacuslife.com","ABL","NASDAQ","USD","0001814287",null,"US00258Y1047","85-1210472","6282",{"Chief Executive Officer, President and Chairman":"Jay Jackson","Co-Founder, President, Managing Partner and Director":"Todd McNealy","Chief Financial Officer":"William Hugh McCauley Jr.","Co-Founder, President and Managing Partner":"Kevin Scott Kirby","Managing Director of Operations and Human Resources":"Krissy Lubrano","General Counsel":"Christopher David Romaine","Vice President of Marketing":"Jeff Smith","Managing Director of Sales":"Stuart Little","Managing Director":"Nick Sawuk"},"770.88M","66.40M","9.52M",null,"0.16","75.06","n/a","n/a","n/a","18,998","11.65","11.88","11.64 - 12.11","5.47 - 13.25","0.18","n/a","n/a","May 13, 2024"],["Able View Inc.","Able View Global Inc. operates as brand management partners of beauty and personal care brands in China.Its brand management services encompass various segments of the brand management value chain, including strategy, branding, digital and social marketing, omni-channel sales, customer service, overseas logistics, warehouse, and fulfilment.The company was founded in 2015 and is based in Shanghai, China.",null,null,null,null,null,null,null,"511 Weihai Road, Room 1803Shanghai, F4 200041China","86-185-0177-0425","ableview.com","ABLV","NASDAQ","USD","0001957489",null,"KYG1149B1086",null,"5960",{"112":"Employees","2015":"Founded","China":"Country","Advertising Agencies":"Industry","Communication Services":"Sector","Jian  Zhu":"CEO","Chief Executive Officer and Chairman":"Jian Zhu","Chief Financial Officer and Director":"Jing Tang"},"60.30M","149.00M","9.44M",null,"0.24","6.00","n/a","n/a","n/a","736","1.480","1.530","1.440 - 1.480","1.182 - 4.150","n/a","n/a","n/a","n/a"],["ABM Industries Incorporated","ABM Industries Incorporated, through its subsidiaries, engages in the provision of integrated facility, infrastructure, and mobility solutions in the United States and internationally.It operates through Business & Industry, Manufacturing & Distribution, Education, Aviation, and Technical Solutions segments.The company offers janitorial, facilities engineering, and parking services for commercial real estate properties, including corporate offices for high tech clients, sports and entertainment venues, and traditional hospitals and non-acute healthcare facilities; provides vehicle maintenance and other services to rental car providers.It also offers integrated facility services, engineering, and other specialized services in various types of manufacturing, distribution, and data center facilities.In addition, the company delivers custodial and landscaping and grounds for public school districts, private schools, colleges, and universities.Further, it supports airlines and airports with services comprising passenger assistance, catering logistics, air cabin maintenance, and transportation services.Additionally, the company provides electric vehicle power design, installation, and maintenance, as well as microgrid systems installations.ABM Industries Incorporated was founded in 1909 and is headquartered in New York, New York.","United States","1909",null,"Specialty Business Services","Industrials","123,000","Scott B. Salmirs","One Liberty Plaza, 7th FloorNew York, New York 10006United States","212 297-0200","abm.com","ABM","NYSE","USD","0000771497",null,"US0009571003","94-1369354","7340",{"President, Chief Executive Officer and Director":"Scott B. Salmirs","Executive Vice President and Chief Financial Officer":"Earl Ray Ellis","Executive Vice President and Chief Operating Officer":"Rene Jacobsen","Executive Vice President, General Counsel and Corporate Secretary":"Andrea R. Newborn Esq.","Executive Vice President and Chief Strategy and Transformation Officer":"Joshua H. Feinberg","Senior Vice President, Chief Accounting Officer, Corporate Controller and Treasurer":"Dean A. Chin","Chief Information Officer":"Melanie Kirkwood Ruiz","Senior Vice President of Investor Relations":"Paul E. Goldberg","Chief Culture and Communication Officer":"Nadeen A. Ayala","Chief Marketing Officer":"Cary Bainbridge"},"2.83B","8.17B","257.50M",null,"3.91","11.45","13.59","$0.90 (2.01%)","Apr 3, 2024","135,100","45.26","44.84","44.32 - 45.26","37.61 - 53.05","1.15","Hold","45.20 (+0.96%)","Jun 4, 2024"],["Airbnb, Inc.","Airbnb, Inc., together with its subsidiaries, operates a platform that enables hosts to offer stays and experiences to guests worldwide.The company's marketplace connects hosts and guests online or through mobile devices to book spaces and experiences.It primarily offers private rooms, primary homes, and vacation homes. The company was formerly known as AirBed & Breakfast, Inc. and changed its name to Airbnb, Inc. in November 2010.Airbnb, Inc. was founded in 2007 and is headquartered in San Francisco, California.","United States","2008","Dec 10, 2020","Travel Services","Consumer Discretionary","6,907","Brian  Chesky","888 Brannan St.San Francisco, California 94103United States","415.800.5959","airbnb.com","ABNB","NASDAQ","USD","0001559720",null,"US0090661010","26-3051428","7340",{"Co-Founder, Chief Executive Officer, Head of Community and Chairman of the Board":"Brian Chesky","Co-Founder, Chief Strategy Officer and Director":"Nathan Blecharczyk","Chief Technology Officer":"Dr. Aristotle N. Balogh","Chief Business Officer and Head of Employee Experience":"David E. Stephenson","Executive Officer":"Catherine Powell","Co-Founder, Chairman of Airbnb.org. and Director":"Joseph Gebbia","Chief Financial Officer":"Elinor B. Mertz","Global Head of Operations":"Tara Lynn Bunch","Chief Accounting Officer":"David C. Bernstein","Chief Legal Officer":"Ronald A. Klain J.D."},"102.94B","9.92B","4.79B",null,"7.24","22.06","36.14","n/a","n/a","4,525,177","161.81","158.33","159.15 - 165.50","103.55 - 170.10","1.25","Hold","144.74 (-9.37%)","May 8, 2024"],["Acumen Pharmaceuticals, Inc.","Acumen Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops targeted therapies for the treatment of Alzheimer's disease.The company focuses on advancing a targeted immunotherapy drug candidate sabirnetug (ACU193), a recombinant humanized immunoglobulin gamma 2 that completed Phase I clinical trial to target soluble amyloid-beta oligomers.The company has a license agreement with Lonza Sales AG to manufacture and commercialize sabirnetug; and a collaboration and license agreement with Halozyme, Inc. for the development of a subcutaneous formulation of sabirnetug.Acumen Pharmaceuticals, Inc. was incorporated in 1996 and is headquartered in Charlottesville, Virginia.","United States","1996","Jul 1, 2021","Biotechnology","Healthcare","51","Daniel J. O'Connell M.B.A.","427 Park St.Charlottesville, Virginia 22902United States","925-368-8508","acumenpharm.com","ABOS","NASDAQ","USD","0001576885",null,"US00509G2093","36-4108129","2836",{"Chief Executive Officer and Director":"Daniel J. O'Connell M.B.A.","Chief Financial Officer and Chief Business Officer":"Matt Zuga","Chief Legal Officer and Corporate Secretary":"Derek M. Meisner Esq., J.D.","President and Chief Development Officer":"Dr. James Doherty Ph.D.","Co-Founder":"Dr. William L. Klein Ph.D.","Chief Operating Officer":"Russell Barton M.S.","Vice President, Finance and Accounting and Corporate Controller":"Kelly Carranza","Vice President and Head of Investor Relations":"Alex Braun M.B.A."},"209.68M","n/a","-52.37M",null,"-1.08","n/a","n/a","n/a","n/a","247,526","3.580","3.480","3.485 - 3.710","1.810 - 11.310","0.08","Strong Buy","12.60 (+261.03%)","May 14, 2024"],["Arbor Realty Trust, Inc.","Arbor Realty Trust, Inc. invests in a diversified portfolio of structured finance assets in the multifamily, single-family rental, and commercial real estate markets in the United States.The company operates through Structured Business and Agency Business segments. It primarily invests in bridge and mezzanine loans, including junior participating interests in first mortgages, and preferred and direct equity, as well as real estate-related joint ventures, real estate-related notes, and various mortgage-related securities.In addition, the company offers bridge financing products to borrowers who seek short-term capital to be used in an acquisition of property; financing by making preferred equity investments in entities that directly or indirectly own real property; mezzanine financing in the form of loans that are subordinate to a conventional first mortgage loan and senior to the borrower's equity in a transaction; junior participation financing in the form of a junior participating interest in the senior debt; and financing products to borrowers who are looking to acquire conventional, workforce, and affordable single-family housing.Further, it underwrites, originates, sells, and services multifamily mortgage loans through conduit/commercial mortgage-backed securities programs.The company qualifies as a real estate investment trust for federal income tax purposes. It generally would not be subject to federal corporate income taxes if it distributes at least 90% of its taxable income to its stockholders.Arbor Realty Trust, Inc. was incorporated in 2003 and is headquartered in Uniondale, New York.","United States","2003","Apr 7, 2004","REIT - Mortgage","Real Estate","647","Ivan Paul Kaufman","333 Earle Ovington Boulevard, Suite 900Uniondale, New York 11553United States","516-506-4200","arbor.com","ABR","NYSE","USD","0001253986",null,"US0389231087","20-0057959","6798",{"Chairman, President and Chief Executive Officer":"Ivan Paul Kaufman","Executive Vice President and Chief Financial Officer":"Paul Anthony Elenio","Executive Vice President and MD of Structured Finance and Principal Transactions":"Fredric G. Weber","Executive Vice President and Chief Operating Officer":"John G. Caulfield","Executive Vice President of Structured Securitization":"Gene Kilgore","Senior Vice President of Operations":"Sean Coon","Chief Investment Officer and Executive Vice President of Residential Financing":"Steven Katz","MD and Chief Accounting Officer":"Thomas J. Ridings Jr., CPA","Executive Vice President and Chief Technology Officer":"Howard Leiner","Senior Vice President":"Lee Roth"},"2.43B","699.99M","303.62M",null,"1.60","8.06","7.46","$1.72 (13.34%)","May 16, 2024","6,957,516","13.40","13.08","12.70 - 13.64","11.06 - 17.74","1.95","Hold","14.71 (+14.12%)","May 3, 2024"],["Absci Corporation","Absci Corporation operates as a data-first generative artificial intelligence (AI) drug creation company in the United States.The company combines AI with scalable wet lab technologies to create biologics for patients. Its integrated drug creation platform is designed to improve upon traditional biologic drug discovery by using AI to simultaneously optimize multiple drug characteristics that may be important to development and therapeutic benefit.The company was founded in 2011 and is headquartered in Vancouver, Washington.","United States","2011","Jul 22, 2021","Biotechnology","Healthcare","155","Sean  McClain","18105 Se Mill Plain BlvdVancouver, Washington 98683United States","(360) 949-1041","absci.com","ABSI","NASDAQ","USD","0001672688",null,"US00091E1091","85-3383487","8731",{"Founder, Chief Executive Officer, President and Director":"Sean McClain","Chief Business Officer and Chief Financial Officer":"Dr. Zachariah Jonasson Ph.D.","Chief Innovation Officer and Member of Scientific Advisory Board":"Dr. Andreas Busch Ph.D.","Senior Vice President and Chief Accounting Officer":"Todd Bedrick CPA","Vice President of Finance and Head of Investor Relations":"Alexander Khan CPA","Chief People Officer":"Karin Wierinck","Chief of Staff":"Wen Sha","Senior Vice President of Biologics Discovery Technology":"Jens Plassmeier Ph.D.","Senior Vice President of Portfolio and Growth Strategy":"Dr. Christine Lemke D.V.M., M.B.A., Ph.D."},"574.46M","5.72M","-110.57M",null,"-1.20","n/a","n/a","n/a","n/a","532,377","5.22","4.98","5.06 - 5.44","1.11 - 6.72","2.37","Strong Buy","10.20 (+100.79%)","May 14, 2024"],["Abbott Laboratories","Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide.It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices.The company provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon.It also offers laboratory and transfusion medicine systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics polymerase chain reaction instrument systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detect and measure infectious agents; point of care systems; cartridges for testing blood gas, chemistry, electrolytes, coagulation, and immunoassay; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for laboratories.In addition, the company provides pediatric and adult nutritional products; rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; diabetes care products, such as glucose and blood glucose monitoring systems; and neuromodulation devices for the management of chronic pain and movement disorders.Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois.","United States","1888",null,"Medical Devices","Healthcare","114,000","Robert B. Ford","100 Abbott Park RoadAbbott Park, Illinois 60064-3500United States","(224) 667-6100","abbott.com","ABT","NYSE","USD","0000001800",null,"US0028241000","36-0698440","2834",{"Chairman of the Board, President and Chief Executive Officer":"Robert B. Ford","Chief Financial Officer and Senior Vice President of Finance":"Philip P. Boudreau","Executive Vice President, General Counsel and Secretary":"Hubert L. Allen","Executive Vice President of Finance":"Robert E. Funck Jr.","Executive Vice President and Group President of Established Pharmaceuticals and Nutritional Products":"Daniel Gesua Sive Salvadori","Executive Vice President and Group President of Medical Devices":"Lisa D. Earnhardt","Senior Vice President of Business and Technology Services and Chief Information Officer":"Sabina Ewing","Vice President and Chief Ethics and Compliance Officer":"Erica L. Battaglia","Vice President of Public Affairs and Corporate Marketing":"Melissa Brotz","Senior Vice President of Commercial Operations, Marketing and Diabetes Care":"Christopher J. Scoggins"},"183.76B","40.33B","5.63B",null,"3.21","32.99","22.08","$2.20 (2.08%)","Apr 12, 2024","2,660,338","106.11","105.92","105.48 - 106.64","89.67 - 121.64","0.74","Buy","123.50 (+16.62%)","Apr 17, 2024"],["Abits Group Inc.","Abits Group Inc., a digital company, engages in the provision of bitcoin mining and related services in the United States.The company was formerly known as Moxian (BVI) Inc and changed its name to Abits Group Inc. in November 2023.Abits Group Inc. was incorporated in 2021 and is based in Tsim Sha Tsui, Hong Kong.","Hong Kong","2010",null,"Capital Markets","Financials","12","Wanhong  Tan","Unit 911, Tower 2, Silvercord, 30 Canton Road, TsimshatsuiHong Kong Sar, F4 2299 1110China","852 2961 4888","abitsgroup.com","ABTS","NASDAQ","USD","0001864055",null,"VGG6S34K1052",null,"6199",{"Chief Executive Officer and Director":"Conglin Deng","Chief Financial Officer and Board Secretary":"Wanhong Tan","Vice President of Creative and Marketing":"Boon Hock Ooi","Vice President of Corporate Affairs":"Zhongwen Chen"},"27.73M","1.68M","-12.61M",null,"-0.36","n/a","n/a","n/a","n/a","2,872","0.770","0.759","0.750 - 0.780","0.565 - 1.800","n/a","n/a","n/a","May 27, 2024"],["Arbutus Biopharma Corporation","Arbutus Biopharma Corporation, a biopharmaceutical company, develops novel therapeutics for chronic Hepatitis B virus (HBV) infection in the United States.Its HBV product pipeline consists of imdusiran (AB-729), a proprietary subcutaneously-delivered RNAi therapeutic product candidate that suppresses all HBV antigens, including HBsAg expression.The company's research and development programs include AB-101, an oral PD-L1 inhibitor to reawaken patients' HBV-specific immune system; and small molecule antiviral medicines to treat coronaviruses, including COVID-19.It has licensing agreements with Gritstone Oncology, Inc; Alnylam Pharmaceuticals, Inc.; Qilu Pharmaceuticals Co, Ltd; Assembly Biosciences, Inc.; Acuitas Therapeutics, Inc.; and Antios Therapeutics, Inc. Arbutus Biopharma Corporation also has a clinical collaboration agreement with Barinthus Biotherapeutics plc to evaluate VTP-300.The company was formerly known as Tekmira Pharmaceuticals Corporation and changed its name to Arbutus Biopharma Corporation in July 2015.Arbutus Biopharma Corporation is headquartered in Warminster, Pennsylvania.","United States",null,null,"Biotechnology","Healthcare","73","Michael J. McElhaugh","701 Veterans CircleWarminster, Pennsylvania 18974United States","604-419-3200","arbutusbio.com","ABUS","NASDAQ","USD","0001447028",null,"CA03879J1003","98-0597776","2834",{"Co-Founder, Interim President, Chief Executive Officer and Director":"Michael J. McElhaugh","Chief Scientific Officer":"Dr. Michael J. Sofia Ph.D.","Chief Financial Officer and Chief Accounting Officer":"David C. Hastings CPA","Vice President of Investor Relations":"Lisa M. Caperelli","General Counsel, Chief Compliance Officer and Secretary":"J. Christopher Naftzger BA, Esq., J.D.","Vice President of Human Resources":"Shannon Briscoe SPHR","Chief Medical Officer":"Dr. Karen Sims M.D., Ph.D.","Corporate Secretary":"R. Hector Mackay-Dunn B.A., J.D., L.L.B., Q.C."},"488.27M","12.99M","-74.39M",null,"-0.44","n/a","n/a","n/a","n/a","676,880","2.710","2.680","2.700 - 2.850","1.690 - 3.290","2.09","Strong Buy","4.33 (+59.78%)","May 2, 2024"],["ABVC BioPharma, Inc.","ABVC BioPharma, Inc., a clinical stage biopharmaceutical company, develops drugs and medical devices to fulfill unmet medical needs in the United States.The company is developing ABV-1501, which is in Phase II clinical trials a combination therapy for triple negative breast cancer; ABV-1504 has completed Phase II clinical trials for major depressive disorders; ABV-1505, which is in Phase II clinical trials for adult attention deficit hyperactivity disorder; ABV-1703, which is in Phase II clinical trials for the treatment of metastatic pancreatic cancer; ABV-1702, which is in Phase II clinical trials to treat myelodysplastic syndromes; and ABV-1601 that is in Phase I/II clinical trials for treating depression in cancer patients.It is also developing ABV-1701 Vitargus that is in Phase II clinical trials for the treatment of retinal detachment or vitreous hemorrhage; and ABV-1519, which is in Phase I/II clinical trials for the treatment of non-small cell lung cancer.ABVC BioPharma, Inc. has a co-development agreement with Rgene Corporation; and collaboration agreements with BioHopeKing Corporation and BioFirst Corporation.The company is based in Fremont, California. ABVC BioPharma, Inc. operates as a subsidiary of YuanGene Corporation.","United States","2015",null,"Biotechnology","Healthcare","16","Dr. Uttam Yashwant Patil Ph.D.","44370 Old Warm Springs Blvd.Fremont, California 94538United States","510-668-0881","abvcpharma.com","ABVC","NASDAQ","USD","0001173313",null,"US00091F3047","26-0014658","2834",{"Chairman and Chief Business Officer":"Eugene Jiang","Chief Executive Officer":"Dr. Uttam Yashwant Patil Ph.D.","Chief Financial Officer and Principal Accounting Officer":"Leeds Chow","Chief Scientific Officer, Chief Strategy Officer and Director":"Dr. Tsung-Shann Jiang EMBA, Ph.D."},"11.41M","152,430","-10.52M",null,"-2.43","n/a","n/a","n/a","n/a","413,022","1.150","1.150","1.070 - 1.150","0.674 - 9.600","0.77","n/a","n/a","May 13, 2024"],["Abivax SA","ABIVAX Société Anonyme, a clinical-stage biotechnology company, focuses on developing therapeutics that harness the body's natural regulatory mechanisms to stablize the immune response in patients with chronic inflammatory diseases.The company is evaluating its lead drug candidate, obefazimod, in Phase 3 clinical trials for the treatment of moderately to severely active ulcerative colitis in adults.ABIVAX Société Anonyme was incorporated in 2013 and is headquartered in Paris, France.","United States","2013",null,"Biotechnology","Healthcare","61","Marc M. P. de Garidel M.B.A.","7 Bd HaussmannParis, I0 75009France","01 53 83 09 63","abivax.com","ABVX","NASDAQ","USD","0001956827",null,"US00370M1036",null,"2834",{"Chief Executive Officer and Interim Chair of Board":"Marc M. P. de Garidel M.B.A.","Founder and Director":"Dr. Philippe Pouletty M.D., Ph.D.","EVice President, Chief Financial Officer and Board Secretary":"Didier Blondel","Chief Scientific Officer":"Didier Scherrer Ph.D.","Senior Vice President of Investor Relations":"Patrick Malloy","Chief People Officer":"Ida Hatoum","Chief Business Officer":"Pierre Courteille M.B.A.","Executive Vice President of Process Development and Manufacturing":"Jérôme Denis","Chief Medical Officer":"Sheldon Sloan M.D.","Chief Commercial Officer":"Michael Ferguson B.S., M.B.A."},"914.82M","5.13M","-164.16M",null,"-3.69","n/a","n/a","n/a","n/a","30,239","14.88","14.92","14.32 - 15.10","8.00 - 17.02","1.37","Buy","18.00 (+23.8%)","Apr 2, 2024"],["Associated Capital Group, Inc.","Associated Capital Group, Inc., together with its subsidiaries, provides investment advisory services in the United States.The company offers alternative investment management services; and operates a direct investment business.It also invests in new and existing businesses. The company was founded in 1976 and is headquartered in Greenwich, Connecticut.Associated Capital Group, Inc. operates as a subsidiary of GGCP Holdings LLC.","United States","1976",null,"Asset Management","Financials","25","Douglas Richard Jamieson","191 Mason StreetGreenwich, Connecticut 06830United States","914-921-5135","associated-capital-group.com","AC","NYSE","USD","0001642122",null,"US0455281065",null,"6211",{"Executive Chairman of the Board":"Mario Joseph Gabelli C.F.A.","President, Chief Executive Officer and Director":"Douglas Richard Jamieson","Chief Financial Officer":"Ian J. McAdams","Executive Vice President, Chief Legal Officer and Secretary":"Peter D. Goldstein Esq.","Executive Director":"Marc Joseph Gabelli","General Counsel and Director of Corporate Development":"David Marc Goldman"},"696.50M","12.68M","37.45M",null,"1.72","18.74","n/a","$0.20 (0.62%)","Nov 30, 2023","3,720","31.75","32.35","31.12 - 32.41","31.12 - 40.55","0.90","n/a","n/a","May 14, 2024"],["Arcosa, Inc.","Arcosa, Inc., together with its subsidiaries, provides infrastructure-related products and solutions for the construction, engineered structures, and transportation markets in the United States.It operates through three segments: Construction Products, Engineered Structures, and Transportation Products.The Construction Products segment offers natural and recycled aggregates; specialty materials; and construction site support equipment, including trench shields and shoring products for residential and non-residential construction, and specialty/other products, as well as for infrastructure construction.The Engineered Structures segment offers utility structures, wind towers, traffic structures, and telecommunication structures for electricity transmission and distribution, wind power generation, highway road construction, and wireless communication markets.The Transportation Products segment offers inland barges, fiberglass barge covers, winches, marine hardware, and steel components for railcars and transportation equipment; cast components for industrial and mining sectors; and axles, circular forgings, and coupling devices for freight, tank, locomotive, and passenger rail transportation equipment, as well as other industrial uses.Arcosa, Inc. was incorporated in 2018 and is headquartered in Dallas, Texas.","United States",null,null,"Engineering & Construction","Industrials","6,075","Ms. Gail M. Peck","500 N. Akard Sreet, Suite 400Dallas, Texas 75201United States","972-942-6500","arcosa.com","ACA","NYSE","USD","0001739445",null,"US0396531008","82-5339416","3440",{"President, Chief Executive Officer and Director":"Antonio Carrillo","Chief Financial Officer":"Gail M. Peck","Chief Legal Officer":"Bryan P. Stevenson","Group President":"Jesse E. Collins Jr.","Principal Accounting Officer and Corporate Controller":"Eric D. Hurst","Senior Vice President of Corporate Administration":"Mary E. Henderson","Director of Investor Relations":"Erin Drabek","Chief Human Resources Officer":"Suzanne M. Myers"},"4.14B","2.36B","142.70M",null,"2.92","29.22","24.15","$0.20 (0.23%)","Apr 12, 2024","480,814","80.43","77.60","79.19 - 86.48","61.98 - 89.07","0.66","Strong Buy","90.00 (+5.47%)","May 2, 2024"],["Atlantic Coastal Acquisition Corp. II","Atlantic Coastal Acquisition Corp. II does not have significant operations.It focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, recapitalization, reorganization, or similar business combination with one or more businesses in financial services industry and mobility sector.The company was incorporated in 2021 and is based in New York, New York. Atlantic Coastal Acquisition Corp. II is a subsidiary of Atlantic Coastal Acquisition Management II LLC.","United States","2021","Jan 14, 2022","Shell Companies","Financials","4","Shahraab  Ahmad","6 St Johns Lane, Floor 5New York, New York 10013United States","248-890-7200","atlanticcoastalacquisition.com","ACAB","NASDAQ","USD","0001893219",null,"US04845A1088","87-1013956","2836",{"Chief Executive Officer and Chairman of the Board":"Shahraab Ahmad","President and Director":"Burt R. Jordan","Chief Financial Officer and Director":"Jason Chryssicas","Chief Strategy Officer and Director":"Anthony D. Eisenberg"},"87.96M","n/a","3.98M",null,"0.11","99.18","n/a","n/a","n/a","100","10.77","10.91","10.77 - 10.91","10.29 - 11.40","-0.01","n/a","n/a","n/a"],["Acri Capital Acquisition Corporation","Acri Capital Acquisition Corporation does not have significant operations.The company focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or other business combination with one or more businesses.It intends to acquire companies in the technology-enabled sectors, including e-commerce, financial services, educational technology services, or health information service in North America.The company was incorporated in 2022 and is based in Austin, Texas.","United States","2022","Jun 10, 2022","Shell Companies","Financials",null,"Ms. Yi  Hua","13284 Pond Spring Rd, Ste 405Austin, Texas 78729United States","(512) 666-1277",null,"ACAC","NASDAQ","USD","0001914023",null,"US00501A1016","87-4328187","6770",{"Chairwoman, Chief Executive Officer and Chief Financial Officer":"Yi Hua"},"60.93M","n/a","581,527",null,"-4.22","n/a","n/a","n/a","n/a","27,315","11.25","11.20","11.20 - 11.26","9.88 - 11.49","n/a","n/a","n/a","n/a"],["ACADIA Pharmaceuticals Inc.","ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization innovative medicines that address unmet medical needs in central nervous system (CNS) disorders and rare diseases in the United States.The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis; and DAYBUE, a novel synthetic analog of the amino-terminal tripeptide of insulin-like growth factor 1 for treatment of Rett Syndrome.It also develops Pimavanserin that is in Phase III ADVANCE-2 study to treat the negative symptoms of schizophrenia; ACP-101 whixh is in Phase III for the treatment of hyperphagia in Prader-Willi syndrome; ACP-204 which is in Phase II for the treatment of Alzheimer's disease psychosis; ACP-2591 that is in Phase I for Rett syndrome and Fragile X syndrome; preclinical antisense oligonucleotide programs; and other programs for neuropsychiatric symptoms.It has a license agreement with Neuren Pharmaceuticals Limited to develop and commercialize trofinetide for Rett syndrome and other indications; and a license and collaboration agreement with Stoke Therapeutics, Inc. to discover, develop and commercialize novel RNA-based medicines for the potential treatment of severe and rare genetic neurodevelopmental diseases of the CNS.The company was formerly known as Receptor Technologies, Inc. and changed its name ACADIA Pharmaceuticals Inc. in 1997.ACADIA Pharmaceuticals Inc. was incorporated in 1993 and is headquartered in San Diego, California.","United States","1993","May 27, 2004","Biotechnology","Healthcare","598","Stephen R. Davis J.D.","12830 El Camino Real, Suite 400San Diego, California 92130United States","858-558-2871","acadia-pharm.com","ACAD","NASDAQ","USD","0001070494",null,"US0042251084","06-1376651","2834",{"President, Chief Executive Officer and Director":"Stephen R. Davis J.D.","Executive Vice President and Chief Financial Officer":"Mark C. Schneyer","Executive Vice President, Chief Operating Officer and Head of Commercial":"Brendan P. Teehan","Vice President, Chief Accounting Officer and Corporate Controller":"James K. Kihara","Executive Vice President and Head of Research and Development":"Dr. Elizabeth H.Z. Thompson Ph.D.","Senior Vice President of Technical Development and Operations":"Benir Ruano","Senior Vice President of Investor Relations and Corporate Communications":"Albert S. Kildani","Executive Vice President, Chief Legal Officer and Secretary":"Jennifer J. Rhodes J.D.","Senior Vice President of Marketing and Commercial Strategy":"Julie Fisher","Senior Vice President and Head of Sales":"Holly Valdiviez"},"2.82B","726.44M","-61.29M",null,"-0.37","n/a","25.38","n/a","n/a","1,118,864","17.44","17.08","17.03 - 17.58","16.16 - 33.99","0.39","Buy","30.90 (+81.23%)","May 8, 2024"],["Aurora Cannabis Inc.","Aurora Cannabis Inc., together with its subsidiaries, produces, distributes, and sells cannabis and cannabis-derivative products in Canada and internationally.It operates through three segments: Canadian Cannabis, European Cannabis, and Plant Propagation. The company produces, distributes, and sells medical and consumer cannabis products in Canada.It is also involved in the distribution of wholesale medical cannabis in the European Union (EU); distribution of wholesale medical cannabis in various international markets, including Australia, the Caribbean, South America, and Israel; supply of propagated vegetables and ornamental plants in North America; and distribution and sale of hemp-derived cannabidiol (CBD) products.In addition, the company cultivates and sells dried cannabis, cannabis oils, capsules, edible cannabis, cannabis extracts, and soft gels, which are ingested in various ways, including smoking, vaporizing, and consumption in the form of oil, capsules, edibles, and extracts; and provides dried flowers, vapes, dried milled strains, strain-specific extracts, strain specific cannabis oils, and concentrates.Further, it offers recreational cannabis products, such as flowers, vapes, ingestibles, concentrates, extracts, and CBD products; and patient counseling and outreach services.The company's adult-use brand portfolio includes Aurora Drift, San Rafael '71, Daily Special, Whistler, Being, and Greybeard, as well as CBD brands, Reliva and KG7; and medical cannabis brands include MedReleaf, CanniMed, Aurora, Whistler Medical Marijuana Co, Pedanios, Bidiol, and CraftPlant.Aurora Cannabis Inc. is headquartered in Edmonton, Canada.","Canada",null,null,"Drug Manufacturers - Specialty & Generic","Healthcare","1,130","Miguel  Martin","2207 90b Street SwEdmonton, A0 T6X 1V8Alberta, Canada","604-362-5207","auroramj.com","ACB","NASDAQ","USD","0001683541",null,"CA05156X8504",null,"2833",{"Chief Executive Officer and Director":"Miguel Martin","Executive Vice President of Operations and Supply Chain":"Alex Miller","Executive Vice President of Human Resources":"Lori Schick","Executive Vice President of Global Business Development":"Andre Jerome","Chief Financial Officer":"Simona King","Vice President of Capital Markets and Investor Relations":"Ananth Krishnan","Executive Vice President, General Counsel and Corporate Secretary":"Nathalie Clark","Vice President of Communications and Public Relations":"Michelle Lefler","Senior Science Advisor":"Dr. Jonathan Page Ph.D.","Senior Vice President of Global Government Relations":"Rick Savone"},"106.00M","200.73M","-107.70M",null,"-3.88","n/a","n/a","n/a","n/a","6,049,313","7.04","6.97","6.64 - 7.30","2.84 - 11.50","2.93","Hold","9.00 (+33.53%)","May 15, 2024"],["Ace Global Business Acquisition Limited","Ace Global Business Acquisition Limited does not have significant operations.The company intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or similar business combination with one or more businesses.It intends to focus on opportunities in the artificial intelligence and related technology market in North America.Ace Global Business Acquisition Limited was incorporated in 2020 and is based in Admiralty, Hong Kong.",null,null,null,null,null,null,null,"6/f Unit B, Central 88, 88-98 Des Voeux Road CentralHong Kong, F4 00000China","85290867042","aceglobal-acq.com","ACBA","NASDAQ","USD","0001844389",null,"VGG0083E1025",null,"6770",{"2020":"Founded","Hong Kong":"Country","Apr 6, 2021":"IPO Date","Shell Companies":"Industry","Financials":"Sector","Eugene Tu  Wong":"CEO","Chief Executive Officer and Chairman of the Board":"Eugene Tu Wong","Chief Financial Officer and Director":"Xue-Wei Tan"},"41.96M","n/a","1.08M",null,"-0.92","n/a","n/a","n/a","n/a","1","12.23","12.23","12.23 - 12.23","10.95 - 12.23","0.03","n/a","n/a","May 15, 2023"],["Accolade, Inc.","Accolade, Inc., together with its subsidiaries, engages in the development and provision of personalized and technology-enabled solutions that help people to understand, navigate, and utilize the healthcare system and their workplace benefits in the United States.The company offers a platform with cloud-based intelligent technology and multimodal support from a team of advocates and clinicians, including registered nurses, physician medical directors, pharmacists, behavioral health specialists, women's health specialists, case management specialists, expert medical opinion providers, and primary care physicians.It also provides medical opinion services to commercial customers; and navigation, care, and advocacy solutions.In addition, the company offers medical consultations that connect patients to qualified condition-specific specialists for adult and pediatric care; and primary care and mental health support solutions.It serves employers who provide employees and their families a single place to turn for their health, healthcare, and benefits needs.The company was incorporated in 2007 and is headquartered in Seattle, Washington.","United States","2007","Jul 2, 2020","Health Information Services","Healthcare","2,400","Rajeev  Singh","660 W. Germantown Pike Suite 500Plymouth Meeting, Pennsylvania 19462United States","610-834-2989","accolade.com","ACCD","NASDAQ","USD","0001481646",null,"US00437E1029","43-2117836","7389",{"Chairman of the Board and Chief Executive Officer":"Rajeev Singh","President":"Robert Cavanaugh","Chief Financial Officer and Treasurer":"Stephen H. Barnes CPA","Senior Vice President of Operations":"Kristen Bruzek","Chief Accounting Officer":"Colin McHugh","Senior Vice President of Investor Relations":"Todd Friedman","Executive Vice President, General Counsel, CCO and Secretary":"Richard Eskew","Chief People Officer and Senior Vice President":"Kelsi McDonald Harris","Executive Vice President of Engineering":"Drew Garner","Executive Vice President, Chief Health Officer and Member of the Medical Advisory Board":"Dr. Shantanu Nundy M.B.A., M.D."},"590.81M","414.29M","-99.81M",null,"-1.33","n/a","n/a","n/a","n/a","659,125","7.58","7.26","7.26 - 7.99","6.33 - 15.36","2.08","Strong Buy","14.92 (+105.51%)","Jun 27, 2024"],["ACCO Brands Corporation","ACCO Brands Corporation designs, manufactures, and markets consumer, school, technology, and office products.It operates through three segments: ACCO Brands North America, ACCO Brands EMEA, and ACCO Brands International.The company provides computer and gaming accessories, planners, dry erase boards, school notebooks, and janitorial supplies; storage and organization products, such as lever-arch binders, sheet protectors, and indexes; sheet protectors and indexes; laminating, binding, and shredding machines; writing instruments and art products; stapling and punching products; and do-it-yourself tools.It offers its products under the AT-A-GLANCE, Barrilito, Derwent, Esselte, Five Star, Foroni, GBC, Hilroy, Kensington, Leitz, Marbig, Mead, NOBO, PowerA, Quartet, Rapid, Rexel, Swingline, Tilibra, Artline, and Spirax brand names.The company markets and sells its products through various channels, including mass retailers, e-tailers, discount, drug/grocery, and variety chains; warehouse clubs; hardware and specialty stores; independent office product dealers; office superstores; wholesalers; contract stationers; and technology specialty businesses, as well as sells products directly to commercial and consumer end-users through its e-commerce platform and direct sales organization.The company was founded in 1893 and is headquartered in Lake Zurich, Illinois.","United States","1893",null,"Business Equipment & Supplies","Industrials","5,600","Thomas W. Tedford","Four Corporate DriveLake Zurich, Illinois 60047United States","847-541-9500","accobrands.com","ACCO","NYSE","USD","0000712034",null,"US00081T1088","36-2704017","2780",{"President, Chief Executive Officer and Director":"Thomas W. Tedford","Executive Vice President and Chief Financial Officer":"Deborah A. O'Connor","Executive Vice President, VP of Americas and President of Americas":"Patrick H. Buchenroth","Executive Vice President, VP of International and President of International":"Cezary L. Monko","Senior Vice President of Global Operations and Supply Chain":"Gregory J. McCormack","Senior Vice President, Corporate Controller and Chief Accounting Officer":"James M. Dudek Jr.","Senior Vice President and Chief Information Officer":"Paul P. Daniel","Senior Director of Investor Relations":"Christopher Paul McGinnis","Senior Vice President, General Counsel and Corporate Secretary":"Pamela Rolnick Schneider","Senior Vice President of Corporate Development":"Mark C. Anderson"},"466.72M","1.79B","-24.40M",null,"-0.27","n/a","4.11","$0.30 (6.15%)","May 16, 2024","653,453","5.050","4.920","4.800 - 5.200","4.640 - 6.620","1.63","Buy","7.50 (+53.69%)","May 2, 2024"],["ProFrac Holding Corp.","ProFrac Holding Corp. operates as a technology-focused energy services holding company in the United States.It operates through three segments: Stimulation Services, Manufacturing, and Proppant Production. The company offers hydraulic fracturing, well stimulation, in-basin frac sand, and other completion services and complementary products and services to upstream oil and natural gas companies engaged in the exploration and production of unconventional oil and natural gas resources.It also manufactures and sells high horsepower pumps, valves, piping, swivels, large-bore manifold systems, and fluid ends.ProFrac Holding Corp. was founded in 2016 and is headquartered in Willow Park, Texas.","United States","2014","May 13, 2022","Oil & Gas Equipment & Services","Energy","2,949","Johnathan Ladd Wilks","333 Shops Boulevard, Suite 301Willow Park, Texas 76087United States","254-776-3722","profrac.com","ACDC","NASDAQ","USD","0001881487",null,"US74319N1000",null,"1389",{"Executive Chairman and President":"Matthew D. Wilks","Chief Executive Officer":"Johnathan L. Wilks","Chief Financial Officer":"Lance D. Turner","Senior Vice President of Operations":"Jeremy Spriggs","Chief Legal Officer, Chief Compliance Officer and Corporate Secretary":"Steven Scrogham","Chief Commercial Officer":"Matthew Greenwood","Senior Vice President of HSE, Compliance and Training":"Paul Kaster"},"1.11B","2.63B","-107.50M",null,"-0.82","n/a","7.65","n/a","n/a","893,511","6.93","6.87","6.93 - 7.17","6.46 - 14.32","n/a","Buy","13.42 (+92.82%)","May 9, 2024"],["Accel Entertainment, Inc.","Accel Entertainment, Inc., together with its subsidiaries, operates as a distributed gaming operator in the United States.It is involved in the installation, maintenance, and operation of gaming terminals; redemption devices that disburse winnings and contain automated teller machine (ATM) functionality; and other amusement devices in authorized non-casino locations, such as restaurants, bars, taverns, convenience stores, liquor stores, truck stops, and grocery stores.The company also provides gaming solutions to the location partners. In addition, it operates stand-alone ATMs in gaming and non-gaming locations, as well as amusement devices, including jukeboxes, dartboards, pool tables, and other related entertainment equipment.The company is headquartered in Burr Ridge, Illinois.","United States","2009",null,"Gambling","Consumer Discretionary","1,330","Andrew Harry Rubenstein","140 Tower DriveBurr Ridge, Illinois 60527United States","630-972-2235","accelentertainment.com","ACEL","NYSE","USD","0001698991",null,"US00436Q1067","98-1350261","7900",{"Co-Founder, President, Chief Executive Officer and Director":"Andrew Harry Rubenstein","Vice Chairman of the Board and Co-Founder":"Gordon Rubenstein","Chief Financial Officer":"Mathew Ellis","General Counsel, Chief Compliance Officer and Secretary":"Derek Harmer","President of U.S. Gaming":"Mark T. Phelan","Chief Accounting Officer":"Christie Kozlik","Chief People Officer":"Karen Raviv","Executive Vice President of Business Development and Governmental Affairs":"Mike Pappas","Chief Customer Officer":"Gabriel Garcia"},"957.56M","1.17B","45.60M",null,"0.53","21.57","13.03","n/a","n/a","628,985","11.23","11.02","11.13 - 11.57","8.84 - 12.05","1.51","n/a","n/a","May 8, 2024"],["Adicet Bio, Inc.","Adicet Bio, Inc., a clinical stage biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for autoimmune diseases and cancer.The company offers gamma delta T cells engineered with chimeric antigen receptors (CARs) to facilitate durable activity in patients.Its lead product candidate is ADI-001, an allogeneic gamma delta T cell therapy expressing a CAR targeting CD20, which is in Phase I clinical trial for the treatment of autoimmune diseases and relapsed or refractory aggressive B cell non-Hodgkin's lymphoma.The company is also developing ADI-270, an armored gamma delta CAR T cell product candidate targeting renal cell carcinoma for treating other CD70+ solid tumor and hematological malignancies indications.The company was founded in 2014 and is based in Boston, Massachusetts.","United States","1947",null,"Biotechnology","Healthcare","143","Dr. Aya  Jakobovits Ph.D.","4 Tri Harbor CourtPort Washington, New York 11050United States","(516) 627-6000","adicetbio.com","ACET","NASDAQ","USD","0000002034",null,"US0070021086","11-1720520","5122",{"Chief Executive Officer, President and Director":"Chen Schor BA, CPA, M.B.A.","Founder and Independent Director":"Dr. Aya Jakobovits Ph.D.","Senior Vice President and Chief Scientific Officer":"Dr. Blake Aftab Ph.D.","Chief Medical Officer and Senior Vice President":"Dr. Francesco Galimi M.D., Ph.D.","Chief Financial Officer":"Brian Nicholas Harvey","Chief Technology Officer":"Dr. Donald Healey Ph.D.","Chief Human Resource Officer":"Amy Locke","Senior Vice President and Chief Regulatory Officer":"Dr. Nancy L. Boman M.D., Ph.D."},"119.15M","n/a","-142.66M",null,"-3.31","n/a","n/a","n/a","n/a","4,863,620","1.450","1.410","1.400 - 1.560","1.100 - 7.500","1.62","Buy","13.86 (+855.86%)","May 14, 2024"],["Arch Capital Group Ltd.","Arch Capital Group Ltd., together with its subsidiaries, provides insurance, reinsurance, and mortgage insurance products worldwide.The company's Insurance segment offers primary and excess casualty coverages; loss sensitive primary casualty insurance programs; directors' and officers' liability, errors and omissions liability, employment practices and fiduciary liability, crime, professional indemnity, and other financial related coverages; medical professional and general liability insurance coverages; and workers' compensation and umbrella liability, as well as commercial automobile and inland marine products.It also provides property, energy, marine, and aviation insurance; travel insurance; accident, disability, and medical plan insurance coverages; captive insurance programs; employer's liability; contract and commercial surety coverages; and collateral protection, debt cancellation, and service contract reimbursement products.This segment markets its products through a group of licensed independent retail and wholesale brokers.Its Reinsurance segment provides casualty reinsurance for third party liability exposures; marine and aviation; motor reinsurance, whole account multi-line treaties, cyber, trade credit, surety, accident and health, workers' compensation catastrophe, agriculture, trade credit, and political risk products; reinsurance protection for catastrophic losses, and personal lines and commercial property exposures; life reinsurance; casualty clash; and risk management solutions.This segment markets its reinsurance products through brokers. The company's Mortgage segment offers direct mortgage insurance and mortgage reinsurance.The company was founded in 1995 and is based in Pembroke, Bermuda.","Bermuda","1995","Sep 13, 1995","Insurance - Diversified","Financials","6,400","Marc  Grandisson","Waterloo House, Ground Floor, 100 Pitts Bay RoadPembroke, D0 HM 08Bermuda","441-278-9250","archgroup.com","ACGL","NASDAQ","USD","0000947484",null,"BMG0450A1053","98-0374481","6331",{"Chief Executive Officer and Director":"Marc Grandisson","President, Chief Underwriting Officer and Chief Executive Officer of Arch Worldwide Insurance Group":"Nicolas Alain Emmanuel Papadopoulo","Executive Vice President, Chief Financial Officer and Treasurer":"Francois Morin","Senior Advisor and Director":"John Donald Vollaro","Chief Executive Officer of Arch Worldwide Reinsurance Group":"Maamoun Rajeh","Chief Executive Officer of Global Mortgage Group":"David Evan Gansberg","Chief Operations Officer":"Christopher Andrew Hovey","Executive Vice President and Chief Investment Officer":"Christine Lee Todd CFA","Chief Information Officer":"Prashant Nema","General Counsel":"Louis T. Petrillo"},"35.42B","13.63B","4.40B",null,"11.62","8.12","11.52","n/a","n/a","1,683,830","94.82","95.17","92.78 - 95.59","69.05 - 96.58","0.57","Buy","101.46 (+7.47%)","Apr 29, 2024"],["Acadia Healthcare Company, Inc.","Acadia Healthcare Company, Inc. provides behavioral healthcare services in the United States and Puerto Rico.The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.Acadia Healthcare Company, Inc. was founded in 2005 and is headquartered in Franklin, Tennessee.","United States","2005",null,"Medical Care Facilities","Healthcare","23,500","Christopher Howal Hunter","6100 Tower Circle, Suite 1000Franklin, Tennessee 37067United States","615-861-6000","acadiahealthcare.com","ACHC","NASDAQ","USD","0001520697",null,"US00404A1097",null,"8093",{"Chief Executive Officer and Director":"Christopher Howal Hunter","Executive Vice President of Operations":"John S. Hollinsworth","Chief Information Officer":"Laura Groschen","Vice President of Investor Relations":"Gretchen Hommrich","Chief Compliance Officer":"Bill Priest","Executive Vice President, General Counsel and Secretary":"Brian P. Farley","Chief Marketing Officer":"Mark Palmenter","Senior Vice President of Strategic Affairs":"Isa Diaz","Chief Development Officer":"David M. Keys CFA","Operations Group President of Comprehensive Treatment Center (CTC) Business":"Dr. Nasser Khan M.D."},"6.11B","2.99B","-11.30M",null,"-0.14","n/a","17.90","n/a","n/a","1,172,349","67.02","66.73","64.74 - 67.24","64.74 - 87.77","1.31","Buy","87.80 (+32.79%)","May 1, 2024"],["Achilles Therapeutics plc","Achilles Therapeutics plc, a biopharmaceutical company, develops precision T cell therapies to treat solid tumors.Its platform identifies mutations formed early in the development of cancer. The company offers PELEUS, a proprietary AI-powered bioinformatics platform, used to identify clonal neoantigens in a patient.It also develops CHIRON, which is in Phase I/IIa clinical trial for use in the treatment of advanced non-small cell lung cancer; and THETIS, a product candidate in Phase I/IIa clinical trial for use in the treatment of metastatic or recurrent melanoma.The company was formerly known as Achilles TX Limited and changed its name to Achilles Therapeutics Plc in February 2021.Achilles Therapeutics Plc was founded in 2016 and is headquartered in London, the United Kingdom.","United Kingdom","2016","Mar 31, 2021","Biotechnology","Healthcare","204","Dr. Iraj  Ali Ph.D.","245 Hammersmith RoadLondon, X0 W6 8PWUnited Kingdom","44 (0)20 8154 4600","achillestx.com","ACHL","NASDAQ","USD","0001830749",null,"US00449L1026",null,"2836",{"Chief Executive Officer and Director":"Dr. Iraj Ali Ph.D.","Founder and Chief Medical Officer":"Dr. Karl Stuart Peggs M.D.","Founder and Chief Scientific Officer":"Dr. Sergio A. Quezada Ph.D.","Chief Financial Officer":"Robert Coutts","Founder":"Dr. Charles Swanton FMEDSCI, M.D., Ph.D.","Vice President of Investor Relations and External Communications":"Lee M. Stern","General Counsel and Company Secretary":"Daniel Carey Cazel Hood","Head of Communications":"Julia Wilson","Executive Vice President of People":"Tariq Ahmed"},"33.02M","n/a","-69.67M",null,"-1.74","n/a","n/a","n/a","n/a","185,038","0.800","0.780","0.780 - 0.848","0.740 - 1.760","1.09","Hold","2.83 (+262.82%)","May 17, 2024"],["Archer Aviation Inc.","Archer Aviation Inc., together with its subsidiaries, engages in designs, develops, and operates electric vertical takeoff and landing aircraft for use in urban air mobility.The company was formerly known as Atlas Crest Investment Corp. and changed its name to Archer Aviation Inc. The company is headquartered in San Jose, California.","United States","2018",null,"Aerospace & Defense","Industrials","578","Mark  Mesler","190 West Tasman DriveSan Jose, California 95134United States","650-272-3233","archer.com","ACHR","NYSE","USD","0001824502",null,"US03945R1023","85-2730902","3721",{"Founder, Chief Executive Officer and Director":"Adam D. Goldstein","Chief Financial Officer":"Mark Mesler","Chief People and Partnerships Officer":"Tosha Perkins","Chief Technology Officer":"Thomas Paul Muniz","General Counsel and Secretary":"Eric Lentell","Senior Vice President and Head of Marketing":"Miles Rogers","Chief Engineer":"Geoff Bower","Head of Certification":"Eric Wright","Head of Design":"Julien Montousse","Chief Avionics Architect":"Scott Furman"},"1.28B","n/a","-457.90M",null,"-1.69","n/a","n/a","n/a","n/a","3,573,000","4.100","4.010","3.885 - 4.160","1.910 - 7.490","2.43","Strong Buy","9.00 (+127.27%)","May 9, 2024"],["Achieve Life Sciences, Inc.","Achieve Life Sciences, Inc., a clinical-stage pharmaceutical company, develops and commercializes cytisinicline for smoking cessation and nicotine addiction.The company offers cytisinicline, a plant-based alkaloid that interacts with nicotine receptors in the brain that reduce the severity of nicotine withdrawal symptoms.It has license and supply agreement with Sopharma AD and University of Bristol Achieve Life Sciences, Inc. is based in Vancouver, Canada.","Canada",null,null,"Biotechnology","Healthcare","22","John A. Bencich M.B.A.","22722 29th Dr. Se, Suite 100Seattle, Washington 98021United States","425-686-1500","achievelifesciences.com","ACHV","NASDAQ","USD","0000949858",null,"US0044685008","95-4343413","2835",{"Executive Chairman":"Dr. Richard A. B. Stewart","Chief Executive Officer and Director":"John A. Bencich M.B.A.","President, Chief Medical Officer and Director":"Dr. Cindy Jacobs M.D., Ph.D.","Principal Accounting Officer":"Jerry Wan","Chief Scientific Officer":"Dr. Anthony Clarke","Executive Vice President of Commercial":"Jaime Xinos"},"162.18M","n/a","-29.82M",null,"-1.50","n/a","n/a","n/a","n/a","76,066","4.730","4.690","4.620 - 4.800","3.030 - 10.300","1.28","Strong Buy","16.33 (+248.19%)","May 9, 2024"],["Albertsons Companies, Inc.","Albertsons Companies, Inc., through its subsidiaries, engages in the operation of food and drug stores in the United States.The company's food and drug retail stores offer grocery products, general merchandise, health and beauty care products, pharmacy, fuel, and other items and services.It also manufactures and processes food products for sale in stores. It operates stores under various banners, including Albertsons, Safeway, Vons, Pavilions, Randalls, Tom Thumb, Carrs, Jewel-Osco, Acme, Shaw's, Star Market, United Supermarkets, Market Street, Haggen, Kings Food Markets, and Balducci's Food Lovers Market; and pharmacies, in-store branded coffee shops, adjacent fuel centers, distribution centers, and manufacturing facilities, as well as various digital platforms.Albertsons Companies, Inc. was founded in 1860 and is headquartered in Boise, Idaho. Albertsons Companies, Inc. operates as a subsidiary of Albertsons Investor Holdings LLC.","United States",null,"Jun 26, 2020","Grocery Stores","Consumer Staples","285,000","Vivek  Sankaran","250 Parkcenter Blvd.Boise, Idaho 83706United States","208-395-6200","albertsonscompanies.com","ACI","NYSE","USD","0001646972",null,"US0130911037",null,"5411",{"Chief Executive Officer and Director":"Vivek Sankaran","President and Chief Financial Officer":"Sharon L. McCollam","Executive Vice President and Chief Operating Officer":"Susan D. Morris","Executive Vice President and Chief Technology and Transformation Officer":"Anuj Dhanda","Senior Vice President and Chief Accounting Officer":"Robert B. Larson","SVice President, Investor Relations, Treasury and Risk Management":"Melissa C. Plaisance","Executive Vice President and General Counsel":"Thomas Michael Moriarty","Executive Vice President of Corporate Development and Real Estate":"Justin Ewing","Executive Vice President and Chief Human Resources Officer":"Michael T. Theilmann","Executive Vice President of Retail Operations and Special Projects and President of ACME & Eastern Divisions":"Jim Perkins"},"11.88B","79.24B","1.30B",null,"2.23","9.22","7.75","$0.48 (2.33%)","Apr 25, 2024","944,488","20.67","20.72","20.51 - 20.69","19.85 - 23.88","0.33","Buy","24.92 (+21.15%)","Apr 22, 2024"],["American Coastal Insurance Corporation","American Coastal Insurance Corporation, through its subsidiaries, primarily engages in the commercial and personal property, and casualty insurance business in the United States.The company offers structure, content, and liability coverage for standard single-family homeowners, renters, and condominium unit owners.It also provides commercial multi-peril property insurance for residential condominium associations and apartments, as well as loss or damage to buildings, inventory, and equipment caused by fire, wind, hail, water, theft, and vandalism.In addition, the company offers equipment breakdown, identity theft, and cyber security policies. The company markets and distributes its products through a network of independent agencies.The company was formerly known as United Insurance Holdings Corp. and changed its name to American Coastal Insurance Corporation in August 2023.American Coastal Insurance Corporation was founded in 1999 and is based in Saint Petersburg, Florida.","United States","1999",null,"Insurance - Property & Casualty","Financials","71","Robert Daniel Peed","800 2nd Ave SSaint Petersburg, Florida 33701United States","727-895-7737","amcoastal.com","ACIC","NASDAQ","USD","0001401521",null,"US9107101027","75-3241967","6331",{"Chairman and Chief Executive Officer":"Robert Daniel Peed","President":"Bennett Bradford Martz CPA","Chief Operating Officer, Vice President and Chief Information Officer":"Christopher Lee Griffith","General Counsel and Corporate Secretary":"Brooke Eileen Adler","Chief Financial Officer":"Svetlana Castle C.P.A., J.D.","Chief Compliance and Risk Officer":"James Andrew Gray Jr., C.P.A.","Senior Vice President of Sales and Agency Relations":"Antonio Gonzalez"},"493.77M","286.54M","309.91M",null,"6.98","1.48","8.10","n/a","n/a","150,731","10.50","10.42","10.23 - 10.52","3.84 - 14.25","-0.19","Buy","15.00 (+45.21%)","May 9, 2024"],["AC Immune SA","AC Immune SA, a clinical stage biopharmaceutical company, discovers, designs, and develops medicines and diagnostic products for the prevention and treatment of neurodegenerative diseases associated with protein misfolding.The company's SupraAntigen and Morphomer platforms are designed to generate biologics and small molecules, which selectively interact with misfolded proteins that are common in a range of neurodegenerative diseases.It is developing Crenezumab, a humanized, conformation-specific monoclonal antibody used to slow Alzheimer's disease (AD) progression; and Semorinemab, an investigational monoclonal anti-Tau antibody that targets the N-terminal portion of the Tau protein and is designed to bind to Tau and slow its spread between neurons for the treatment of AD.The company is also developing ACI-24.060 for the treatment of down syndrome-related AD; ACI-7104.056, to treat Parkinson's disease; and ACI-35.030, designs to stimulate a patient's immune system to produce antibodies against pathological phosphorylated Tau.In addition, it is developing diagnostic programs, consisting of PI-2620, a Tau diagnostic for AD, as well as non-AD Tauopathies; and ACI-12589, a-sync PET tracer that supports the differential diagnosis of multiple system atrophy from other neurodegenerative disease.Further, the company is researching and developing Morphomer Tau aggregation inhibitors to evaluate candidates in AD and NeuroOrphan Tauopathies.Additionally, it has discovery and preclinical stage molecules targeting range of neurodegenerative diseases, which include diagnostics targeting TDP-43, alpha-synuclein, and NLRP3.The company has license agreements and collaborations with Genentech, Inc.; Janssen Pharmaceuticals, Inc.; Life Molecular Imaging SA; and Eli Lilly and Company.AC Immune SA was incorporated in 2003 and is headquartered in Lausanne, Switzerland.","Switzerland","2003","Sep 23, 2016","Biotechnology","Healthcare","133","Dr. Andrea  Pfeifer Ph.D.","Epfl Innovation Park, Building B1015 Lausanne, V8 00000Switzerland","41 21 345 91 21","acimmune.com","ACIU","NASDAQ","USD","0001651625",null,"CH0329023102",null,"2834",{"Co-Founder, Chief Executive Officer and Director":"Dr. Andrea Pfeifer Ph.D.","Chief Financial Officer and Vice President of Finance":"Christopher Roberts","Chief Technical Operations Officer":"Piergiorgio Donati","Chief Administrative Officer":"Jean-Fabien Monin","Chief Human Resources Officer":"Howard Donovan","Chief Scientific Officer":"Madiha Derouazi","Senior Vice President of Investor Relations and Corporate Communications":"Dr. Gary Anthony Waanders Ph.D.","General Counsel":"Alexandre Caratsch","Vice President of U.S. Finance and Corporate Development":"Julian Snow","Head of AD - SME":"Dr. David T. Hickman"},"237.08M","17.62M","-64.56M",null,"-0.71","n/a","n/a","n/a","n/a","116,678","2.430","2.440","2.370 - 2.450","1.900 - 5.140","1.01","Strong Buy","16.00 (+555.74%)","May 14, 2024"],["ACI Worldwide, Inc.","ACI Worldwide, Inc., a software company, develops, markets, installs, and supports a range of software products and solutions for facilitating digital payments in the United States and internationally.The company operates in three segments: Banks, Merchants, and Billers. The company offers ACI Acquiring, a solution to process credit, debit, and prepaid card transactions, deliver digital innovation, and fraud prevention; ACI Issuing, a digital payment issuing solution for new payment offering; and ACI Enterprise Payments Platform that provides payment processing and orchestration capabilities for digital payments.It also provides ACI Low Value Real-Time Payments, a platform for processing real-time payments; and ACI High Value Real-Time Payments, a payments engine that offers multi-bank, multi-currency, 24x7 payment processing, and SWIFT messaging.In addition, the company offers ACI Payments Orchestration Platform for optimizing payments; omni-channel payment platform; ACI Fraud Management, a real-time approach to fraud management; and ACI Speedpay, an integrated suite of digital billing, payment, disbursement, and communication services.The company offers electronic bill presentment and payment services to consumer finance, insurance, healthcare, higher education, utility, government, telecommunications, and mortgage sectors; implementation services, include product installations and configurations, and custom software modifications; and business and technical consultancy, on-site support, product education, and testing services, as well as distributes or acts as a sales agent for software developed by third parties.It markets its products under the ACI Worldwide brand. The company was formerly known as Transaction Systems Architects, Inc. and changed its name to ACI Worldwide, Inc. in July 2007.The company was founded in 1975 and is based in Elkhorn, Nebraska.","United States","1975","Feb 23, 1995","Software - Infrastructure","Technology","3,212","Thomas Woodrow Warsop III","6060 Coventry DriveElkhorn, Nebraska 68022United States","239-403-4600","aciworldwide.com","ACIW","NASDAQ","USD","0000935036",null,"US0044981019","47-0772104","7372",{"Chief Executive Officer, President and Director":"Thomas Woodrow Warsop III","Executive Vice President, Chief Financial Officer and Chief Accounting Officer":"Scott W. Behrens","Executive Vice President of Demand Merchant Solutions and Chief Product Officer":"Debbie Guerra","Executive Vice President and Chief Revenue Officer":"Alessandro da Silva","Executive Vice President and Chief Technology and Operations Officer":"Abe Kuruvilla","Executive Vice President, Chief Legal and Risk Officer, General Counsel and Secretary":"Dennis P. Byrnes","Head of Communications and Corporate Affairs":"Nick Karoglou","Interim Chief Human Resources Officer":"Karen Hobbs","Chief Development Officer":"Craig A. Maki","Head of Strategy and Finance":"John Kraft"},"3.70B","1.48B","146.07M",null,"1.35","26.01","23.84","n/a","n/a","573,830","36.04","35.46","35.01 - 36.04","19.56 - 36.37","1.23","Strong Buy","37.00 (+5.35%)","Apr 30, 2024"],["Axcelis Technologies, Inc.","Axcelis Technologies, Inc. designs, manufactures, and services ion implantation and other processing equipment used in the fabrication of semiconductor chips in the United States, Europe, and Asia Pacific.The company offers high energy, high current, and medium current implanters for various application requirements.It also provides aftermarket lifecycle products and services, including used tools, spare parts, equipment upgrades, maintenance services, and customer training.It sells its equipment and services to semiconductor chip manufacturers through its direct sales force.The company was founded in 1978 and is headquartered in Beverly, Massachusetts.","United States","1995","Jul 11, 2000","Semiconductor Equipment & Materials","Technology","1,704","Dr. Russell J. Low Ph.D.","108 Cherry Hill DriveBeverly, Massachusetts 01915United States","978-787-4000","axcelis.com","ACLS","NASDAQ","USD","0001113232",null,"US0545402085","34-1818596","3559",{"Executive Chairperson":"Mary G. Puma","Chief Executive Officer, President and Director":"Dr. Russell J. Low Ph.D.","Executive Vice President and Chief Financial Officer":"James G. Coogan","Executive Vice President of Human Resources and Legal, General Counsel and Corporate Secretary":"Lynnette C. Fallon","Executive Vice President of Marketing and Applications":"Gregory F. Redinbo Ph.D.","Senior Advisor":"Kevin J. Brewer","Executive Vice President of Engineering":"Gerald M. Blumenstock","Executive Vice President of Corporate Marketing and Strategy":"Douglas A. Lawson","Executive Vice President of Global Customer Operations":"Dr. Christopher Tatnall Ph.D."},"3.64B","1.13B","250.16M",null,"7.57","14.72","14.70","n/a","n/a","745,334","110.82","106.64","110.11 - 114.16","93.77 - 201.00","1.63","Buy","151.67 (+36.09%)","May 1, 2024"],["Arcellx, Inc.","Arcellx, Inc., together with its subsidiary, engages in the development of various immunotherapies for patients with cancer and other incurable diseases in the United States.The company's lead ddCAR product candidate is anitocabtagene autoleucel, which is in phase 2 clinical trial for the treatment of patients with relapsed or refractory multiple myeloma (rrMM).It also develops ACLX-001, a product candidate in Phase 1 clinical trials targeting BCMA to treat rrMM; and ACLX-002, which is in Phase 1 clinical trials that targets CD123 for treating relapsed or refractory acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS).In addition, the company's preclinical product includes ACLX-003 for the treatment of AML and MDS. Further, it focuses on the development of product candidates for solid tumor programs.It has a strategic alliance with Kite Pharma, Inc. to co-develop and co-commercialize anitocabtagene autoleucel.The company was formerly known as Encarta Therapeutics, Inc. and changed its name to Arcellx, Inc. in January 2016.Arcellx, Inc. was incorporated in 2014 and is headquartered in Redwood City, California.","United States","2015","Feb 4, 2022","Biotechnology","Healthcare","130","Rami  Elghandour","800 Bridge ParkwayRedwood City, California 94065United States","240-327-0603","arcellx.com","ACLX","NASDAQ","USD","0001786205",null,"US03940C1009","47-2855917","2836",{"Chairman of the Board, Chief Executive Officer and President":"Rami Elghandour","Chief Financial Officer":"Michelle Lim Gilson","Chief Medical Officer":"Dr. Christopher R. Heery M.D.","Chief Technical Officer":"Narinderjeet Singh M.S.","Chief Scientific Officer":"David Tice Ph.D.","Chief Investor and Communications Officer":"Myesha Lacy","General Counsel and Chief Legal Officer":"Maryam Abdul-Kareem J.D., M.S.","Chief People Officer":"Kate Aiken","Chief Commercial Officer":"Neeraj P. Teotia","Chief Business Officer":"Aileen Fernandes"},"2.78B","110.32M","-70.69M",null,"-1.47","n/a","n/a","n/a","n/a","387,208","54.69","53.29","52.37 - 55.85","30.74 - 75.10","0.02","Strong Buy","74.18 (+40.79%)","May 14, 2024"],["AECOM","AECOM, together with its subsidiaries, provides professional infrastructure consulting services worldwide.It operates in three segments: Americas, International, and AECOM Capital. The company offers planning, consulting, architectural and engineering design, construction and program management, and investment and development services to public and private clients.It is also involved in the investment and development of real estate projects. In addition, the company provides construction services, including building construction and energy, and infrastructure and industrial construction.It serves transportation, water, government, facilities, environmental, and energy sectors. The company was formerly known as AECOM Technology Corporation and changed its name to AECOM in January 2015.AECOM was incorporated in 1980 and is headquartered in Dallas, Texas.","United States","1980","May 10, 2007","Engineering & Construction","Industrials","52,000","W. Troy Rudd","13355 Noel Road, Suite 400Dallas, Texas 75240United States","(972) 788-1000","aecom.com","ACM","NYSE","USD","0000868857",null,"US00766T1007","61-1088522","8711",{"Chief Executive Officer and Director":"W. Troy Rudd","President":"Lara Poloni","Chief Financial and Operations Officer":"Gaurav Kapoor","Executive Vice President and Chief Legal Officer":"David Y. Gan","Chief Strategy Officer":"Todd Edward Battley","Chief Technical Officer":"Giles Price","Senior Vice President of Finance and Investor Relations":"William Gabrielski","Vice President of Global Communications and Corporate Responsibility":"Brendan Ranson-Walsh","Chief Human Resources Officer":"Shirley A. Adams","Chief Sustainability Officer and Vice President":"Gary Lawrence"},"12.88B","14.90B","61.83M",null,"0.45","210.49","20.65","$0.88 (0.93%)","Apr 23, 2024","478,025","95.33","94.23","94.19 - 95.33","74.40 - 98.72","1.23","Strong Buy","105.86 (+11.76%)","May 6, 2024"],["ACM Research, Inc.","ACM Research, Inc., together with its subsidiaries, develops, manufactures, and sells single-wafer wet cleaning equipment for enhancing the manufacturing process and yield for integrated chips worldwide.It offers space alternated phase shift technology for flat and patterned wafer surfaces, which employs alternating phases of megasonic waves to deliver megasonic energy in a uniform manner on a microscopic level; timely energized bubble oscillation technology for patterned wafer surfaces at advanced process nodes, which provides cleaning for 2D and 3D patterned wafers; Tahoe technology for delivering cleaning performance using less sulfuric acid and hydrogen peroxide; and electro-chemical plating technology for advanced metal plating.The company markets and sells its products under the SAPS, TEBO, ULTRA C, ULTRA Fn, Ultra ECP, Ultra ECP map, and Ultra ECP ap trademarks through direct sales force and third-party representatives.ACM Research, Inc. was incorporated in 1998 and is headquartered in Fremont, California.","United States","1998","Nov 3, 2017","Semiconductor Equipment & Materials","Technology","1,590","Dr. Hui  Wang Ph.D.","42307 Osgood Road, Suite IFremont, California 94539United States","510-445-3700","acmrcsh.com","ACMR","NASDAQ","USD","0001680062",null,"US00108J1097",null,"3559",{"Founder, Chairman, Chief Executive Officer and President":"Dr. Hui Wang Ph.D.","Chief Financial Officer, Executive Vice President, Secretary and Treasurer":"Mark A. McKechnie","Vice President of Sales - North America":"Jim Straus"},"1.67B","557.72M","77.35M",null,"1.16","23.28","18.12","n/a","n/a","882,630","27.37","26.51","26.85 - 27.81","9.10 - 34.40","1.38","Strong Buy","30.57 (+13.22%)","May 8, 2024"],["Accenture plc","Accenture plc, a professional services company, provides strategy and consulting, industry X, song, and technology and operation services worldwide.The company offers application services, including agile transformation, DevOps, application modernization, enterprise architecture, software and quality engineering, data management; intelligent automation comprising robotic process automation, natural language processing, and virtual agents; and application management services, as well as software engineering services; strategy and consulting services; data and analytics strategy, data discovery and augmentation, data management and beyond, data democratization, and industrialized solutions comprising turnkey analytics and artificial intelligence (AI) solutions; metaverse; and sustainability services.It also provides change management, HR transformation and delivery, organization strategy and design, talent strategy and development, and leadership and culture services; digital commerce; infrastructure services, including cloud infrastructure managed, cloud and data center, network, digital workplace, database platforms, service management, and cloud and infrastructure security services; data-enabled operating models; technology consulting and AI services; and technology consulting services.In addition, the company offers engineering and R&D digitization, smart connected products, product as-a-service enablement, capital projects, intelligent asset management, digital industrial workforce, and autonomous robotic systems; business process outsourcing; and services related to technology innovation.Further, it provides cloud, ecosystem, marketing, security, supply chain management, zero-based transformation, customer experience, finance consulting, mergers and acquisitions, and sustainability services.The company has a collaboration with Salesforce, Inc. to develop Salesforce Life Sciences Cloud. The company was founded in 1951 and is based in Dublin, Ireland.","Ireland","1989",null,"Information Technology Services","Technology","733,000","Ms. Julie T. Spellman Sweet","1 Grand Canal Square, Grand Canal HarbourDublin, L2 D2Ireland","353-1-646-2000","accenture.com","ACN","NYSE","USD","0001467373",null,"IE00B4BNMY34","98-0627530","7389",{"Chief Executive Officer and Chairman":"Julie T. Spellman Sweet","Chief Financial Officer":"Kathleen R. McClure","Chief Executive Officer of EMEA":"Jean-Marc Ollagnier","Chief Executive Officer of North America":"Manish Sharma","Chief Operating Officer":"John Walsh","Chief Accounting Officer and Corporate Controller":"Melissa A. Burgum","Chief Technology and Innovation Officer":"Paul R. Daugherty","Chief Information and Asset Engineering Officer":"Rajendra Prasad","Managing Director and Head of Investor Relations":"Angie Park","General Counsel and Corporate Secretary":"Joel Unruch"},"190.95B","64.57B","7.03B",null,"11.03","27.53","24.77","$5.16 (1.70%)","Apr 10, 2024","2,088,318","302.52","300.34","301.67 - 304.96","261.68 - 387.51","1.18","Buy","391.94 (+29.05%)","Jun 20, 2024"],["ACNB Corporation","ACNB Corporation, a financial holding company, offers banking, insurance, and financial services to individual, business, and government customers in the United States.The company provides checking, savings, and money market deposit accounts, as well as time deposits and debit cards.It also offers commercial lending products, such as commercial mortgages, real estate development and construction loans, accounts receivable and inventory financing, and agricultural and governmental loans; consumer lending products, including home equity loans and lines of credit, automobile and recreational vehicle loans, manufactured housing loans, and personal lines of credit; and mortgage lending programs include personal residential mortgages, and residential construction and investment mortgage loans.In addition, the company provides other services that are related to testamentary trusts, life insurance trusts, charitable remainder trusts, guardianships, powers of attorney, custodial accounts, and investment management and advisory accounts; and retail brokerage services.Further, it acts as a trustee to invest in, protect, manage, and distribute financial assets. Additionally, the company offers property and casualty, health, life, and disability insurance products to commercial and personal clients; and online, telephone, and mobile banking, as well as automated teller machine services.ACNB Corporation was founded in 1857 and is headquartered in Gettysburg, Pennsylvania.","United States","1857",null,"Banks - Regional","Financials","413","James P. Helt","16 Lincoln Square, P O Box 3129Gettysburg, Pennsylvania 17325United States","(717) 334-3161","acnb.com","ACNB","NASDAQ","USD","0000715579",null,"US0008681092","23-2233457","6022",{"President, Chief Executive Officer and Director":"James P. Helt","Executive Vice President and Chief Lending and Revenue Officer of ACNB Bank":"Douglas A. Seibel","Executive Vice President, Chief Financial Officer and Treasurer":"Jason H. Weber C.F.A., CPA, FRM","Senior Vice President, General Counsel, Secretary and Chief Governance Officer":"Kevin J. Hayes Esq.","Executive Vice President of Maryland Market President":"Mark E. Blacksten","Executive Vice President and Chief Strategy Officer":"Brett D. Fulk"},"282.72M","105.92M","31.69M",null,"3.72","8.94","9.71","$1.28 (3.85%)","May 31, 2024","6,476","33.50","33.41","33.05 - 33.50","27.43 - 48.55","0.60","Buy","42.50 (+27.86%)","Apr 25, 2024"],["Ascent Industries Co.","Ascent Industries Co. an industrials company, produces and distributes stainless steel pipe and tube and specialty chemicals in the United States and internationally.The company operates through two segments, Tubular Products and Specialty Chemicals. It manufactures welded pipes and tubes, primarily from stainless steel, duplex, and nickel alloys; and ornamental stainless steel tubes for automotive, commercial transportation, marine, food services, construction, furniture, healthcare, and other industries.The company also produces defoamers, surfactants, and lubricating agents for end users, including companies that supply agrochemical paper, metal working, coatings, water treatment, paint, mining, oil and gas, and janitorial and other applications.In addition, it provides contract manufacturing services, as well as operates as a multi-purpose plant to process various difficult to handle materials, including flammable solvents, viscous liquids, and granular solids.The company was formerly known as Synalloy Corporation and changed its name to Ascent Industries Co. in August 2022.Ascent Industries Co. was founded in 1945 and is based in Oak Brook, Illinois.","United States","1945",null,"Steel","Materials","514","J. Bryan Kitchen","1400 16th Street, Suite 270Oak Brook, Illinois 60523United States","804-822-3260","ascentco.com","ACNT","NASDAQ","USD","0000095953",null,"US8715651076","57-0426694","3317",{"Executive Chairman":"Benjamin L. Rosenzweig","President, Chief Executive Officer and Director":"J. Bryan Kitchen","Chief Financial Officer":"Ryan Kavalauskas","Chief Legal Officer and Corporate Secretary":"Douglas Glenn Tackett Jr.","President of Ascent Tubular":"John W. Johnson","Corporate Secretary":"Robert A. Peay"},"102.26M","193.18M","-26.63M",null,"-2.63","n/a","n/a","n/a","n/a","1,263","10.24","10.13","10.10 - 10.30","7.20 - 11.19","0.71","Strong Buy","20.00 (+98.02%)","May 8, 2024"],["Aclarion, Inc.","Aclarion, Inc., a healthcare technology company, leverages for Magnetic Resonance Spectroscopy (MRS) in the United States.It develops NOCISCAN Post-Processor suite of software applications comprising NOCICALC that receives the raw un-processed NOCISCAN MRS exam data and post-processes that raw data into final spectra and performs various degenerative pain biomarker; and NOCIGRAM, a clinical decision support software.The company was formerly known as Nocimed, Inc. and changed its name to Aclarion, Inc. in December 2021.Aclarion, Inc. was incorporated in 2008 and is based in Broomfield, Colorado.","United States","2008","Apr 22, 2022","Health Information Services","Healthcare","4","Brent  Ness","8181 Arista Place, Ste 100Broomfield, Colorado 80021United States","833 275 2266","aclarion.com","ACON","NASDAQ","USD","0001635077",null,"US6551872012","47-3324725","8071",{"Executive Chairman":"Dr. Jeffrey John Thramann M.D.","Chief Financial Officer":"John Lorbiecki","Chief Strategy Officer":"Ryan Bond","Chief Executive Officer, President and Director":"Brent Ness"},"2.40M","75,404","-4.91M",null,"-8.82","n/a","n/a","n/a","n/a","340,065","0.300","0.286","0.285 - 0.300","0.267 - 25.600","0.44","n/a","n/a","May 14, 2024"],["ACRES Commercial Realty Corp.","ACRES Commercial Realty Corp., a real estate investment trust (REIT), focuses on the origination, holding, and management of commercial real estate mortgage loans and equity investments in commercial real estate property in the United States.It invests in commercial real estate-related assets, including floating-rate first mortgage loans, first priority interests in first mortgage loans, subordinated interests in first mortgage loans, mezzanine financing, preferred equity investments, and commercial mortgage-backed securities.The company qualifies as a real estate investment trust for federal income tax purposes. It generally would not be subject to federal corporate income taxes if it distributes at least 90% of its taxable income to its stockholders.The company was formerly known as Exantas Capital Corp. and changed its name to ACRES Commercial Realty Corp. in February 2021.ACRES Commercial Realty Corp. was incorporated in 2005 and is based in Uniondale, New York.","United States","2005",null,"REIT - Mortgage","Real Estate","4","Mark Steven Fogel","390 Rxr PlazaUniondale, New York 11556United States","516-535-0015","acresreit.com","ACR","NYSE","USD","0001332551",null,"US00489Q1022","20-2287134","6798",{"President, Chief Executive Officer and Director":"Mark Steven Fogel","Senior Vice President, Chief Financial Officer and Treasurer":"Eldron C. Blackwell","Chief Legal Officer, Senior Vice President and Secretary":"Jaclyn Alyce Jesberger","Vice President of Operations":"Kyle K. Brengel","Vice President, Chief Accounting Officer and Controller":"Linda M. Kilpatrick","Senior Vice President of Corporate Finance and Investor Relations Officer":"Steven Landgraber","Senior Vice President":"Jeffrey Dean Blomstrom","Executive Vice President of Resource America":"George Edward Carleton","Executive Vice President of Commercial Real Estate Lending Business Division":"Paul Andrew Hughson J.D.","Head of CMBS Investing":"George E. Carlton"},"104.71M","91.13M","2.97M",null,"0.35","39.00","6.14","n/a","n/a","7,906","13.23","13.00","13.00 - 13.74","6.62 - 14.35","1.99","Buy","13.25 (-2.93%)","May 1, 2024"],["Ares Commercial Real Estate Corporation","Ares Commercial Real Estate Corporation, a specialty finance company, originates and invests in commercial real estate (CRE) loans and related investments in the United States.It provides a range of financing solutions for the owners, operators, and sponsors of CRE properties.The company originates senior mortgage loans, subordinate debt and preferred equity products, mezzanine loans, and other CRE investments, including commercial mortgage-backed securities.It has elected and qualified to be taxed as a real estate investment trust for the United States federal income tax purposes under the Internal Revenue Code of 1986.Ares Commercial Real Estate Corporation was incorporated in 2011 and is based in New York, New York.","United States","2011","Apr 26, 2012","REIT - Mortgage","Real Estate","1,200","Bryan Patrick Donohoe","245 Park Avenue, 42nd FloorNew York, New York 10167United States","212.515.3400","arescre.com","ACRE","NYSE","USD","0001529377",null,"US04013V1089","45-3148087","6798",{"Chief Executive Officer":"Bryan Patrick Donohoe","Chief Financial Officer and Treasurer":"Tae-Sik Yoon","General Counsel, Vice President and Secretary":"Anton Feingold","Partner, Head of Ares Real Estate and Chairman of the Board":"William Stephen Benjamin","President":"David Roth CFA, J.D.","Partner of Public Investor Relations and Communications":"John W. Stilmar","Partner and Senior Advisor":"Carl G. Drake C.F.A.","Partner and Co-Head of European Real Estate Equity":"John Ruane","Partner":"Andrew E. Holm"},"376.60M","92.93M","-38.87M",null,"-0.72","n/a","193.84","$0.91 (13.15%)","Mar 27, 2024","444,856","7.10","6.99","6.86 - 7.20","6.36 - 11.24","1.45","Hold","7.38 (+6.65%)","May 9, 2024"],["Aclaris Therapeutics, Inc.","Aclaris Therapeutics, Inc. a clinical-stage biopharmaceutical company, engages in the development of novel drug candidates for immune-inflammatory diseases in the United States.The company operates through two segments, Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing therapies to address significant unmet needs for immuno-inflammatory diseases.The Contract Research segment provides laboratory services. It develops Zunsemetinib (ATI-450), an MK2 inhibitor which is under Phase 1b/2 trials for the treatment of metastatic breast and pancreatic cancer; ATI-1777, a soft JAK 1/3 inhibitor, completed Phase 2b trails for the treatment of moderate to severe atopic dermatitis and other dermatologic conditions; and ATI-2138, an oral covalent inhibitor of ITK and JAK3 inhibitor under Phase 1 trials as a treatment for T cell-mediated autoimmune diseases.The company was incorporated in 2012 and is headquartered in Wayne, Pennsylvania.","United States","2012","Oct 7, 2015","Diagnostics & Research","Healthcare","86","Dr. Neal S. Walker D.O., M.D.","701 Lee Road, Suite 103Wayne, Pennsylvania 19087United States","484-324-7933","aclaristx.com","ACRS","NASDAQ","USD","0001557746",null,"US00461U1051","46-0571712","2834",{"Co-Founder, President, Chairman and Interim Chief Executive Officer":"Dr. Neal S. Walker D.O., M.D.","Chief Scientific Officer":"Dr. Joseph Monahan Ph.D.","Chief Financial Officer":"Kevin Balthaser","General Counsel and Corporate Secretary":"Matthew Rothman J.D.","Senior Vice President of Chemistry":"Dr. Jon Jacobsen Ph.D.","Chief Business Officer":"James Loerop"},"96.92M","31.25M","-88.48M",null,"-1.27","n/a","n/a","n/a","n/a","683,415","1.310","1.310","1.310 - 1.400","0.590 - 11.120","0.23","Hold","11.50 (+745.59%)","May 7, 2024"],["Acrivon Therapeutics, Inc.","Acrivon Therapeutics, Inc., a clinical stage biopharmaceutical company, engages in developing oncology medicines for the patients whose tumors are predicted to be sensitive to each specific medicine by utilizing its proteomics-based patient responder identification platform.The company's Acrivon Predictive Precision Proteomics, a precision medicine platform enables the creation of drug specific proprietary OncoSignature companion diagnostics that are used to identify the patients to benefit from its drug candidates.Its lead clinical candidate is ACR-368, a selective small molecule inhibitor targeting CHK1 and CHK2, which is in Phase II clinical trial across various tumor types, including platinum-resistant ovarian, endometrial, and bladder cancer.The company is also developing its preclinical stage pipeline programs targeting critical nodes in the DNA damage response, or DDR, pathways; and ACR-2316, a dual WEE1/PKMYT1 inhibitor.Acrivon Therapeutics, Inc. was incorporated in 2018 and is based in Watertown, Massachusetts.","United States","2018","Nov 15, 2022","Biotechnology","Healthcare","58","Dr. Peter  Blume-Jensen M.D., Ph.D.","480 Arsenal Way, Suite 100Watertown, Massachusetts 02472United States","617-207-8979","acrivon.com","ACRV","NASDAQ","USD","0001781174",null,"US0048901096","82-5125532","2834",{"Co-Founder, Chairman of the Board, Chief Executive Officer, President and Acting Chief Scientific Officer":"Dr. Peter Blume-Jensen M.D., Ph.D.","Co-Founder, Executive Vice President of Business Operations, Site Head, Treasurer, Secretary and Director":"Kristina Masson M.B.A., Ph.D.","Chief Financial Officer":"Rasmus Holm-Jorgensen","Chief Operating Officer":"Dr. Eric J. Devroe Ph.D.","Vice President of Finance and Accounting":"Katharine Peterson CPA","Senior Vice President and Head of Investor Relations and Corporate Affairs":"Dr. Adam D. Levy M.B.A., Ph.D.","Vice President of Quality and Compliance":"Bruce Close","Chief Legal Officer":"Mary-Alice Miller J.D.","Vice President and Head of Human Resources":"Parvin Miah","Chief Development Officer":"Dr. Erick Gamelin M.D., Ph.D."},"296.10M","n/a","-60.39M",null,"-2.74","n/a","n/a","n/a","n/a","374,700","8.51","8.46","8.31 - 10.29","3.19 - 14.30","n/a","Strong Buy","22.63 (+135.98%)","May 14, 2024"],["Acasti Pharma Inc.","Acasti Pharma Inc. engages in the development and commercialization of pharmaceutical products for rare and orphan diseases in Canada.The company's lead product candidate is the GTX-104, an intravenous infusion to treat subarachnoid hemorrhage.It also develops GTX-102, an oral mucosal spray for the treatment of ataxia-telangiectasia; and GTX-101, a topical bioadhesive film-forming bupivacaine spray for postherpetic neuralgia.The company was incorporated in 2002 and is headquartered in Laval, Canada.","Canada",null,null,"Biotechnology","Healthcare","32","Prashant  Kohli","103 Carnegie Center, Suite 300Princeton, New Jersey 08540United States","609-649-9272","acastipharma.com","ACST","NASDAQ","USD","0001444192",null,"CA00430K8656",null,"2834",{"Chief Executive Officer and Director":"Prashant Kohli","Principal Financial and Accounting Officer":"Robert J. DelAversano CPA","Member of Scientific Advisory Board and Chief Medical Officer":"Dr. R. Loch MacDonald M.D., Ph.D.","Vice President of Program Management":"Amresh Kumar Ph.D.","Vice President of Clinical Operations":"Carrie D'Andrea"},"27.82M","n/a","-38.77M",null,"-3.72","n/a","n/a","n/a","n/a","13,161","2.970","2.960","2.875 - 3.084","1.720 - 3.840","1.53","Strong Buy","6.00 (+98.02%)","Jun 21, 2024"],["Enact Holdings, Inc.","Enact Holdings, Inc. operates as a private mortgage insurance company in the United States.It engages in writing and assuming residential mortgage guaranty insurance. The company also offers private mortgage insurance products primarily insuring prime-based, individually underwritten residential mortgage loans; contract underwriting services for mortgage lenders; and mortgage-related reinsurance products.It primarily serves originators of residential mortgage loans. The company was formerly known as Genworth Mortgage Holdings, Inc. and changed its name to Enact Holdings, Inc. in May 2021.Enact Holdings, Inc. was founded in 1981 and is headquartered in Raleigh, North Carolina. Enact Holdings, Inc. operates as a subsidiary of Genworth Holdings Inc.","United States","1981","Sep 16, 2021","Insurance - Specialty","Financials","465","Rohit  Gupta","8325 Six Forks RoadRaleigh, North Carolina 27615United States","(919) 846-4100","enactmi.com","ACT","NASDAQ","USD","0001823529",null,"US29249E1091","46-1579166","6411",{"President, Chief Executive Officer and Director":"Rohit Gupta","Executive Vice President, Chief Financial Officer and Treasurer":"Hardin Dean Mitchell","Executive Vice President and Chief Operating Officer":"Brian Michael Gould","Executive Vice President, General Counsel and Secretary":"Evan Scott Stolove","Executive Vice President and Chief Risk Officer":"Michael Paul Derstine","Vice President, Controller and Principal Accounting Officer":"James Robert McMullen","Vice President of Investor Relations":"Daniel Kohl","Chief Customer Experience Officer":"Neenu Sohi Kainth"},"4.87B","1.16B","650.51M",null,"4.05","7.55","8.01","$0.74 (2.42%)","May 29, 2024","325,337","30.33","29.99","29.90 - 30.77","22.19 - 31.26","0.54","Buy","30.67 (+0.29%)","May 1, 2024"],["Acacia Research Corporation","Acacia Research Corporation, together with its subsidiaries, invests in intellectual property and related absolute return assets; and engages in the licensing and enforcement of patented technologies.The company operates through three segments, Intellectual Property Operations, Industrial Operations, and Energy Operations.The company owns or controls the rights to various patent portfolios, which include U.S. patents and foreign counterparts covering technologies used in a range of industries.It also owns, manufactures, and distributes printers and consumable products through dealers and distributors for various industrial printing applications.In addition, the company offers supply-chain printing solutions for manufacturing, transportation and logistics, retail distribution, food and beverage distribution, and pharmaceutical distribution industries; and line matrix printers for mission critical applications within labeling and inventory management, build sheets, invoicing, manifests and bills of lading, and reporting industries.Further, it involved in the acquisition, production and development of oil and gas assets. Acacia Research Corporation was incorporated in 1993 and is headquartered in New York, New York.","United States","1993","Jul 8, 1996","Business Equipment & Supplies","Industrials","170","Martin D. McNulty Jr.","767 3rd Avenue, 6th FloorNew York, New York 10017United States","332-236-8500","acaciaresearch.com","ACTG","NASDAQ","USD","0000934549",null,"US0038813079","95-4405754","6794",{"Director, Chief Executive Officer, Chief Operating Officer and Head of M&A":"Martin D. McNulty Jr.","General Counsel":"Jason W. Soncini","Vice President and Chief Intellectual Property Officer":"Marc W. Booth","Interim Chief Financial Officer, Principal Accounting Officer and Corporate Controller":"Kirsten Hoover","Chief Administrative Officer":"Robert Rasamny","Vice President Human Resources":"Irene Byrne","Principal":"Daniel Troy","Corporate Secretary":"Jennifer Graff"},"502.11M","125.10M","55.14M",null,"0.58","8.66","n/a","n/a","n/a","174,065","4.98","4.91","4.95 - 5.06","3.43 - 5.47","0.47","Strong Buy","7.00 (+39.44%)","May 9, 2024"],["Acme United Corporation","Acme United Corporation supplies cutting, measuring, first aid, and sharpening products to the school, home, office, hardware, sporting goods, and industrial markets in the United States, Canada, Europe, and internationally.The company offers scissors, shears, knives, rulers, pencil sharpeners, paper trimmers, safety cutters, lettering products, glue guns, and other craft products under the Westcott brand name; and cutting tools under the Clauss brand.It also provides sharpening knives, scissors, chisels, skis, skates, and other edge under the DMT brand.In addition, the company offers first aid kit and safety solutions under the First Aid Only brand; portable eyewash solution and over-the-counter medication, including active ingredients aspirin, acetaminophen, and ibuprofen under the PhysiciansCare brand; bodily fluid and spill clean-up solution under the Spill Magic brand; various first aid kit, refill, and safety supplies, including CPR kits, burn kits, and automotive and emergency first aid kits under the First Aid Central; first aid kits for the promotional products industry under Safety Made brand; and alcohol prep pads, alcohol wipes, benzalkonium chloride wipes, various antiseptic wipes, castile soaps, and lens cleaning wipes under the Med-Nap brand.It sells its products directly and through its independent manufacturer representatives to wholesale, contract, and retail stationery distributors; office supply super stores, mass market retailers, industrial and medical distributors, school supply distributors, drug store retailers, sporting goods stores, hardware chains, and wholesale florists, as well as through its websites.The company was formerly known as Acme Shear Company and changed its name to Acme United Corporation in 1971.Acme United Corporation was founded in 1867 and is based in Shelton, Connecticut.","United States","1867",null,"Household & Personal Products","Consumer Staples","645","Walter C. Johnsen","1 Waterview DriveShelton, Connecticut 06484United States","203-254-6060","acmeunited.com","ACU","NYSEAMERICAN","USD","0000002098",null,"US0048161048","06-0236700","3420",{"Chairman of the Board and Chief Executive Officer":"Walter C. Johnsen","President, Chief Operating Officer and Executive Director":"Brian S. Olschan","Vice President, Chief Financial Officer, Secretary and Treasurer":"Paul G. Driscoll","Vice President and Chief Information Officer":"William Dossmann","Managing Director of Europe":"Georg Bettin","Vice President and Controller":"Scott Torreso"},"155.10M","191.50M","17.79M",null,"4.86","8.76","16.59","$0.60 (1.41%)","Mar 27, 2024","8,938","41.84","41.10","41.47 - 42.55","23.24 - 50.99","0.70","n/a","n/a","Apr 19, 2024"],["ACV Auctions Inc.","ACV Auctions Inc. operates a digital marketplace that connects buyers and sellers for the online auction of wholesale vehicles.The company's marketplace platform includes digital marketplace, which connects buyers and sellers by providing online auction, which facilitates real-time transactions of wholesale vehicles; Run List for pre-filtering and pre-screening of vehicles up to 24 hours prior to an auction taking place; ACV transportation service to enable the buyers to see real-time transportation quotes and status reports of the vehicle; ACV capital, a short-term inventory financing services for buyers to purchase vehicles; and Go Green's seller assurance service for against claims related to defects in the vehicle.It also provides remarketing centers, which offers value-added services, such as vehicle reconditioning and storage for dealers and commercial partners.In addition, the company offers data services, including True360 report, which provides cosmetic and structural vehicle assessments integrated into vehicle history reports for dealer to make wholesale and retail transaction decisions on and off the marketplace; ACV market report provides transaction data and condition reports for comparable used vehicles, including pricing data from third-party sources and allows dealers to determine pricing and valuation strategies for used vehicles; and ACV MAX inventory management software enables dealers to manage their inventory and set pricing while turning vehicles.Further, it provides data and technology through inspection, such as condition reports, virtual lift solutions, apex device, and vehicle intelligence platform; and marketplace enablement, comprising MyACV application, private marketplaces, operations automation, live appraisals, and programmatic buying service.ACV Auctions Inc. was incorporated in 2014 and is headquartered in Buffalo, New York.","United States","2014","Mar 24, 2021","Auto & Truck Dealerships","Consumer Discretionary","2,170","George G. Chamoun","640 Ellicott StreetBuffalo, New York 14203United States","585-317-0406","acvauctions.com","ACVA","NASDAQ","USD","0001637873",null,"US00091G1040","47-2415221","7389",{"Chief Executive Officer and Director":"George G. Chamoun","Chief Financial Officer":"William R. Zerella","Chief Operating Officer":"Vikas Mehta","Chief Legal Officer and Secretary":"Leanne Fitzgerald","Chief Sales Officer":"Michael Waterman","Chief Technology Officer":"Bahman Koohestani","Vice President of Investor Relations":"Timothy M. Fox","Associate Director of Communications":"Maura Duggan","Chief Corporate Development and Strategy Officer":"Craig Eric Anderson","Chief Marketing Officer":"Kate Cadou Clegg"},"3.03B","481.23M","-75.26M",null,"-0.47","n/a","434.78","n/a","n/a","970,379","17.83","17.38","17.54 - 18.00","12.84 - 19.54","1.57","Strong Buy","20.08 (+12.75%)","May 8, 2024"],["Acurx Pharmaceuticals, Inc.","Acurx Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, develops antibiotics to treat bacterial infections.The company's lead antibiotic candidate is ibezapolstat, a novel mechanism of action that targets the polymerase IIIC enzyme that is in Phase 2b clinical trial to treat patients with clostridium difficile infections.It also develops ACX-375C, a potential oral and parenteral treatment targeting gram-positive bacteria, including methicillin-resistant staphylococcus aureus, vancomycin-resistant enterococcus, and penicillin-resistant streptococcus pneumonia.Acurx Pharmaceuticals, Inc. was incorporated in 2017 and is headquartered in Staten Island, New York.","United States","2017","Jun 25, 2021","Biotechnology","Healthcare","4","Robert J. DeLuccia","259 Liberty AvenueStaten Island, New York 10305United States","917-533-1469","acurxpharma.com","ACXP","NASDAQ","USD","0001736243",null,"US00510M1045",null,"2834",{"Co-Founder and Executive Chairman":"Robert J. DeLuccia","Co-Founder, President, Chief Executive Officer and Director":"David P. Luci CPA, Esq., J.D.","Co-Founder and Chief Financial Officer":"Robert G. Shawah CPA, CPA"},"34.34M","n/a","-14.58M",null,"-1.15","n/a","n/a","n/a","n/a","32,396","2.200","2.120","2.100 - 2.206","1.170 - 8.820","-1.90","Strong Buy","12.00 (+466.04%)","May 15, 2024"],["Adagene Inc.","Adagene Inc., a clinical stage biotechnology company, engages in the research, development, and production of monoclonal antibody drugs for cancers.The company's product candidates include ADG106, a human ligand-blocking agonistic anti- CD137 IgG4 monoclonal antibodies (mAbs) that is in Phase 1b/2 clinical trials for the treatment advanced solid tumors and non-Hodgkin's lymphoma; ADG126, a masked fully-human anti-CTLA-4 mAb that is in Phase 1 clinical trial for the treatment advanced/metastatic solid tumors; and ADG116, a human ligand-blocking anti-CTLA-4 mAb, which is in Phase 1b/2 clinical development for the treatment of advanced/metastatic solid tumors.It also offers ADG104, an anti-PD-L1 mAb that is in Phase 2 clinical development; ADG125, a novel anti-CSF-1R mAb, which is in Phase I clinical trial; ADG206, a masked, Fc engineered anti-CD137 agonistic POWERbody; ADG153, a masked anti-CD47 IgG1 SAFEbody, which is in preclinical for the treatment hematologic and solid tumors; ADG138, novel HER2xCD3 POWERbody, which is in preclinical for the treatment HER2-expressing solid tumors; and ADG152, a v POWERbody, which is in preclinical stage for the treatment off-tumor toxicities, as well as develops anti-CD28 bispecific POWERbody TCEs.The company was incorporated in 2011 and is headquartered in Suzhou, China.","China","2011","Feb 9, 2021","Biotechnology","Healthcare","174","Dr. Peter P.  Luo Ph.D.","4f, Building C14, No. 218, Xinghu Street, Suzhou Industrial ParkJiangsu, F4 00000China","86-512-87773632","adagene.com","ADAG","NASDAQ","USD","0001818838",null,"US0053291078",null,"2834",{"Co- Founder, Chairman, Chief Executive Officer and President of Research &amp; Development":"Dr. Peter P. Luo Ph.D.","Chief Financial Officer and Director":"Man Kin Tam M.B.A.","Chief Scientific Officer":"Dr. Jc Xu M.D., Ph.D.","Vice President of Investor Relations and Corporate Communications":"Ami Celeste Knoefler","Head of Human Resources":"Ling Zhou","Chief Manufacturing Officer":"Dr. Qinghai Zhao","Senior Vice President of Bioinformatics and Information Technology and Director":"Yan Li M.B.A.","Senior Vice President and Head of Clinical Operations":"Xiaohong She","Senior Vice President of Early Drug Discovery":"Dr. Guizhong Liu Ph.D.","Vice President and Head of Business Development":"Alexander Goergen"},"106.32M","18.11M","-18.95M",null,"-0.44","n/a","n/a","n/a","n/a","6,837","2.520","2.480","2.380 - 2.580","1.100 - 4.380","0.45","Strong Buy","5.00 (+107.47%)","May 14, 2024"],["Adaptimmune Therapeutics plc","Adaptimmune Therapeutics plc, a clinical-stage biopharmaceutical company, provides novel cell therapies primarily to cancer patients in the United States and the United Kingdom.It develops SPEARHEAD-1 that is in phase II clinical trials with ADP-A2M4 for synovial sarcoma; SURPASS-3 that is in phase II clinical trial with ADP-A2M4CD8 for people with platinum resistant ovarian cancer; and SURPASS that is in phase I clinical trials in patients with head and neck, and urothelial cancers.The company has strategic collaboration and license agreement with Genentech, Inc. and F. Hoffman-La Roche Ltd to develop personalized allogeneic and allogeneic T-cell therapies; research, collaboration, and license agreement with Universal Cells, Inc.; third-party collaborations with Noile-Immune and Alpine Immune Sciences; and strategic alliance agreement with the MD Anderson Cancer Center.Adaptimmune Therapeutics plc was founded in 2008 and is headquartered in Abingdon, the United Kingdom.","United Kingdom","2008","May 6, 2015","Biotechnology","Healthcare","449","Adrian G.  Rawcliffe","60 Jubilee Avenue, Milton ParkAbingdon, Oxfordshire, X0 OX14 4RXUnited Kingdom","44 1235 430000","adaptimmune.com","ADAP","NASDAQ","USD","0001621227",null,"US00653A1079",null,"2836",{"Chief Executive Officer, Principal Accounting Officer and Director":"Adrian G. Rawcliffe","Chief Financial Officer":"Gavin Hilary James Wood ACA, BA (Hons)","Chief Operating Officer":"William C. Bertrand Jr., Esq., J.D.","Chief Medical Officer":"Dr. Elliot Norry B.A., M.D.","Chief Commercial Officer":"Cintia Piccina Pharm.D.","Co-Founder and Chief Business & Strategy Officer":"Dr. Helen Katrina Tayton-Martin MBA, Ph.D.","Chief Scientific Officer":"Joanna Brewer Ph.D.","Vice President of Corporate Affairs and Investor Relations":"Dr. Juli P. Miller Ph.D.","Senior Vice President and General Council":"Kerry Sharp","Senior Director of Corporate Communications":"Dana Lynch"},"270.33M","60.28M","-113.87M",null,"-0.54","n/a","n/a","n/a","n/a","849,990","1.220","1.190","1.170 - 1.240","0.420 - 2.050","2.38","Buy","5.50 (+362.19%)","May 15, 2024"],["Adobe Inc.","Adobe Inc., together with its subsidiaries, operates as a diversified software company worldwide.It operates through three segments: Digital Media, Digital Experience, and Publishing and Advertising.The Digital Media segment offers products, services, and solutions that enable individuals, teams, and enterprises to create, publish, and promote content; and Document Cloud, a unified cloud-based document services platform.Its flagship product is Creative Cloud, a subscription service that allows members to access its creative products.This segment serves content creators, students, workers, marketers, educators, enthusiasts, and communicators.The Digital Experience segment provides an integrated platform and set of applications and services that enable brands and businesses to create, manage, execute, measure, monetize, and optimize customer experiences from analytics to commerce.This segment serves marketers, advertisers, agencies, publishers, merchandisers, merchants, web analysts, data scientists, developers, and executives across the C-suite.The Publishing and Advertising segment offers products and services, such as e-learning solutions, technical document publishing, web conferencing, document and forms platform, web application development, and high-end printing, as well as Advertising Cloud offerings.It also provides consulting, technical support, and learning services. The company offers its products and services directly to enterprise customers through its sales force and local field offices, as well as to end users through app stores and through its website at adobe.com.It also distributes products and services through distributors, value-added resellers, systems integrators, software vendors and developers, retailers, and original equipment manufacturers.The company was formerly known as Adobe Systems Incorporated and changed its name to Adobe Inc. in October 2018.Adobe Inc. was founded in 1982 and is headquartered in San Jose, California.","United States","1982","Aug 20, 1986","Software - Infrastructure","Technology","29,945","Shantanu  Narayen","345 Park AveSan Jose, California 95110-2704United States","(408) 536-6000","adobe.com","ADBE","NASDAQ","USD","0000796343",null,"US00724F1012","77-0019522","7372",{"Chairman and Chief Executive Officer":"Shantanu Narayen","Chief Financial Officer and Executive Vice President of Finance, Technology Services and Operations":"Daniel J. Durn","President of Digital Media Business":"David Wadhwani","Chief Strategy Officer and Executive Vice President of Design and Emerging Products":"Scott K. Belsky","President of Digital Experience Business":"Dr. Anil S. Chakravarthy","Senior Vice President, Chief Accounting Officer and Corporate Controller":"Mark S. Garfield","Senior Vice President and Chief Information Officer":"Cynthia A. Stoddard","Vice President of Investor Relations":"Jonathan Vaas","Executive Vice President, General Counsel, Chief Trust Officer and Corporate Secretary":"Dana Rao","Chief People Officer and Executive Vice President of Employee Experience":"Gloria Chen"},"219.75B","19.94B","4.80B",null,"10.46","46.48","25.90","n/a","n/a","2,805,206","482.27","476.57","477.57 - 487.49","331.89 - 638.25","1.27","Buy","617.50 (+27.01%)","Jun 13, 2024"],["Agree Realty Corporation","Agree Realty Corporation is a publicly traded real estate investment trust that is RETHINKING RETAIL through the acquisition and development of properties net leased to industry-leading, omni-channel retail tenants.As of December 31, 2023, the Company owned and operated a portfolio of 2,135 properties, located in 49 states and containing approximately 44.2 million square feet of gross leasable area.The Company's common stock is listed on the New York Stock Exchange under the symbol ADC.","United States",null,"Apr 15, 1994","REIT - Retail","Real Estate","72","Joel N. Agree","32301 Woodward AvenueRoyal Oak, Michigan 48073United States","248-737-4190","agreerealty.com","ADC","NYSE","USD","0000917251",null,"US0084921008","38-3148187","6798",{"Executive Chairman of the Board":"Richard A. Agree","President, Chief Executive Officer and Director":"Joel N. Agree","Chief Financial Officer, Secretary and Investor Relations Professional":"Peter Coughenour","Chief Operating Officer":"Nicole Witteveen","General Counsel":"Danielle M. Spehar","Chief Growth Officer":"Craig Erlich","Chief Accounting Officer":"Stephen Breslin","Director of Corporate Finance":"Brian Michael Hawthorne","Chief Information Officer and Vice President of Continuous Improvement":"Larry Kaufman","Director of Development":"Josh Bratton"},"5.91B","560.33M","165.77M",null,"1.70","34.58","31.67","$3.00 (5.10%)","Apr 29, 2024","443,720","58.58","58.00","58.07 - 59.05","52.69 - 69.26","0.53","Buy","66.65 (+13.39%)","Apr 23, 2024"],["ADC Therapeutics SA","ADC Therapeutics SA focuses on advancing its proprietary antibody drug conjugate (ADC) technology platform to transform the treatment paradigm for patients with hematologic malignancies and solid tumors.Its flagship product is ZYNLONTA, a CD19-directed ADC, received accelerated approval from the U.S. Food and Drug Administration and conditional approval from the European Commission for the treatment of relapsed or refractory diffuse large B-cell lymphoma (DLBCL) after two or more lines of systemic therapy.The company is also seeking to continue expanding ZYNLONTA into international markets and into earlier lines of DLBCL and indolent lymphomas, including follicular lymphoma (FL) and marginal zone lymphoma (MZL) as a single agent and in combination through its LOTIS-5 confirmatory Phase 3 clinical trial and LOTIS-7 Phase 1b clinical trial, as well as through investigator-initiated trials (IITs).In addition, it is investigating a CD-22 targeted compound, ADCT-602 that is in a Phase 1/2 investigator-initiated study in relapsed or refractory B-cell acute lymphoblastic leukemia.Further, its clinical-stage pipeline consists of ADCT-601 (mipasetamab uzoptirine) targeting AXL as a single agent and/or in combination in sarcoma, pancreatic, and NSCLC, as well as pre-clinical stage pipeline includes a portfolio of next generation investigational ADCs targeting Claudin-6, NaPi2b, PSMA, and other undisclosed targets.The company was incorporated in 2011 and is headquartered in Epalinges, Switzerland.","Switzerland",null,"May 15, 2020","Biotechnology","Healthcare","273","Dr. Ameet  Mallik M.B.A., M.S.","13625 Technology DriveEden Prairie, Minnesota 55344United States","9529388080","adctherapeutics.com","ADCT","NYSE","USD","0000061478",null,"CH0499880968","41-0743912","3661",{"Chief Executive Officer and Director":"Dr. Ameet Mallik M.B.A., M.S.","Chief Financial Officer":"Jose I. Carmona M.B.A.","Chief Medical Officer":"Dr. Mohamed Zaki M.D., Ph.D.","Corporate Controller and Chief Accounting Officer":"Lisa Michelle Kallebo","Chief Technical Operations Officer":"Dr. Michael Mulkerrin Ph.D.","Chief Scientific Officer":"Dr. Patrick van Berkel Ph.D.","Investor Relations Officer":"Amanda Hamilton","Chief Legal Officer":"Peter J. Graham Esq.","Vice President of Investor Relations and Corporate Communications":"Eugenia Litz","Senior Vice President and Chief People Officer":"Kimberly Pope"},"405.79M","69.56M","-240.05M",null,"-2.94","n/a","n/a","n/a","n/a","312,431","4.960","4.730","4.810 - 5.105","0.360 - 6.040","1.74","Buy","7.33 (+49.59%)","May 6, 2024"],["Color Star Technology Co., Ltd.","Color Star Technology Co., Ltd., an entertainment and education company, provides online entertainment performances and music education services in the United States and China.The company operates Color World, an online platform of curriculum that includes music, sports, animation, painting and calligraphy, film and television, life skills, etc. Its Color World platform provides celebrity lectures, celebrity concert videos, celebrity peripheral products, and artist interactive communication services.The company was formerly known as Huitao Technology Co., Ltd. and changed its name to Color Star Technology Co., Ltd. in May 2020.The company was founded in 2002 and is based in New York, New York.","United States","2002",null,"Entertainment","Communication Services","47","Louis  Luo","80 Broad Street, 5th FloorNew York, New York 10005United States","929-317-2699","colorstarinternational.com","ADD","NASDAQ","USD","0001747661",null,"KYG2287A2093",null,"8200",{"Chief Executive Officer and Director":"Louis Luo","Chief Financial Officer":"Lili Jiang","Vice President of Technology":"Yang Liu","Director of Corporate Administration and Human Resources":"Jiaqing Wang","Director of Corporate Communications":"John Shaw","Finance Controller":"Yanwei He"},"2.57M","n/a","-37.85M",null,"-4.13","n/a","n/a","n/a","n/a","15,080","0.233","0.236","0.221 - 0.260","0.170 - 1.860","2.24","n/a","n/a","Jun 4, 2024"],["Adeia Inc.","Adeia Inc., together with its subsidiaries, operates as a media and semiconductor intellectual property licensing company in the United States, Canada, Asia, Europe, the Middle East, and internationally.The company licenses its patent portfolios across various markets, including multichannel video programming distributors comprising cable, satellite, and telecommunications television providers that aggregate and distribute linear content over networks, as well as television providers that aggregate and stream linear content over broadband networks; over-the-top video service providers and social media companies, such as subscription video-on-demand and advertising-supported streaming service providers, as well as content providers, networks, and media companies.It also licenses consumer electronics manufacturers, which includes producers of smart televisions, streaming media devices, video game consoles, mobile devices, content storage devices, and other connected media devices; semiconductors, including providers of sensors, radio frequency components, memory, and logic devices; and social media companies that allow users to stream and upload user-generated content.The company licenses its innovations under the Adeia brand name. Adeia Inc. was formerly known as Xperi Corporation and changed its name to Adeia Inc. in December 2019.The company was incorporated in 2019 and is headquartered in San Jose, California.","United States","1990",null,"Software - Application","Technology","130","Paul E. Davis","3025 Orchard ParkwaySan Jose, California 95134United States","(408) 473-2500","adeia.com","ADEA","NASDAQ","USD","0001803696",null,"US00676P1075",null,"4841",{"Chief Executive Officer and Director":"Paul E. Davis","Chief Financial Officer":"Keith A. Jones","Chief Legal Officer and Corporate Secretary":"Kevin Tanji","Chief Licensing Officer and GM of Media":"Dr. Mark Kokes","Chief Licensing Officer and GM of Semiconductor":"Dana Escobar","Chief Technology Officer":"Serhad Doken","Chief Corporate Development Officer":"Jarl Berntzen","Chief People Officer":"Christina Sawyer","Chief intellectual property (IP) officer":"Joseph Guiliano"},"1.08B","388.79M","67.37M",null,"0.60","16.68","7.51","$0.20 (2.00%)","Mar 11, 2024","453,206","10.25","10.01","9.90 - 10.26","7.18 - 13.39","1.13","Strong Buy","15.67 (+56.54%)","May 6, 2024"],["Analog Devices, Inc.","Analog Devices, Inc. designs, manufactures, tests, and markets integrated circuits (ICs), software, and subsystems products in the United States, rest of North and South America, Europe, Japan, China, and rest of Asia.The company provides data converter products, which translate real-world analog signals into digital data, as well as translates digital data into analog signals; power management and reference products for power conversion, driver monitoring, sequencing, and energy management applications in the automotive, communications, industrial, and consumer markets; and power ICs that include performance, integration, and software design simulation tools for accurate power supply designs.It also offers amplifiers to condition analog signals; and radio frequency and microwave ICs to support cellular infrastructure; and micro-electro-mechanical systems technology solutions, including accelerometers used to sense acceleration, gyroscopes for sense rotation, inertial measurement units to sense multiple degrees of freedom, and broadband switches for radio and instrument systems, as well as isolators.In addition, the company provides digital signal processing and system products for numeric calculations.It serves clients in the industrial, automotive, consumer, instrumentation, aerospace, defense and healthcare, and communications markets through a direct sales force, third-party distributors, and independent sales representatives, as well as online.Analog Devices, Inc. was incorporated in 1965 and is headquartered in Wilmington, Massachusetts.","United States","1965","Apr 3, 1972","Semiconductors","Technology","26,000","Vincent T. Roche","One Analog WayWilmington, Massachusetts 01887United States","(781) 329-4700","analog.com","ADI","NASDAQ","USD","0000006281",null,"US0326541051","04-2348234","3674",{"Chief Executive Officer and Chair of the Board of Directors":"Vincent T. Roche","Co-Founder and Board Member":"Dr. Raymond S. Stata Ph.D.","Executive Vice President of Global Operations and Technology":"Vivek Jain","Executive Vice President and Chief Customer Officer":"Anelise Sacks","Executive Vice President and President of Business Units":"Gregory M. Bryant","Executive Vice President and Chief Financial Officer":"Richard C. Puccio Jr.","Corporate Vice President and Chief Accounting Officer":"Michael Sondel","Senior Vice President and Chief Technology Officer":"Alan Lee","Vice President, Investor Relations and FP&A":"Michael C. Lucarelli","Chief Legal Officer and Corporate Secretary":"Janene I. Asgeirsson"},"99.00B","11.57B","2.82B",null,"5.59","35.71","33.80","$3.68 (1.84%)","Mar 4, 2024","2,372,267","199.04","196.49","199.04 - 201.83","154.99 - 204.20","1.16","Buy","208.00 (+4.19%)","May 22, 2024"],["Adial Pharmaceuticals, Inc.","Adial Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment or prevention of addiction and related disorders.Its lead product is AD04, a serotonin-3 antagonist, which is in Phase III clinical trial for the treatment of alcohol use disorder.The company also focuses on developing drug candidates for non-opioid pain reduction and other diseases and disorders.Adial Pharmaceuticals, Inc. was founded in 2010 and is based in Charlottesville, Virginia.","United States","2010","Jul 30, 2018","Biotechnology","Healthcare","4","Cary John Claiborne MBA","1180 Seminole Trail, Suite 495Charlottesville, Virginia 22901United States","434-422-9800","adialpharma.com","ADIL","NASDAQ","USD","0001513525",null,"US00688A2050","80-0667150","2834",{"Chief Executive Officer, President and Director":"Cary John Claiborne MBA","Founder and Chief Medical Officer":"Dr. Bankole A. Johnson DSc, FRCPsych, M.D., M.Phil, Ph.D.","Chief Financial Officer, Treasurer and Secretary":"Joseph A. M. Truluck M.B.A., MBA","Chief Operating Officer and Director":"Tony Goodman","Chief Legal Officer":"John R. Martin J.D.","Controller":"Catherine Fratila"},"6.89M","n/a","-5.12M",null,"-3.60","n/a","n/a","n/a","n/a","107,241","1.800","1.790","1.670 - 1.826","0.770 - 14.000","1.53","Strong Buy","150.00 (+8,723.53%)","May 14, 2024"],["Archer-Daniels-Midland Company","Archer-Daniels-Midland Company engages in the procurement, transportation, storage, processing, and merchandising of agricultural commodities, ingredients, flavors, and solutions in the United States, Switzerland, the Cayman Islands, Brazil, Mexico, Canada, the United Kingdom, and internationally.It operates in three segments: Ag Services and Oilseeds, Carbohydrate Solutions, and Nutrition. The company originates, merchandises, stores, and transports agricultural raw materials, such as oilseeds and soft seeds.It also engages in the agricultural commodity and feed product import, export, and distribution; and various structured trade finance activities.In addition, the company offers soybean meal and oil; vegetable and salad oils and protein meals; ingredients for the food, feed, energy, and industrial customers; margarine, shortening, and other food products; and partially refined oils to produce biodiesel and glycols for use in chemicals, paints, and other industrial products.Further, it provides peanuts, peanut-derived ingredients, and cotton cellulose pulp; sweeteners, corn and wheat starches, syrup, glucose, wheat flour, and dextrose; alcohol, and other food and animal feed ingredients; ethyl alcohol and ethanol; corn gluten feed and meal; distillers' grains; corn germ; and citric acids.Additionally, the company provides proteins, natural flavors, flavor systems, natural colors, emulsifiers, soluble fiber, polyols, hydrocolloids, probiotics, prebiotics, postbiotics, enzymes, and botanical extracts; and other specialty food and feed ingredients; edible beans; formula feeds, and animal health and nutrition products; and contract and private label pet treats and food products.It also offers futures commission merchant; commodity brokerage services; cash margins and securities pledged to commodity exchange clearinghouse; and cash pledged as security under certain insurance arrangements.The company was founded in 1902 and is headquartered in Chicago, Illinois.","United States","1902",null,"Farm Products","Consumer Staples","41,802","Juan Ricardo Luciano","77 W. Wacker Dr.Chicago, Illinois 60601United States","312-634-8233","adm.com","ADM","NYSE","USD","0000007084",null,"US0394831020","41-0129150","2070",{"Chairman, Chief Executive Officer and President":"Juan Ricardo Luciano","President of Animal Nutrition and Senior Vice President of Nutrition Operations":"Joseph Daniel Taets","Senior Vice President and President of Carbohydrate Solutions":"Christopher M. Cuddy","Senior Vice President and President of Agricultural Services and Oilseeds":"Gregory A. Morris","Senior Vice President and Interim Chief Financial Officer":"Ismael Roig","Senior Vice President of Global Operations":"Dermot O'Grady","Vice President and Corporate Controller":"Molly L. Strader Fruit","Senior Vice President and Chief Information Officer":"Kristy J. Folkwein","Senior Vice President and Chief Science Officer":"Dr. Nuria Miquel","Vice President of Investor Relations":"Megan Britt"},"29.69B","91.71B","3.04B",null,"5.72","10.34","10.37","$2.00 (3.38%)","May 15, 2024","2,580,511","59.31","59.35","58.86 - 59.68","50.72 - 87.30","0.77","Hold","66.21 (+11.9%)","Apr 30, 2024"],["ADMA Biologics, Inc.","ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally.The company offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primary humoral immunodeficiency (PI); ASCENIV, an IVIG product for the treatment of PI; and Nabi-HB for the treatment of acute exposure to blood containing Hepatitis B surface antigen and other listed exposures to Hepatitis B.It develops a pipeline of plasma-derived therapeutics, including products related to the methods of treatment and prevention of S.pneumonia infection for an immunoglobulin. In addition, it operates source plasma collection facilities.The company sells its products through independent distributors, drug wholesalers, specialty pharmacies, and other alternate site providers.ADMA Biologics, Inc. was incorporated in 2004 and is headquartered in Ramsey, New Jersey.","United States","2004",null,"Biotechnology","Healthcare","624","Adam S. Grossman","C/o Adma Biologics, Inc., 465 State Route 17Ramsey, New Jersey 07446United States","(201) 478-5552","admabiologics.com","ADMA","NASDAQ","USD","0001368514",null,"US0008991046","56-2590442","2836",{"Co-Founder, President, Chief Executive Officer and Director":"Adam S. Grossman","Co-Founder and Vice Chairman of the Board":"Dr. Jerrold B. Grossman D.P.S., Ph.D.","Executive Vice President, Chief Financial Officer and GM of ADMA BioCenters":"Brian Lenz CPA","Chief Operating Officer and Senior Vice President of Compliance":"Kaitlin Kestenberg","Vice President of Marketing and Corporate Development":"Drew Pantello","Executive Director of Human Resources":"Cindy Petersen","Senior Director of Business Development and Corporate Strategy":"Skyler Bloom"},"1.58B","258.22M","-28.24M",null,"-0.13","n/a","21.20","n/a","n/a","2,903,849","6.78","6.74","6.65 - 6.81","3.06 - 6.81","0.43","Strong Buy","7.88 (+15.71%)","May 13, 2024"],["Advent Technologies Holdings, Inc.","Advent Technologies Holdings, Inc., an advanced materials and technology development company, operates in the fuel cell and hydrogen technology markets in North America, Europe, and Asia.It develops, manufactures, and assembles fuel cell systems and critical components that determine the performance of hydrogen fuel cells and other energy systems.The company offers high-temperature proton exchange membrane (HT-PEM) fuel cells, including membrane electrode assemblies, bipolar plates, and reformers, as well as provides fuel-cell stack assembly and testing services.It serves stationary power, portable power, automotive, aviation, energy storage, and sensor markets.The company is headquartered in Boston, Massachusetts.","United States","2006",null,"Utilities - Renewable","Utilities","175","Dr. Vassilios  Gregoriou Ph.D.","500 Rutherford Avenue, Suite 102Boston, Massachusetts 02129United States","857-264-7035","advent.energy","ADN","NASDAQ","USD","0001744494",null,"US00788A1051","83-0982969","3690",{"Chief Executive Officer and Chairman":"Dr. Vassilios Gregoriou Ph.D.","Chief Operating Officer, General Counsel and Corporate Secretary":"James F. Coffey J.D.","Chief Technology Officer and Executive Director":"Dr. Emory Sayre De Castro Ph.D.","Chief Strategy Officer":"Dr. Christos Kaskavelis Ph.D.","Senior Vice President of Corporate Business Development - Advent Technologies SA and Director":"Dr. Panoraia Gourdoupi Ph.D.","Senior Vice President":"Morten Hougaard Sorensen"},"8.31M","5.31M","-93.29M",null,"-1.76","n/a","n/a","n/a","n/a","1,461,722","0.121","0.115","0.104 - 0.121","0.104 - 1.130","0.06","Hold","0.60 (+421.74%)","May 14, 2024"],["Adient plc","Adient plc engages in the design, development, manufacture, and market of seating systems and components for passenger cars, commercial vehicles, and light trucks.The company's automotive seating solutions include complete seating systems, frames, mechanisms, foams, head restraints, armrests, and trim covers.It serves automotive original equipment manufacturers in North America and South America; Europe, Middle East, and Africa; and the Asia Pacific/China.Adient plc was incorporated in 2016 and is based in Dublin, Ireland.","Ireland",null,null,"Auto Parts","Consumer Discretionary","70,000","Jerome J. Dorlack","3 Dublin Landings, North Wall QuayDublin, L2 D01 H104Ireland","1-734-254-5000","adient.com","ADNT","NYSE","USD","0001670541",null,"IE00BD845X29",null,"3714",{"President, Chief Executive Officer and Director":"Jerome J. Dorlack","Executive Vice President, Chief Legal and Human Resource Officer and Corporate Secretary":"Heather M. Tiltmann","Executive Vice President of APAC":"Jian James Huang","Executive Vice President of EMEA":"Michel Pierre-Rose Berthelin","Executive Vice President and Chief Financial Officer":"Mark A. Oswald","Senior Vice President and Chief Accounting Officer":"Gregory Scott Smith","Executive Vice President - Americas":"James Conklin","Vice President of Global Sustainability":"Stephanie S. Marianos"},"2.50B","15.19B","158.00M",null,"1.63","16.82","8.82","n/a","n/a","2,107,731","30.37","30.22","26.97 - 30.89","26.97 - 46.51","2.40","Buy","42.83 (+56.26%)","May 3, 2024"],["Automatic Data Processing, Inc.","Automatic Data Processing, Inc. provides cloud-based human capital management solutions worldwide.It operates in two segments, Employer Services and Professional Employer Organization (PEO). The Employer Services segment offers strategic, cloud-based platforms, and human resources (HR) outsourcing solutions.Its offerings include payroll services, benefits administration, talent management, HR management, workforce management, insurance, retirement, and compliance services, as well as integrated HCM solutions.The PEO Services segment provides HR outsourcing solution to businesses through a co-employment model.This segment offers employee benefits, protection and compliance, talent engagement, expertise, comprehensive outsourcing, and recruitment process outsourcing services.Automatic Data Processing, Inc. was founded in 1949 and is headquartered in Roseland, New Jersey.","United States","1949",null,"Staffing & Employment Services","Industrials","63,000","Ms. Maria  Black","One Adp BoulvardRoseland, New Jersey 07068United States","(973) 974-5000","adp.com","ADP","NASDAQ","USD","0000008670",null,"US0530151036","22-1467904","7374",{"President, Chief Executive Officer and DIrector":"Maria Black","Chief Financial Officer":"Don Edward McGuire","Chief Operating Officer":"John C. Ayala","Chief Administrative Officer":"Michael Anthony Bonarti","President of Global Sales":"Joseph DeSilva Jr.","Corporate Controller and Principal Accounting Officer":"Brock Albinson","Global Chief Information Officer":"Max Li","Corporate Vice President, Chief Legal Officer and General Counsel":"David Kwon","Vice President of External Communications":"Allyce Hackmann","Chief Marketing Officer":"Gus Blanchard"},"99.37B","18.91B","3.70B",null,"8.97","26.97","24.57","$5.60 (2.32%)","Jun 14, 2024","1,491,510","243.02","242.03","239.32 - 243.67","205.53 - 256.84","0.79","Hold","252.67 (+4.46%)","May 1, 2024"],["Adaptive Biotechnologies Corporation","Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases.The company offers immunosequencing platform which combines a suite of proprietary chemistry, computational biology, and machine learning to generate clinical immunomics data to decode the adaptive immune system.It also provides clonoSEQ diagnostic test which detects and monitors the remaining number of cancer cells that are present in a patient's body during and after treatment, known as Minimal Residual Disease (MRD).The company offers products and services for life sciences research, clinical diagnostics, and drug discovery applications.Adaptive Biotechnologies Corporation has strategic collaborations with Genentech, Inc. for the development, manufacture, and commercialization of neoantigen directed T cell therapies for the treatment of a range of cancers; and Microsoft Corporation to develop diagnostic tests for the early detection of various diseases from a single blood test.The company was formerly known as Adaptive TCR Corporation and changed its name to Adaptive Biotechnologies Corporation in December 2011.Adaptive Biotechnologies Corporation was incorporated in 2009 and is headquartered in Seattle, Washington.","United States","2009","Jun 27, 2019","Biotechnology","Healthcare","709","Ms. Julie  Rubinstein","1165 Eastlake Ave ESeattle, Washington 98109United States","206-659-0067","adaptivebiotech.com","ADPT","NASDAQ","USD","0001478320",null,"US00650F1093","27-0907024","2836",{"Co-Founder, Chief Executive Officer and Chairman":"Chad M. Robins M.B.A.","President and Chief Operating Officer":"Julie Rubinstein","Co-Founder and Chief Scientific Officer":"Dr. Harlan S. Robins Ph.D.","Vice President, Chief Financial Officer and Principal Accounting Officer":"Kyle Piskel","Chief Commercial Officer of Immune Medicine":"Dr. Sharon Benzeno Ph.D.","Founder":"Christopher Carlson Ph.D.","Vice President of Investor Relations":"Karina Calzadilla","Senior Vice President, General Counsel and Corporate Secretary":"Stacy L. Taylor","Chief People Officer":"Francis T. Lo","Chief Commercial Officer of MRD":"Susan Bobulsky"},"443.58M","170.28M","-225.25M",null,"-1.56","n/a","n/a","n/a","n/a","1,085,966","2.990","2.930","2.950 - 3.140","2.280 - 9.080","1.24","Buy","6.80 (+125.91%)","May 7, 2024"],["Ault Disruptive Technologies Corporation","Ault Disruptive Technologies Corporation does not have significant operations.It focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or other business combination with one or more businesses in technology sector.Ault Disruptive Technologies Corporation was incorporated in 2021 and is based in Las Vegas, Nevada.","United States","2021","Dec 16, 2021","Shell Companies","Financials","1","William B. Horne","11411 Southern Highlands Pkwy 240Las Vegas, Nevada 89141United States","(949) 444-5464","aultdisruptive.com","ADRT","NYSEAMERICAN","USD","0001864032",null,"US05150A1043","86-2279256","6770",{"Chief Executive Officer and Director":"William B. Horne","President, General Counsel and Director":"Henry C. W. Nisser Esq.","Chief Financial Officer":"Kenneth S. Cragun CPA","Senior Vice President of Finance":"David J. Katzoff"},"37.92M","n/a","834,518",null,"0.10","128.90","n/a","n/a","n/a","5","12.89","12.69","12.89 - 13.48","10.41 - 15.18","0.01","n/a","n/a","n/a"],["ADS-TEC Energy PLC","ADS-TEC Energy PLC provide intelligent and decentralized energy storage systems in Europe and North America.Its portfolio of ecosystem platforms provides DC-based ultra-fast chargers for EVs on power limited grids, energy storage and management solutions for commercial and industrial applications, and energy storage and management solutions for residential sector coupling applications.The company offers ChargeBox, which contains the battery and power inverters; ChargePost, a semi-mobile ultra-high-power charger; and ChargeTrailer, a mobile high power charging system in the form of a standard truck trailer, that has a variety of integrated inverters, air-conditioners, an energy management unit, and security firewall, as well as a communication unit through mobile radio and DC-charging technology.It also provides PowerBooster, a battery energy system that boosts capacity for the charging process; Container-Systems, a custom battery system for large-scale applications as 20- or 40-foot container solutions; rack systems; and digital services.In addition, the company is developing MyPowerplant platform for residential applications. Its products are used in private homes, public buildings, commercial enterprises, industrial and infrastructure solutions, and self-sufficient energy supply systems.ADS-TEC Energy PLC was founded in 2008 and is based in Dublin, Ireland.","Ireland","1980",null,"Electrical Equipment & Parts","Industrials","189","Thomas Gerhart Speidel","10 Earlsfort Terrace, Dublin 2Dublin, L2 D02 T380Ireland","35319201000","adstec-energy.com","ADSE","NASDAQ","USD","0001879248",null,"IE000DU292E6",null,"3790",{"Founder, Chief Executive Officer and Director":"Thomas Gerhart Speidel","Chief Financial Officer":"Wolfgang Breme","Chief Technology Officer":"Dr. Thorsten Ochs","Chief Sales Officer":"John S. Neville","Chief Marketing Officer":"Elaine Weidman-Grunewald","Chief Production Officer":"Hakan Konyar","Global Head of Corporate Affairs":"John Tuccillo","Chief Purchase and Logistics Officer":"Sebastian Schypulla","Senior Vice President":"Renato Gross","President and Chief Executive Officer of ADS-TEC Energy Inc":"Gowton Achaibar"},"534.19M","119.32M","-61.20M",null,"-1.22","n/a","n/a","n/a","n/a","36,391","10.70","10.77","10.38 - 10.93","2.13 - 11.48","0.47","Hold","3.00 (-72.14%)","May 14, 2024"],["Autodesk, Inc.","Autodesk, Inc. provides 3D design, engineering, and entertainment technology solutions worldwide.The company offers AutoCAD Civil 3D, a surveying, design, analysis, and documentation solution for civil engineering, including land development, transportation, and environmental projects; BuildingConnected, a SaaS preconstruction solution; AutoCAD, a software for professional design, drafting, detailing, and visualization; AutoCAD LT, a drafting and detailing software; computer-aided manufacturing (CAM) software for computer numeric control machining, inspection, and modelling for manufacturing; Fusion 360, a 3D CAD, CAM, and computer-aided engineering tool; and Industry Collections tools for professionals in architecture, engineering and construction, product design and manufacturing, and media and entertainment collection industries.It also provides Inventor tools for 3D mechanical design, simulation, analysis, tooling, visualization, and documentation; Vault, a data management software to manage data in one central location, accelerate design processes, and streamline internal/external collaboration; Maya and 3ds Max software products that offer 3D modeling, animation, effects, rendering, and compositing solutions; and ShotGrid, a cloud-based software for review and production tracking in the media and entertainment industry.It sells its products and services to customers directly, as well as through a network of resellers and distributors.Autodesk, Inc. was incorporated in 1982 and is headquartered in San Francisco, California.","United States","1982",null,"Software - Application","Technology","13,700","Dr. Andrew  Anagnost","One Market, Ste. 400.San Francisco, California 94105United States","(415) 507-5000","autodesk.com","ADSK","NASDAQ","USD","0000769397",null,"US0527691069","94-2819853","7372",{"President, Chief Executive Officer and Director":"Dr. Andrew Anagnost","Executive Vice President and Chief Financial Officer":"Deborah L. Clifford","Executive Vice President and Chief Operating Officer":"Steven M. Blum","Executive Vice President, Corporate Affairs, Chief Legal Officer and Corporate Secretary":"Ruth Ann Keene","Executive Vice President and Chief People Officer":"Rebecca Pearce","Founder":"Greg Lutz","Vice President and Chief Accounting Officer":"Stephen W. Hope","Executive Vice President and Chief Technology Officer":"Venmal Arasu"},"46.03B","5.35B","917.00M",null,"4.25","50.63","27.57","n/a","n/a","1,185,355","214.37","209.95","214.14 - 217.35","189.54 - 279.53","1.42","Buy","279.06 (+29.68%)","May 23, 2024"],["ADT Inc.","ADT Inc. provides security, interactive, and smart home solutions to residential and small business customers in the United States.It operates through two segments, Consumer and Small Business, and Solar. The company provides burglar and life safety alarms, smart security cameras, smart home automation systems, and video surveillance systems.It primarily offers security designed to detect intrusion, control access, sense movement, smoke, fire, carbon monoxide, flooding, temperature, and other environmental conditions and hazards; and address personal medical emergencies, such as injuries or unanticipated falls.The company also provides automation and smart home solutions that allow customers to use their smart phones, smart phone application, or touchscreen panels in their homes to arm and disarm their security systems; record and view real-time video; and creates customized and automated schedules for connected devices; programs systems to react to defined events; integrates system with third-party connected devices, such as cameras, lights, thermostats, appliances, and garage doors, as well as offers monitoring and maintenance services.In addition, the company offers energy storage solutions, energy efficiency upgrades, and roofing services.It offers its products under the ADT, ADT Pulse, ADT+, and ADT Commercial brand names. The company was formerly known as Prime Security Services Parent, Inc. and changed its name to ADT Inc. in September 2017.ADT Inc. was founded in 1874 and is headquartered in Boca Raton, Florida.","United States","1874","Jan 19, 2018","Security & Protection Services","Industrials","14,300","James David DeVries","1501 Yamato RoadBoca Raton, Florida 33431United States","212-515-3200","adt.com","ADT","NYSE","USD","0001703056",null,"US00090Q1031","47-4116383","7381",{"Chief Executive Officer, President and Chairman":"James David DeVries","Interim Chief Financial Officer, President of Corporate Development and Chief Transformation Officer":"Jeffrey A. Likosar","Executive Vice President and Chief Operating Officer":"Donald M. Young","Executive Vice President, Chief Legal Officer and Secretary":"David W. Smail Esq.","Vice President, Chief Accounting Officer and Controller":"Steven Burzo","Senior Vice President and Chief Technology Officer":"Raya Sevilla","Executive Vice President and Chief People and Administration Officer":"David A. Scott","Senior Vice President of Finance, Investor Relations and Communications":"Jill Sullivan Greer","Executive Vice President and Chief Marketing Officer":"DeLu Jackson","Senior Vice President and Chief Human Resources Officer":"Amelia O. Pulliam"},"5.72B","5.26B","673.40M",null,"0.74","9.03","10.90","$0.22 (3.29%)","Jun 13, 2024","3,816,975","6.75","6.65","6.57 - 6.83","5.44 - 7.60","1.57","Hold","8.33 (+24.7%)","Apr 25, 2024"],["AdTheorent Holding Company, Inc.","AdTheorent Holding Company, Inc., a digital media platform, provides programmatic digital advertising services for advertising agency and brand customers in the United States, Canada, and internationally.It uses machine learning and advanced data science to organize, analyze, and operationalize non-sensitive data to deliver real-world value for customers.The company offers predictive targeting solutions across various customer industry verticals and consumer screens, including customized targeting, measurement, and analytical services; and location-based targeting and geo-intelligence solutions.AdTheorent Holding Company, Inc. was founded in 2012 and is headquartered in New York, New York.","United States","2020",null,"Advertising Agencies","Communication Services","301","James A. Lawson","330 Hudson Street, 13th FloorNew York, New York 10013United States","800-804-1359","adtheorent.com","ADTH","NASDAQ","USD","0001838672",null,"US00739D1090","85-3978415","7370",{"Chief Executive Officer and Director":"James A. Lawson","Chief Revenue Officer":"William Todd","Co-Founder and Chief Innovation Officer":"Josh Walsh","Chief Financial Officer":"Patrick Elliott","Chief Technology Officer":"Andrew L. Anderson","Vice President of Communications and Marketing":"Melanie Berger","Senior Vice President of National Sales":"Nick Cheetany","Senior Vice President of Human Resources":"Amy Raucher","Senior Vice President of Strategy":"Calynn Krieger","Senior Vice President and Chief Information Security Officer":"Indir Avdagic"},"296.78M","172.99M","-4.62M",null,"-0.05","n/a","27.38","n/a","n/a","6,491,726","3.210","3.240","3.200 - 3.300","1.110 - 3.980","1.25","Buy","4.92 (+51.85%)","May 2, 2024"],["ADTRAN Holdings, Inc.","ADTRAN Holdings, Inc., through its subsidiaries, provides networking and communications platforms, software, systems, and services in the United States, Germany, the United Kingdom, and internationally.It operates through two segments, Network Solutions, and Services & Support. It offers residential gateways; ethernet passive optical network ONUs; gigabit passive optical network/XGS-PON ONTs; traditional SSE, routers, and switches; edge cloud; carrier ethernet network interface devices; Optical Line Terminals; Packet Aggregation, Copper Access, and Oscilloquartz; optical transport and engine solutions; infrastructure monitoring solution; and training, professional, software, and managed services.The company also provides various software, such as Mosaic One SaaS, n-Command, Procloud, MCP, AOE and ACI-E, and Ensemble Controller.It serves large, medium, and small service providers; alternative service providers, such as utilities, municipalities and fiber overbuilders; cable/MSOs; and SMBs and distributed enterprises.ADTRAN Holdings, Inc. was incorporated in 1985 and is headquartered in Huntsville, Alabama.","United States","1985","Aug 9, 1994","Communication Equipment","Technology","3,227","Thomas R. Stanton","901 Explorer BlvdHuntsville, Alabama 35806United States","256-963-8220","adtran.com","ADTN","NASDAQ","USD","0000926282",null,"US00486H1059","87-2164282","3661",{"President, Chief Executive Officer and Chairman":"Thomas R. Stanton","Senior Vice President, Chief Financial Officer, Corporate Secretary and Treasurer":"Ulrich Dopfer","Chief Technology Officer":"Dr. Christoph Glingener","Chief Revenue Officer":"James D. Wilson Jr.","Vice President of Human Resources":"Joia Thompson","Chief Technology Officer of The EMEA and APAC Regions":"Ronan Kelly","President at CalChip Connect":"TJ Rancour","Head of Global Business Development":"Keith Atwell"},"375.01M","1.28B","-118.86M",null,"-1.32","n/a","78.74","$0.18 (3.90%)","Aug 18, 2023","499,968","4.680","4.620","4.620 - 4.930","4.340 - 11.020","1.09","Buy","7.75 (+67.75%)","May 6, 2024"],["Aditxt, Inc.","Aditxt, Inc., a biotech company, develops technologies focuses on improving the health of the immune system through immune mapping and reprogramming.The company develops AditxtScore that allows individuals to understand, manage, and monitor their immune profiles in order to be informed about attacks on or by their immune system; and Apoptotic DNA Immunotherapy, a nucleic acid-based technology that utilizes an approach that mimics the way the body naturally induces tolerance to its own tissues.It is also developing ADi products for organ transplantation, including skin grafting, autoimmune diseases, and allergies.Aditxt, Inc. has a license agreement with Loma Linda University and Leland Stanford Junior University.The company was formerly known as ADiTx Therapeutics, Inc. and changed its name to Aditxt, Inc. in July 2021.Aditxt, Inc. was incorporated in 2017 and is headquartered in Richmond, Virginia.","United States","2017","Jun 30, 2020","Biotechnology","Healthcare","47","Amro A. Albanna","737 N. Fifth Street, Suite 200Richmond, Virginia 23219United States","909-488-0844","aditxt.com","ADTX","NASDAQ","USD","0001726711",null,"US0070256047","82-3204328","2834",{"Co-Founder, Chairman and Chief Executive Officer":"Amro A. Albanna","Co-Founder, Chief Innovation Officer, Secretary and Director":"Dr. Shahrokh Shabahang D.D.S., M.S., Ph.D.","Chief Financial Officer":"Thomas J. Farley CPA","Chief Commercialization Officer":"Corinne D. Pankovcin CPA, M.B.A.","Chief Operating Officer":"Rowena Albanna","Director of Human Resources":"Jennifer Lee","Senior Vice President of Clinical Development ? Transplantation":"Dr. Dolly B. Tyan Ph.D.","Senior Vice President of Preclinical Research and Discovery":"Ge Chen M.D., M.S."},"4.51M","645,176","-32.70M",null,"-108.15","n/a","0.37","n/a","n/a","43,912","2.370","2.400","2.280 - 2.400","2.140 - 68.080","1.03","Strong Buy","61.00 (+2,552.17%)","May 14, 2024"],["Addus HomeCare Corporation","Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States.The company operates through three segments: Personal Care, Hospice, and Home Health. The Personal Care segment provides non-medical assistance with activities of daily living.This segment offers services that include assistance with bathing, grooming, oral care, feeding and dressing, medication reminders, meal planning and preparation, housekeeping, and transportation services.The Hospice segment provides palliative nursing care, social work, spiritual counseling, homemaker, and bereavement counseling services for people who are terminally ill, as well as related services for their families.The Home Health segment offers skilled nursing and physical, occupational, and speech therapy for the individuals who requires assistance during an illness or after hospitalization.The company's payor clients include federal, state, and local governmental agencies; managed care organizations; commercial insurers; and private individuals.Addus HomeCare Corporation was founded in 1979 and is headquartered in Frisco, Texas.","United States","1979","Oct 28, 2009","Medical Care Facilities","Healthcare","34,846","R. Dirk Allison","6303 Cowboys Way, Suite 600Frisco, Texas 75034United States","469-535-8200","addus.com","ADUS","NASDAQ","USD","0001468328",null,"US0067391062","20-5340172","8082",{"Chief Executive Officer and Chairman of the Board":"R. Dirk Allison","President and Chief Operating Officer":"W. Bradley Bickham","Chief Financial Officer, Executive Vice President, Secretary and Treasurer":"Brian W. Poff","Executive Vice President and Chief Compliance and Quality Officer":"Monica Raines","Executive Vice President and Chief Development Officer":"Cliff Blessing","Senior Vice President and Chief Accounting Officer":"Zach Simpson","Executive Vice President and Chief Information Officer":"Michael D. Wattenbarger","Executive Vice President and Chief Legal Officer":"Sean P. Gaffney","Executive Vice President and Chief Human Resource Officer":"Roberton James Stevenson","Executive Vice President and Chief Government Relations Officer":"Darby Anderson"},"1.61B","1.06B","62.52M",null,"3.83","25.64","20.13","n/a","n/a","115,101","99.28","98.41","96.39 - 99.28","78.35 - 104.61","0.95","Buy","103.00 (+4.89%)","May 6, 2024"],["AllianceBernstein Holding L.P.","AllianceBernstein Holding L.P. is a publicly owned investment manager.The firm is a related adviser The firm manages separate client focused portfolios for its clients. The firm primarily invests in common and preferred stocks, warrants and convertible securities, government and corporate fxed-income securities, commodities, currencies, real estate-related assets and infation-protected securities.The firm employs quantitative analysis along with long-term purchases, short-term purchases, trading, short sales, margin transactions, option strategies including writing covered options, uncovered options and spread strategies to make its investments.The firm obtains external research to complement its in-house research. The firm was formerly known as Alliance Capital Management Holding LP.AllianceBernstein Holding L.P. was founded in 1967 and is based in Nashville,Tennessee.","United States","1987","Apr 14, 1988","Asset Management","Financials","4,707","Karl K Sprules","501 Commerce StreetNashville, Tennessee 37203United States","(615) 622-0000","alliancebernstein.com","AB","NYSE","USD","0000825313",null,"US01881G1067","13-3434400","6282",{"President and Director":"Seth Perry Bernstein","Chief Operating Officer":"Karl K Sprules","Senor Vice President, General Counsel and Corporate Secretary":"Mark Randall Manley J.D.","Head of Global Client Group and Head of Private Wealth":"Onur Erzan","Chief Executive Officer":"Robert P. van Brugge","Chief Financial Officer":"Jacqueline Marks","Chief Investment Officer and Head of Multi-Asset and Hedge Fund Solutions":"Daniel J. Loewy C.F.A., CFA","Senior Vice President, Controller and Chief Accounting Officer":"Thomas Simeone","Head of Investor Relations":"Mark C. Griffin CFA","Director of Corporate Communications":"John Meyers"},"3.82B","309.68M","273.97M",null,"2.41","13.76","10.09","$2.92 (8.81%)","May 3, 2024","244,494","32.82","32.55","32.70 - 33.70","25.83 - 35.84","1.28","Strong Buy","41.19 (+24.22%)","Apr 25, 2024"],["Ameris Bancorp","Ameris Bancorp operates as the bank holding company for Ameris Bank that provides range of banking services to retail and commercial customers.It operates through five segments: Banking Division, Retail Mortgage Division, Warehouse Lending Division, SBA Division, and Premium Finance Division.The company offers commercial and retail checking, regular interest-bearing savings, money market, individual retirement, and certificates of deposit accounts.It also provides commercial real estate, residential real estate mortgage, agricultural, and commercial and industrial loans; consumer loans, including motor vehicle, home improvement, and home equity loans, as well as loans secured by savings accounts and personal credit lines.In addition, the company originates, administers, and services commercial insurance premium loans, equipment finance loans, and small business administration loans.It operates full service domestic banking offices, and mortgage and loan production offices. The company was founded in 1971 and is headquartered in Atlanta, Georgia.","United States","1971",null,"Banks - Regional","Financials","2,765","H. Palmer Proctor Jr.","3490 Piedmont Rd, Suite 1550Atlanta, Georgia 30305United States","(404) 639-6500","amerisbank.com","ABCB","NASDAQ","USD","0000351569",null,"US03076K1088","58-1456434","6022",{"Executive Chairman":"James B. Miller Jr.","Vice Chairman and Chief Executive Officer":"H. Palmer Proctor Jr.","Corporate Executive Vice President and Chief Financial Officer":"Nicole S. Stokes CPA","Corporate Executive Vice President and Chief Strategy Officer":"James Allan LaHaise III","Corporate Executive Vice President and Chief Banking Officer":"Lawton E. Bassett III","Corporate Executive Vice President and Chief Information Officer":"Ross L. Creasy","Corporate Executive Vice President and Chief Legal Officer":"Jody L. Spencer Esq., J.D.","Corporate Executive Vice President and Chief Risk Officer":"William B. McKendry","Executive Vice President and Managing Director in Homebuilder Division":"Ross McWilliams","Corporate Executive Vice President and Chief Credit Officer":"Doug Strange"},"3.44B","935.22M","269.11M",null,"3.89","12.81","10.97","$0.60 (1.20%)","Mar 27, 2024","271,131","49.86","48.68","49.19 - 49.99","28.39 - 53.99","1.06","Strong Buy","50.20 (+0.76%)","Apr 25, 2024"],["AbCellera Biologics Inc.","AbCellera Biologics Inc. builds an engine for antibody drug discovery and development.Its engine discovers antibodies from natural immune responses, which are pre-enriched for antibodies.The company's preclinical products are ABCL635 for metabolic and endocrine conditions; and ABCL575 for atopic dermatitis.It has a research collaboration and license agreement with Eli Lilly and Company; a research collaboration with Confo Therapeutics for the discovery of therapeutic antibody candidates targeting two undisclosed GPCR targets; and strategic collaboration with Biogen Inc. to discover therapeutic antibodies for neurological conditions, as well as collaboration with Viking Global Investors and ArrowMark Partners.The company was incorporated in 2012 and is headquartered in Vancouver, Canada.","Canada","2012","Dec 11, 2020","Biotechnology","Healthcare","586","Dr. Carl L.G. Hansen Ph.D.","2215 Yukon StreetVancouver, A1 V5Y 0A1British Columbia, Canada","(604) 559-9005","abcellera.com","ABCL","NASDAQ","USD","0001703057",null,"CA00288U1066",null,"2834",{"Chief Executive Officer, President and Chairperson":"Dr. Carl L.G. Hansen Ph.D.","Chief Financial Officer":"Andrew Booth M.B.A.","Chief Operating Officer and Director":"Dr. Veronique Lecault Ph.D.","Chief Legal Officer, CCO, Compliance Officer, Corporate Secretary and Privacy Officer":"Tryn T. Stimart Esq., J.D., M.Sc.","Chief Commercial Officer":"Neil Aubuchon B.A., M.B.A.","Senior Director of Finance and Accounting":"Marcie Thiessen CPA, CGA","Chief Technology Officer":"Dr. Ester Falconer Ph.D.","Head of Corporate Communications":"Kathleen Reid B.A.","Director of Corporate Development":"Graham Craig M.Sc.","Senior Vice President of Partnering":"Murray McCutcheon Ph.D."},"1.18B","38.03M","-146.40M",null,"-0.51","n/a","27.47","n/a","n/a","2,199,529","3.920","3.850","3.920 - 4.200","3.620 - 8.050","0.36","Strong Buy","19.00 (+371.46%)","May 7, 2024"],["Ambev S.A.","Ambev S.A., through its subsidiaries, engages in the production, distribution, and sale of beer, draft beer, carbonated soft drinks, other non-alcoholic beverages, malt, and food products.It offers beer primarily under the Skol, Brahma, Antarctica, Brahva, Budweiser, Bud Light, Beck, Leffe and Hoegaarden, Bucanero, Cristal, Mayabe, Presidente, Presidente Light, Brahma Light, Bohemia, The One, Corona, Modelo Especial, Stella Artois, Quilmes Clásica, Paceña, Taquiña, Huari, Becker, Cusqueña, Michelob Ultra, Busch, Pilsen, Ouro Fino, Banks, Deputy, Patricia, Labatt Blue, Alexander Keith's, and Kokanee brands.The company also provides carbonated soft drinks, bottled water, isotonic beverages, energy drinks, coconut water, powdered and natural juices, and ready-to-drink teas under the Guaraná Antarctica, Gatorade, H2OH!, Lipton Iced Tea, Fusion, Do Bem, Pepsi-Cola, Canada Dry, Squirt, Red Rock, Red Bull, Seven Up, Nutrl, Bud Light Seltzer, Palm Bay, and Mike's brands.It offers its products through a network of third-party distributors and a direct distribution system.The company was founded in 1885 and is headquartered in São Paulo, Brazil. Ambev S.A. operates as a subsidiary of Interbrew International B.V.","Brazil","1885",null,"Beverages - Brewers","Consumer Staples","42,774","Jean Jereissati Neto","Rua Dr. Renato Paes De Barros, 1017, 3 Andar ParteSao Paulo, D5 04530-000Brazil","55(11)2122-1414","ambev.com.br","ABEV","NYSE","USD","0001565025",null,"US02319V1035",null,"2080",{"Chief Executive Officer and Member of Executive Board":"Jean Jereissati Neto","Member of Board of Executive Officers, Chief Financial and IR and Shared Services Officer":"Lucas Machado Lira","Vice President Officer of Commercial and Member of Executive Board of Officers":"Eduardo Braga Cavalcanti de Lacerda","Vice President Officer of People and Management and Member of Executive Board of Officers":"Ricardo Morais Pereira de Melo","Vice President Officer of Legal and Compliance, Member of Executive Board of Officers and Secretary":"Leticia Rudge Barbosa Kina","Vice President Officer of Logistics and Member of Executive Board of Officers":"Paulo André Zagman","Vice President Officer of Information Technology and Member of Board of Executive Officers":"Eduardo Eiji Horai","Vice President Officer of Marketing and Member of Executive Board of Officers":"Daniel Wakswaser Cordeiro","Industrial Vice President Officer and Member of Executive Board of Officers":"Valdecir Duarte","Vice President Officer of Non-Alcoholic Beverages and Future Beverages and Member of Board of Executive Officer":"Daniela Gavranic Cachich"},"38.28B","16.37B","2.98B",null,"0.18","13.50","12.80","$0.15 (6.21%)","Dec 22, 2023","5,471,231","2.440","2.410","2.410 - 2.450","2.230 - 3.230","0.53","Hold","3.20 (+31.69%)","May 8, 2024"],["Advantage Solutions Inc.","Advantage Solutions Inc. provides business solutions to consumer goods manufacturers and retailers in North America and internationally.It operates in two segments, Sales and Marketing. The Sales segment offers brand-centric services, such as headquarter relationship management; analytics, insights, and intelligence; and brand-centric merchandising services.This segment also provides retailer-centric services comprising retailer-centric merchandising and in-store media services.The Marketing segment offers brand-centric services, including shopper and consumer marketing, and brand experiential services; retailer-centric services, such as retail experiential and private label services; and digital marketing, and digital media and advertising services.The company was formerly known as Karman Holding Corp. and changed its name to Advantage Solutions Inc. in March 2016.The company was founded in 1987 and is headquartered in Irvine, California.","United States","1987",null,"Advertising Agencies","Communication Services","70,000","David A. Peacock","8001 Forsyth Blvd, Suite 1025Clayton, Missouri 63105United States","(314) 655-9333","advantagesolutions.net","ADV","NASDAQ","USD","0001776661",null,"US00791N1028","83-4629508","7389",{"Chief Executive Officer and Director":"David A. Peacock","Chief Financial Officer":"Christopher Robert Growe","Chief Accounting Officer and Principal Accounting Officer":"Bevin Conley","Chief Legal Officer and Corporate Secretary":"Bryce O. Robinson","Vice President of Corporate Marketing and Communications":"Will Minton","Chief Human Resources Officer":"Pamela Morris-Thornton","Chief Operating Officer of Experiential Services":"Andrea Young","Chief Operating Officer, Retailer Services":"Michael Taylor","Senior Vice President of Finance and Operations":"Dan Morrison","Chief Communications Officer":"Kelli Hammersmith"},"1.47B","4.22B","-63.26M",null,"-0.20","n/a","9.41","n/a","n/a","534,678","4.660","4.560","4.535 - 4.710","1.180 - 4.950","1.66","Buy","3.15 (-30.92%)","May 9, 2024"],["Adverum Biotechnologies, Inc.","Adverum Biotechnologies, Inc., a clinical-stage company, develops gene therapy product candidates to treat ocular diseases.Its lead product candidate is ixoberogene soroparvovec (ADVM-022), a single intravitreal injection gene therapy candidate used for the treatment of patients with wet age-related macular degeneration and diabetic macular edema which is in phase 2 clinical trials.The company is developing ADVM-062 (AAV.7m8-L-opsin), a novel gene therapy product candidate for the treatment of blue cone monochromacy via a single IVT injection.Adverum Biotechnologies, Inc. has license and collaboration agreements with University of California; GenSight Biologics; Lexeo Therapeutics; and Virovek, Inc. The company was formerly known as Avalanche Biotechnologies, Inc. and changed its name to Adverum Biotechnologies, Inc. in May 2016.Adverum Biotechnologies, Inc. was incorporated in 2006 and is headquartered in Redwood City, California.","United States","2006","Jul 31, 2014","Biotechnology","Healthcare","121","Dr. Laurent  Fischer","100 Cardinal WayRedwood City, California 94063United States","(650) 649-1004","adverum.com","ADVM","NASDAQ","USD","0001501756",null,"US00773U1088","20-5258327","2836",{"President, Chief Executive Officer and Director":"Dr. Laurent Fischer","Chief Financial Officer, Principal Financial Officer and Principal Accounting Officer":"Linda M. Rubinstein M.A.","Chief Operating Officer":"Kishor Peter Soparkar J.D.","Chief Development Officer":"Dr. Setareh Seyedkazemi Pharm.D.","Chief Technology Officer":"Dr. R. Andrew Ramelmeier Ph.D.","Chief Scientific Officer":"Dr. Romuald Corbau Ph.D.","Senior Vice President and General Counsel":"John W. Rakow J.D.","Chief People Officer":"Dena House","Senior Vice President of Regulatory Affairs":"Carla Fiankan","Senior Vice President of Quality":"Michael Steel"},"216.47M","3.60M","-117.17M",null,"-11.60","n/a","n/a","n/a","n/a","899,803","10.10","10.00","10.00 - 10.69","7.40 - 29.70","0.79","Strong Buy","34.40 (+229.82%)","May 13, 2024"],["Addex Therapeutics Ltd","Addex Therapeutics Ltd discovers, develops, and commercializes small-molecule pharmaceutical products for central nervous system (CNS) disorders in Switzerland.The company focuses on the discovery of G-protein coupled receptors and enzymes. Its lead programs include Dipraglurant for the treatment of Parkinson's disease levodopa-induced dyskinesia and dystonia, and post-stroke/TBI recovery; ADX71149, a novel orally active metabotropic glutamate receptor subtype 2 positive allosteric modulator (mGlu2 PAM) for the treatment of epilepsy; and GABAB PAM for the treatment of pain, anxiety, overactive bladder, and addiction, as well as substance use disorder.Addex Therapeutics Ltd has license and collaboration agreement with Janssen Pharmaceuticals Inc. for the discovery, development, and commercialization of novel mGlu2 PAM compounds for the treatment of CNS and related diseases; license and research agreement with Indivior PLC discovery, development, and commercialization of novel GABAB PAM compounds for the treatment of addiction and other CNS diseases; and The Charcot\"Marie\"Tooth Association to evaluate the role of GABAB PAM compounds in preclinical models of CMT1A.The company was formerly known as Addex Pharmaceuticals Ltd. Addex Therapeutics Ltd was founded in 2002 and is based in Geneva, Switzerland.","Switzerland","2002",null,"Biotechnology","Healthcare","23","Timothy Mark Dyer","Chemin Des Mines 9Geneva, V8 CH-1202Switzerland","01141228841555","addextherapeutics.com","ADXN","NASDAQ","USD","0001574232",null,"US00654J2069",null,"2834",{"Co-Founder, Chief Executive Officer and Director":"Timothy Mark Dyer","Chief Medical Officer and Director":"Dr. Roger G. Mills M.D.","Head of Finance":"Lénaic Teyssédou","Head of Discovery - Chemistry":"Dr. Jean-Philippe Rocher Ph.D.","Head of Discovery - Biology":"Dr. Robert Lutjens","Head of Translational Science":"Dr. Mikhail Kalinichev Ph.D."},"11.57M","1.96M","-12.57M",null,"-0.15","n/a","n/a","n/a","n/a","7,827","9.10","8.82","8.94 - 9.39","5.00 - 27.90","1.76","n/a","n/a","May 13, 2024"],["Adams Resources & Energy, Inc.","Adams Resources & Energy, Inc., through its subsidiaries, primarily engages in the marketing, transportation, terminalling, and storage of crude oil and other related products in the United States.The company operates through four segments: Crude Oil Marketing, Transportation, Pipeline and Storage, and Logistics and Repurposing.It purchases and sells crude oil to refiners and other customers primarily onshore in Texas, North Dakota, Michigan, Wyoming, Colorado, and Louisiana; owns and operates a fleet of 164 tractor-trailer rigs; and maintains pipeline inventory locations and injection stations.The company also transports liquid chemicals, pressurized gases, asphalt, and dry bulk on a hire basis in the United States, Canada, and Mexico; and operates truck terminals in Houston, Corpus Christi, Nederland, Freeport, Baton Rouge, St. Rose, Sterlington, Jacksonville, Tampa, Augusta, Mobile, Charlotte, Cincinnati, South Charleston, Memphis, East St. Louis, and Joliet.In addition, it operates crude oil and condensate pipeline system, which connects the Eagle Ford Basin to the Gulf Coast waterborne market; and transports crude oil, condensate, fuels, oils, and other petroleum products on a for hire basis in the Eagle Ford basin.The company was founded in 1947 and is headquartered in Houston, Texas.","United States","1947",null,"Oil & Gas Refining & Marketing","Energy","741","Kevin J. Roycraft","17 S. Briar Hollow Ln.Houston, Texas 77027United States","713-881-3600","adamsresources.com","AE","NYSEAMERICAN","USD","0000002178",null,"US0063513081","74-1753147","5172",{"Chief Executive Officer, President and Director":"Kevin J. Roycraft","Executive Vice President, Chief Financial Officer and Treasurer":"Tracy E. Ohmart","President of Service Transport Company":"Wade M. Harrison","President of GulfMark Energy, Inc":"Greg L. Mills","Chief Operating Officer":"Mike Leggio","Corporate Secretary":"David B. Hurst"},"72.05M","2.75B","212,000",null,"0.08","350.88","n/a","$0.96 (3.42%)","Mar 7, 2024","1,372","28.10","29.00","28.07 - 29.00","22.67 - 38.60","0.84","Strong Buy","50.00 (+78.13%)","May 14, 2024"],["AltEnergy Acquisition Corp.","AltEnergy Acquisition Corp. does not have significant operations.The company intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses in the renewable energy or related clean technology sectors.AltEnergy Acquisition Corp. was incorporated in 2021 and is based in New York, New York.","United States","2021","Oct 29, 2021","Shell Companies","Financials","3","Russell M. Stidolph","137 Rowayton Avenue, Suite 400Rowayton, Connecticut 06853United States","(203) 295-3343","altenergyacquisition.com","AEAE","NASDAQ","USD","0001852016",null,"US02157M1080","86-2157013","6770",{"Chairman and Chief Executive Officer":"Russell M. Stidolph","Chief Financial Officer":"Jonathan R. Darnell"},"79.27M","n/a","6.40M",null,"0.22","50.91","n/a","n/a","n/a","4","11.19","11.20","11.10 - 11.30","10.27 - 11.86","0.06","n/a","n/a","n/a"],["Ameren Corporation","Ameren Corporation, together with its subsidiaries, operates as a public utility holding company in the United States.The company operates through four segments: Ameren Missouri, Ameren Illinois Electric Distribution, Ameren Illinois Natural Gas, and Ameren Transmission.It engages in the rate-regulated electric generation, transmission, and distribution activities; and rate-regulated natural gas distribution business.In addition, the company generates electricity through coal, nuclear, and natural gas, as well as renewable sources, such as hydroelectric, wind, methane gas, and solar.It serves residential, commercial, and industrial customers. The company was founded in 1881 and is headquartered in Saint Louis, Missouri.","United States","1901",null,"Utilities - Regulated Electric","Utilities","9,372","Martin J. Lyons Jr.","1901 Chouteau Ave, Mc 1310St Louis, Missouri 63166-6149United States","314-621-3222","ameren.com","AEE","NYSE","USD","0001002910",null,"US0236081024","43-1723446","4931",{"President, Chief Executive Officer and Chairman of the Board":"Martin J. Lyons Jr.","Senior EVice President, Chief Financial Officer, Chairman and President of Ameren Services":"Michael L. Moehn","Executive Vice President, General Counsel and Secretary":"Chonda Jordan Nwamu Esq.","President and Chairman of Ameren Missouri":"Mark C. Birk","Chairman and President of Ameren Illinois":"Leonard P. Singh","Senior Vice President of Finance and Chief Accounting Officer":"Theresa A. Shaw","Director of Investor Relations and Corporate Modeling":"Andrew Kirk","Senior Vice President and Chief Transformation Officer":"Bruce A. Steinke","Chief Nuclear Officer and Senior Vice President of Ameren Missouri":"Fadi M. Diya","Executive Vice President of Corporate Communications and Chief Human Resources Officer of Ameren Services":"Mark C. Lindgren"},"19.75B","7.50B","1.15B",null,"4.39","16.88","15.68","$2.68 (3.62%)","Mar 12, 2024","2,130,055","75.09","75.25","72.70 - 75.69","67.03 - 90.72","0.45","Hold","79.60 (+7.44%)","May 2, 2024"],["Aegon N.V.","Aegon Ltd. provides insurance, pensions, retirement, and asset management services in the United States, the Netherlands, the United Kingdom, and internationally.The company offers life, accident, property and casualty, and health insurance; annuities, retirement plans, mutual funds, and stable value solutions; residential mortgage and digital baking services; and retail and institutional investment management solutions and retirement savings vehicles and strategies.It offers its products under the Aegon and Transamerica brands. Aegon Ltd. was founded in 1844 and is headquartered in The Hague, the Netherlands.","Netherlands","1983",null,"Insurance - Diversified","Financials","15,658","E.  Friese","Aegonplein 50, Po Box 85The Hague, P7 2501 CBNetherlands","011-31-70-344-7308","aegon.com","AEG","NYSE","USD","0000769218",null,"US0076CA1045",null,"6311",{"Chief Executive Officer, Chairman of Management Board and Executive Director":"E. Friese","Chief Financial Officer and Member of Executive Board":"Matthew James Rider","Chief Executive Officer of Aegon International and Member of the Management Board":"Dr. Marco Baptist Arie Keim RA","General Counsel, Executive Vice President and Member of the Management Board":"J. Onno van Klinken","Chief Executive Officer of Aegon Asset Management and Member of Management Board":"Bas Christian NieuweWeme","Chief Executive Officer of Aegon UK and Member of Management Board":"Michael Anthony Holliday-Williams","Chief Transformation Officer and Member of Management Board":"Duncan Russell","Member of the Management Board and Chief Executive Officer of Aegon Americas":"Wilford Herndon Fuller","Chief Human Resources Officer and Member of the Management Board":"Elisabetta Caldera","Chief Technology Officer and Member of the Management Board":"Deborah Waters"},"11.03B","55.69B","2.20B",null,"1.01","n/a","4.38","$0.17 (2.74%)","Jun 17, 2024","2,663,764","6.30","6.26","6.26 - 6.34","4.30 - 6.38","1.19","n/a","n/a","May 15, 2024"],["Antelope Enterprise Holdings Limited","Antelope Enterprise Holdings Limited, through its subsidiaries, provides livestream e-commerce services and business management and information systems consulting services in the People's Republic of China.The company operates an online social ecommerce and live broadcast streaming platform enhances product promotion, transaction speed, and marketing effectiveness of industries and applications to anchors and influencers.It also provides business management consulting; and information system technology consulting services, including the sales of software use rights for digital data deposit platforms and asset management systems, and online social media platform development and consulting.The company was formerly known as China Ceramics Co., Ltd. and changed its name to Antelope Enterprise Holdings Limited in October 2020.Antelope Enterprise Holdings Limited was founded in 1993 and is headquartered in Jinjiang, the People's Republic of China.","China","1993","Nov 16, 2007","Building Products & Equipment","Industrials","297","Weilai  Zhang","The Empire State Building, 350 Fifth Avenue, Suite 7540New York, New York 10118United States","1-838-500 8888","aehltd.com","AEHL","NASDAQ","USD","0001470683",null,"VGG041JN1222",null,"4899",{"Chief Financial Officer":"Man Hen","Chief Executive Officer and Chairman":"Weilai Zhang","Sales Deputy General Manager":"Pei Zhi Su","Special Advisor":"Jia Dong Huang","Executive Director":"Junjie Dong","Corporate Secretary and Director":"Tingting Zhang"},"9.24M","63.62M","1.42M",null,"-1.01","0.72","n/a","n/a","n/a","11,733","1.865","1.820","1.760 - 1.870","1.220 - 16.400","1.49","n/a","n/a","May 14, 2024"],["Aehr Test Systems","Aehr Test Systems provides test solutions for testing, burning-in, and semiconductor devices in wafer level, singulated die, and package part form, and installed systems worldwide.Its product portfolio includes FOX-XP and FOX-NP systems that are full wafer contact and singulated die/module test and burn-in systems that can test, burn-in, and stabilize range of devices, including silicon carbide-based and other power semiconductors, 2D and 3D sensors used in mobile phones, tablets and other computing devices, memory semiconductors, processors, microcontrollers, systems-on-a-chip, and photonics and integrated optical devices.The company also offers FOX-CP system, a low-cost single-wafer compact test solution for logic, memory, and photonic devices; FOX WaferPak Contactor, a full wafer contactor capable of testing wafers up to 300mm that enables integrated circuit manufacturers to perform test, burn-in, and stabilization of full wafers on the FOX-P systems.In addition, it provides FOX DiePak Carrier, a reusable temporary package that enables IC manufacturers to perform final test and burn-in of bare die and modules; and FOX DiePak Loader.The company was incorporated in 1977 and is headquartered in Fremont, California.","United States","1977","Aug 14, 1997","Semiconductor Equipment & Materials","Technology","104","Gayn  Erickson","400 Kato TerraceFremont, California 94539United States","(510) 623-9400","aehr.com","AEHR","NASDAQ","USD","0001040470",null,"US00760J1088","94-2424084","3825",{"Founder and Independent Chairman":"Rhea J. Posedel","President, Chief Executive Officer and Director":"Gayn Erickson","Executive Vice President of Sales and Marketing":"Vernon Rogers","Chief Financial Officer, Executive Vice President of Finance and Secretary":"Chris P. Siu","Chief Operating Officer":"Adil Engineer","Chief Technology Officer":"Donald P. Richmond II","Executive Vice President of Research &amp; Development":"Dr. Avijit K. Ray-Chaudhuri"},"336.57M","71.89M","15.40M",null,"0.52","22.38","38.04","n/a","n/a","513,269","11.95","11.76","11.60 - 12.29","10.19 - 54.10","1.97","Hold","12.00 (+3.09%)","Apr 9, 2024"],["Alset EHome International Inc.","Alset Inc., together with its subsidiaries, engages in the real estate development, financial services, digital transformation technologies, biohealth activities, and consumer products businesses in the United States, Singapore, Hong Kong, Australia, and South Korea.It operates through four segments: Real Estate, Digital Transformation Technology, Biohealth, and Other Business Activities segments.The Real Estate segment develops property projects and participates in third-party property development projects; and owns, operates, and manages real estate development projects with a focus on land subdivision developments and house rental projects.The Digital Transformation Technology segment provides consulting, implementation, and development services with various technologies, including blockchain, e-commerce, social media, and payment solutions.Its technology platform focuses on business-to-business solutions, such as communications and workflow, instant messaging, international calling, social media, e-commerce and payment systems, and direct marketing solutions.The Biohealth segment engages in developing, researching, testing, manufacturing, licensing, and distributing biohealth products and services.The Other Business Activities segment offers corporate strategy and business development, asset management, corporate restructuring, and leveraged buy-out expertise services.It also operates cafes which is located in Singapore and South Korea. The company was formerly known as Alset EHome International Inc. and changed its name to Alset Inc. in October 2022.Alset Inc. was incorporated in 2018 and is headquartered in Bethesda, Maryland.","United States","2014",null,"Real Estate - Development","Real Estate","60","Fai Heng  Chan","4800 Montgomery Lane, Suite 210Bethesda, Maryland 20814United States","(301) 971-3955","alsetehomeintl.com","AEI","NASDAQ","USD","0001750106",null,"US02115D2080","83-1079861","6500",{"Founder, Chairman of the Board and Chief Executive Officer":"Fai Heng Chan","Co-Chief Executive Officer and Executive Director":"Tung Moe Chan BApSc, MBA, MEng","Co-Chief Financial Officer":"Rongguo Wei CPA","Chief Development Officer":"Charles W. S. MacKenzie","Executive Director":"Sheng Hon Lim","Chief Legal Officer":"Michael Gershon","Consultant":"Anthony S. Chan CPA"},"4.66M","22.09M","-58.95M",null,"-6.52","n/a","n/a","n/a","n/a","36,994","0.490","0.510","0.484 - 0.540","0.482 - 2.080","0.73","n/a","n/a","May 14, 2024"],["Advanced Energy Industries, Inc.","Advanced Energy Industries, Inc. provides precision power conversion, measurement, and control solutions in the United States and internationally.The company's plasma power products offer solutions to enable innovation for semiconductor and thin film plasma processes, such as dry etch and deposition.It also provides high and low voltage power products used in a range of applications, such as semiconductor equipment, industrial production, medical and life science equipment, data centers computing, networking, and telecommunications.In addition, the company supplies sensing, controls, and instrumentation products for advanced measurement and calibration of power and temperature.Further, the company provides calibration, conversions, upgrades, and refurbishments and used equipment to companies, as well as repair services.Further, it offers warranty and after-market repair services. It offers its products through a direct sales force, independent sales representatives, channel partners, and distributors.Advanced Energy Industries, Inc. was incorporated in 1981 and is headquartered in Denver, Colorado.","United States","1981","Nov 17, 1995","Electrical Equipment & Parts","Industrials","10,000","Stephen D. Kelley","Attn:  Paul Oldham, 1595 Wynkoop St, Suite 800Denver, Colorado 80202United States","(970) 407-6626","advancedenergy.com","AEIS","NASDAQ","USD","0000927003",null,"US0079731008","84-0846841","3679",{"President, Chief Executive Officer and Director":"Stephen D. Kelley","Executive Vice President and Chief Financial Officer":"Paul R. Oldham","Executive Vice President and Chief Operating Officer":"Eduardo Bernal Acebedo","Executive Vice President, General Counsel and Corporate Secretary":"Elizabeth Karpinski Vonne","Executive Vice President and Global Head of Sales":"John Donaghey","Senior Vice President and Chief Accounting Officer":"Bernard R. Colpitts Jr.","Senior Vice President and Chief Technology Officer":"Randy Heckman","Senior Vice President and Chief People Officer":"Rory G. O'Byrne","Vice President and Corporate Controller":"William George Trupkiewicz","Senior Vice President of Strategic and Corporate Marketing":"Peter Gillespie"},"3.66B","1.56B","102.58M",null,"2.72","35.16","23.47","$0.40 (0.42%)","May 23, 2024","253,510","98.24","95.63","95.63 - 98.97","81.86 - 126.38","1.54","Buy","111.86 (+16.97%)","May 1, 2024"],["Agnico Eagle Mines Limited","Agnico Eagle Mines Limited, a gold mining company, exploration, development, and production of precious metals.It explores for gold. The company's mines are located in Canada, Australia, Finland and Mexico, with exploration and development activities in Canada, Australia, Europe, Latin America, and the United States.Agnico Eagle Mines Limited was incorporated in 1953 and is headquartered in Toronto, Canada.","Canada","1953",null,"Gold","Materials","16,105","Ammar  Al-Joundi M.B.A.","145 King Street East, Suite 400Toronto, A6 M5C 2Y7Ontario, Canada","4169471212","agnicoeagle.com","AEM","NYSE","USD","0000002809",null,"CA0084741085",null,"1040",{"Executive Vice President of Finance and Chief Financial Officer":"James R. Porter B.A.Sc., CPA, CA, CPA, (Illinois)","Executive Vice President and Chief Strategy and Technology Officer":"Jean Robitaille","Executive Vice President and Chief Operating Officer of Ontario, Australia and Mexico":"Natasha Nella Dominica Vaz MBA, P. Eng.","Chief Executive Officer, President and Director":"Ammar Al-Joundi M.B.A.","Executive Vice President of Legal, General Counsel and Corporate Secretary":"Christopher Vollmershausen L.L.B.","Vice President of Corporate Development":"Peter J. Netupsky C.A., C.F.A., CPA","Vice President of Health, Safety, Social Affairs and People":"Jason Allaire","Executive Vice President and Chief Operating Officer of Nunavut, Quebec and Europe":"Dominique Girard B.Sc., ENG., P.Eng.","Executive Vice President of Operational Excellence":"Carol-Ann Plummer-Theriault B.Sc., Eng., P.Eng.","Executive Vice President of Exploration":"Guy Gosselin Eng., Ing, M.Sc., P.Eng., P.Geo."},"32.45B","6.95B","471.61M",null,"0.92","70.70","27.98","$1.60 (2.46%)","May 31, 2024","1,771,902","65.38","65.12","64.30 - 65.53","43.22 - 67.80","1.07","Buy","58.67 (-9.79%)","Apr 25, 2024"],["Aethlon Medical, Inc.","Aethlon Medical, Inc., a medical therapeutic company, focuses on developing products to treat cancer and life-threatening infectious diseases in the United States.It develops Hemopurifier, a clinical-stage immunotherapeutic device that removes tumor-derived exosomes and life-threatening viruses and use in organ transplantation.The company was incorporated in 1999 and is based in San Diego, California.","United States",null,null,"Medical Devices","Healthcare","15","James B. Frakes M.B.A.","11555 Sorrento Valley Road, Suite 203San Diego, California 92121United States","858-459-7800","aethlonmedical.com","AEMD","NASDAQ","USD","0000882291",null,"US00808Y4061","13-3632859","3841",{"Chief Operating Officer":"Guy F. Cipriani BS (Eng.), MBA","Chief Medical Officer":"Dr. Steven P. LaRosa M.D.","Interim Chief Executive Officer, Chief Financial Officer, Secretary and Director":"James B. Frakes M.B.A.","Chief Scientific Officer":"Dr. Lee D. Arnold Ph.D."},"3.64M","574,245","-12.25M",null,"-5.09","n/a","0.21","n/a","n/a","5,666","1.330","1.355","1.330 - 1.400","1.300 - 5.000","1.94","Strong Buy","10.00 (+632.6%)","Jun 26, 2024"],["Alliance Entertainment Holding Corporation","Alliance Entertainment Holding Corporation operates as a wholesaler, distributor, and e-commerce provider for the entertainment industry worldwide.It offers vinyl records, video games, digital video discs, blu-rays, toys, compact discs, collectibles, and other entertainment and consumer products.The company also provides third party logistics products and services. It distributes its physical media, entertainment products, hardware, and accessories through multi-channel strategy.The company was founded in 1990 and is headquartered in Plantation, Florida.","United States","1990",null,"Entertainment","Communication Services","761","Jeffrey  Walker","8201 Peters Road, Suite 1000Plantation, Florida 33324United States","(954) 255-4000","aent.com","AENT","NASDAQ","USD","0001823584",null,"US01861F1021","85-2373325","5099",{"Executive Chairman of the Board":"Bruce Ogilvie Jr.","Chief Executive Officer, Chief Financial Officer, Principal Financial and Accounting Officer and Director":"Jeffrey Walker","President of Distribution Solutions":"Ben Means"},"101.86M","1.13B","-6.93M",null,"-0.15","n/a","n/a","n/a","n/a","1,259","2.001","2.030","2.000 - 2.050","0.651 - 4.100","0.30","Strong Buy","6.00 (+200.0%)","May 9, 2024"],["American Eagle Outfitters, Inc.","American Eagle Outfitters, Inc. operates as a multi-brand specialty retailer in the United States and internationally.The company provides jeans, apparel and accessories, and personal care products for women and men under the American Eagle brand; and intimates, apparel, activewear, and swim collections under the Aerie and OFFLINE by Aerie brands.It also offers menswear products under the Todd Snyder New York brand; and fashion clothing and accessories under the Unsubscribed brand.The company sells its products through own and licensed retail stores; concession-based shops-within-shops; and digital channels, such as www.ae.com, www.aerie.com, www.toddsnyder.com, and www.unsubscribed.com.American Eagle Outfitters, Inc. was founded in 1977 and is headquartered in Pittsburgh, Pennsylvania.","United States","1977","Apr 13, 1994","Apparel Retail","Consumer Discretionary","43,100","Jay L. Schottenstein","77 Hot Metal StreetPittsburgh, Pennsylvania 15203United States","(412) 432-3300","aeo-inc.com","AEO","NYSE","USD","0000919012",null,"US02553E1064","13-2721761","5651",{"Executive Chairman of the Board and Chief Executive Officer":"Jay L. Schottenstein","Executive Vice President and Chief Financial Officer":"Michael A. Mathias","Executive Vice President and Chief Human Resources Officer":"Marisa A. Baldwin","President and Executive Creative Director of AE and Aerie":"Jennifer M. Foyle","Senior Vice President, Chief Accounting Officer and Controller":"James H. Keefer Jr.","Vice President of Corporate Communications and Investor Relations":"Judy Meehan","Senior Director of Governance and Compliance and Corporate Secretary":"Jennifer B. Stoecklein","Head of Stores-US and Executive Vice President":"Dennis R. Parodi","Executive Vice President - Chief Talent and Culture Officer":"Sherry Harris","Executive Vice President and President of Asia Pacific":"Kitty Yung"},"4.79B","5.26B","170.04M",null,"0.86","28.26","14.53","$0.50 (2.06%)","Apr 11, 2024","2,919,952","24.71","24.47","24.24 - 24.88","9.95 - 26.44","1.58","Hold","21.08 (-13.25%)","May 22, 2024"],["AEON Biopharma, Inc.","AEON Biopharma, Inc., a clinical stage biopharmaceutical company, focuses on developing botulinum toxins.It develops ABP-450 (prabotulinumtoxinA) injection for debilitating medical conditions, which completed Phase 2 study for the treatment of cervical dystonia and has an ongoing Phase 2 study for the treatment of both chronic and episodic migraine, as well as develops ABP-450 for the treatment of gastroparesis and posttraumatic stress disorder.The company is based in Irvine, California.","United States",null,null,"Biotechnology","Healthcare","10","Dr. Chad K. Oh M.D.","5 Park Plaza, Suite 1750Irvine, California 92614United States","(949) 354-6499","aeonbiopharma.com","AEON","NYSEAMERICAN","USD","0001837607",null,"US00791X1000","85-3940478","2834",{"President, Chief Executive Officer and Director":"Marc Forth","Chief Medical Officer":"Dr. Chad K. Oh M.D.","Chief Financial Officer":"Peter A. Reynolds CPA","Executive Vice President, Chief Legal Officer and Corporate Secretary":"Alex Wilson"},"64.80M","n/a","24.05M",null,"0.65","2.62","n/a","n/a","n/a","909,375","1.400","3.360","1.380 - 1.750","1.400 - 17.170","0.41","Strong Buy","18.00 (+958.82%)","May 15, 2024"],["AerCap Holdings N.V.","AerCap Holdings N.V. engages in the lease, financing, sale, and management of commercial flight equipment in China, Hong Kong, Macau, the United States, Ireland, and internationally.The company offers aircraft asset management services, such as remarketing aircraft and engines; collecting rental and maintenance rent payments, monitoring aircraft maintenance, monitoring and enforcing contract compliance, and accepting delivery and redelivery of aircraft and engines; and conducting ongoing lessee financial performance reviews.Its aircraft asset management services also include periodically inspecting the leased aircraft and engines; coordinating technical modifications to aircraft to meet new lessee requirements; conducting restructuring negotiations in connection with lease defaults; repossessing aircraft and engines; arranging and monitoring insurance coverage; registering and de-registering aircraft; arranging for aircraft and engine valuations; and providing market research services.In addition, the company provides cash management services, including treasury services, such as the financing, refinancing, hedging, and ongoing cash management of vehicles; and administrative services comprising accounting and corporate secretarial services consisting of the preparation of budgets and financial statements.Further, it offers airframe and engine parts and supply chain solutions to airlines; maintenance, repair, and overhaul service providers; and aircraft parts distributors.The company had a portfolio of owned, managed, or on order aircraft. AerCap Holdings N.V. was founded in 1995 and is headquartered in Dublin, Ireland.","Ireland","1995","Nov 21, 2006","Rental & Leasing Services","Industrials","679","Aengus  Kelly","Aercap House, 65 St. Stephen's GreenDublin, L2 2Ireland","35 31 819 2010","aercap.com","AER","NYSE","USD","0001378789",null,"NL0000687663",null,"7359",{"Chief Executive Officer and Executive Director":"Aengus Kelly","Chief Financial Officer":"Peter L. Juhas","Chief Investment Officer":"Bart Ligthart","Chief Technical Officer":"John Burke","Chief Information and Information Security Officer":"Jorg Koletzki","Head of Investor Relations":"Joseph McGinley C.F.A.","General Counsel":"Vincent Drouillard","Company Secretary and Chief Compliance Officer":"Risteard Sheridan","Vice President of Corporate Communications":"Gillian Culhane","Head of Human Resources":"Theresa Murray"},"18.41B","7.73B","3.31B",null,"15.13","5.84","7.44","n/a","n/a","770,742","87.47","86.82","86.85 - 88.16","54.28 - 88.54","1.85","Strong Buy","90.29 (+3.07%)","May 1, 2024"],["The AES Corporation","The AES Corporation, together with its subsidiaries, operates as a diversified power generation and utility company in the United States and internationally.The company owns and/or operates power plants to generate and sell power to customers, such as utilities, industrial users, and other intermediaries; owns and/or operates utilities to generate or purchase, distribute, transmit, and sell electricity to end-user customers in the residential, commercial, industrial, and governmental sectors; and generates and sells electricity on the wholesale market.It uses various fuels and technologies to generate electricity, such as coal, gas, hydro, wind, solar, and biomass, as well as renewables comprising energy storage and landfill gas.The company owns and/or operates a generation portfolio of approximately 34,596 megawatts and distributes power to 2.6 million customers.The company was formerly known as Applied Energy Services, Inc. and changed its name to The AES Corporation in April 2000.The AES Corporation was incorporated in 1981 and is headquartered in Arlington, Virginia.","United States","1981","Jun 25, 1991","Utilities - Diversified","Utilities","9,600","Andres Ricardo Gluski Weilert","4300 Wilson BoulevardArlington, Virginia 22203United States","(703) 522-1315","aes.com","AES","NYSE","USD","0000874761",null,"US00130H1059","54-1163725","4991",{"President, Chief Executive Officer and Director":"Andres Ricardo Gluski Weilert","Executive Vice President and Chief Financial Officer":"Stephen Coughlin","Executive Vice President and Chief Human Resources Officer":"Letitia D. Mendoza","Executive Vice President and President of Renewables":"Bernerd Da Santos","Executive Vice President and President of Energy Infrastructure":"Juan Ignacio Rubiolo","Executive Vice President, Chief Operating Officer and President of New Energy Technologies":"Ricardo Manuel Falu","Senior Vice President and Chief Accounting Officer":"Sherry L. Kohan","Vice President of Investor Relations":"Susan Pasley Keppelman Harcourt","Executive Vice President, General Counsel and Corporate Secretary":"Paul L. Freedman","Senior Manager of Global Press and Media Relations":"Gail Chalef"},"13.27B","12.51B","530.00M",null,"0.73","25.58","9.43","$0.69 (3.70%)","Apr 30, 2024","10,817,079","18.72","18.93","18.35 - 19.68","11.43 - 23.07","1.09","Buy","21.14 (+13.23%)","May 2, 2024"],["Atlas Energy Solutions Inc.","Atlas Energy Solutions Inc. engages in the production, processing, and sale of mesh and sand that are used as a proppant during the well completion process in the Permian Basin of Texas and New Mexico.The company provides transportation and logistics, storage solutions, and contract labor services. It sells its products and services to oil and natural gas exploration and production companies, and oilfield services companies.Atlas Energy Solutions Inc. was founded in 2017 and is headquartered in Austin, Texas.","United States","2017","Mar 9, 2023","Oil & Gas Equipment & Services","Energy","371","John G. Turner","5918 W. Courtyard Drive, Suite 500Austin, Texas 78730United States","(512) 220-1200","atlas.energy","AESI","NYSE","USD","0001910950",null,"US6420451089","88-0523830","1400",{"Founder and Executive Chairman":"Ben M. Brigham II","President, Chief Executive Officer and Chief Financial Officer":"John G. Turner","General Counsel and Secretary":"Dathan Christopher Voelter","Vice President of Operations":"Chad M. McEver","Vice President of Technology":"Shaam Farooq","Executive Vice President of Sales and Marketing":"Jeffrey Allison","Vice President of Human Resources and EHS":"Kirk Ginn","Chief Supply Chain Officer":"Chris Scholla","Vice President of Finance":"Brian Anthony Leveille","Former Chief Operating Officer":"Hunter Wallace"},"2.41B","613.96M","105.43M",null,"1.48","14.84","8.39","$0.20 (0.91%)","Feb 21, 2024","499,675","21.92","21.94","21.66 - 22.10","15.28 - 24.69","n/a","Strong Buy","25.17 (+14.57%)","May 6, 2024"],["Aeva Technologies, Inc.","Aeva Technologies, Inc. engages in the design, manufacturing, and sale of LiDAR sensing systems, and related perception and autonomy-enabling software solutions in the United States, Thailand, Europe, the Middle East, and Asia.The company develops its products using frequency modulated continuous wave sensing technology. It offers 4D LiDAR sensing system with embedded software for automated driving, consumer electronics, consumer health, industrial automation, and security applications.The company was founded in 2017 and is based in Mountain View, California.","United States","2019",null,"Software - Infrastructure","Technology","301","Andrew  Fung","555 Ellis StreetMountain View, California 94043United States","(650) 481-7070","aeva.com","AEVA","NYSE","USD","0001789029",null,"US00835Q1031","84-3080757","3714",{"Co-Founder, President, Chief Technology Officer and Chairman of the Board":"Mina Rezk","Co-Founder, Chief Executive Officer and Director":"Soroush Salehian Dardashti","Chief Financial Officer":"Saurabh Sinha","Director of Investor Relations":"Andrew Fung","Vice President of Global Sales":"Barrs Lang","Head of Engineering in Germany":"Axel Gern"},"180.64M","4.31M","-149.33M",null,"-3.30","n/a","n/a","n/a","n/a","462,608","3.200","3.100","3.200 - 3.620","2.325 - 7.600","1.40","Buy","11.90 (+247.95%)","May 7, 2024"],["American Electric Power Company, Inc.","American Electric Power Company, Inc., an electric public utility holding company, engages in the generation, transmission, and distribution of electricity for sale to retail and wholesale customers in the United States.It operates through Vertically Integrated Utilities, Transmission and Distribution Utilities, AEP Transmission Holdco, and Generation & Marketing segments.The company generates electricity using coal and lignite, natural gas, renewable, nuclear, hydro, solar, wind, and other energy sources.It also supplies and markets electric power at wholesale to other electric utility companies, rural electric cooperatives, municipalities, and other market participants.American Electric Power Company, Inc. was incorporated in 1906 and is headquartered in Columbus, Ohio.","United States","1906",null,"Utilities - Regulated Electric","Utilities","17,250","Benjamin Gwynn Stonestreet Fowke III","1 Riverside PlazaColumbus, Ohio 43215United States","614-716-1000","aep.com","AEP","NASDAQ","USD","0000004904",null,"US0255371017","13-4922640","4911",{"Interim President, Interim Chief Executive Officer and Director":"Benjamin Gwynn Stonestreet Fowke III","Executive Vice President and Chief Financial Officer":"Charles E. Zebula","Executive Vice President, General Counsel and Secretary":"David M. Feinberg","Executive Vice President of Energy Services":"Christian T. Beam","Executive Vice President of Utilities":"Peggy I. Simmons","Senior Vice President, Controller, Chief Accounting Officer and Principal Accounting Officer":"Kate Sturgess","Executive Vice President and Chief Information and Technology Officer":"Therace M. Risch","Vice President of Investor Relations":"Darcy Reese","Chief Compliance Officer":"Gina E. Mazzei-Smith","Executive Vice President and Chief Human Resources Officer":"Phillip R. Ulrich"},"46.70B","19.32B","2.81B",null,"5.36","16.53","15.12","$3.52 (3.97%)","May 9, 2024","3,304,983","89.00","88.25","87.95 - 89.30","69.38 - 92.88","0.51","Buy","90.88 (+2.57%)","Apr 30, 2024"],["Aeries Technology, Inc","Aeries Technology, Inc. operates as a professional services and consulting partner in the United States and internationally.The company offers management consultancy services for private equity sponsors and their portfolio companies, including software solutions, product management, IT infrastructure, information and cyber security, ERP and CRM platform management, business process management, and digital transformation services.The company was founded in 2012 and is based in Orem, Utah.","United States","2012",null,"Consulting Services","Industrials","1,483","Sudhir Appukuttan Panikassery","190 Elgin AvenueGeorge Town, E9 KY1-9008Cayman Islands","415-629-9066","ir.aeriestechnology.com","AERT","NASDAQ","USD","0001853044",null,"KYG0136H1020",null,"8742",{"Chief Executive Officer and Director":"Sudhir Appukuttan Panikassery","Chief Technology Officer":"Unni Nambiar","Chief Revenue Officer and Chief Operating Officer of Americas":"Bhisham Khare","Chief Financial Officer":"Rajeev Gopala Krishna Nair","Chief Investment Officer and Director":"Daniel S. Webb","Chief Strategy Officer":"Narayan Shetkar CFA","Head of Mexico Operations":"Mario Jimenez"},"76.50M","105.90M","-19.68M",null,"125,472.71","0.00","n/a","n/a","n/a","1,643","2.025","2.010","2.025 - 2.120","1.500 - 11.400","n/a","n/a","n/a","May 21, 2024"],["Aeterna Zentaris Inc.","Aeterna Zentaris Inc., a specialty biopharmaceutical company, engages in developing and commercializing therapeutics and diagnostic tests in Canada, Switzerland, Ireland, Denmark, Germany, the United States, and internationally.Its lead product is Macrilen (macimorelin), an orally available peptidomimetic ghrelin receptor (GHSR-1a) agonist that stimulates the secretion of growth hormone by binding to the GHSR-1a for the diagnosis of patients with adult growth hormone deficiency and childhood-onset growth hormone deficiency, as well as endocrinology and oncology indications; AEZS-150, a delayed clearance parathyroid hormone fusion polypeptide that is in preclinical trial for the treatment of chronic hypoparathyroidism; and AEZS-130 that is in preclinical trial for the treatment of amyotrophic lateral sclerosis.The company also has a license and research agreement with University of Wuerzburg to develop, manufacture, and commercialize AIM biologicals for the treatment of neuromyelitis optica spectrum disorder; and for pre-clinical development towards the potential treatment of Parkinson's disease.In addition, it has a license agreement with Consilient Health Ltd. and NK MEDITECH Ltd. for the development and commercialization of macimorelin; a distribution and commercialization agreement with Er-Kim Pharmaceuticals Bulgaria Eood for the commercialization of macimorelin for the diagnosis of growth hormone deficiency in children and adults; as well as The University of Sheffield, the United Kingdom for the development, manufacture, and commercialization of parathyroid hormone fusion polypeptides for the treatment of chronic hypoparathyroidism.Aeterna Zentaris Inc. was incorporated in 1990 and is headquartered in Toronto, Canada.","United States",null,"Jul 18, 1996","Biotechnology","Healthcare","12","Dr. Klaus  Paulini Ph.D.","C/o Norton Rose Fulbright Canada Llp, 222 Bay Street, Suite 3000, Po Box 53Toronto, A6 M5K 1E7Ontario, Canada","843-900-3201","zentaris.com","AEZS","NASDAQ","USD","0001113423",null,"CA0079755017",null,"2834",{"President, Chief Executive Officer and Executive Director":"Dr. Klaus Paulini Ph.D.","Senior Vice President of Finance and Chief Financial Officer":"Giuliano La Fratta","Senior Vice President of Non-Clinical Development and Chief Scientific Officer":"Dr. Michael Teifel Ph.D.","Chief Medical Officer and Senior Vice President of Clinical Development":"Dr. Nicola Ammer M.D.","Senior Vice President Manufacturing and Supply Chain":"Dr. Matthias Gerlach"},"9.47M","4.50M","-16.55M",null,"-13.64","n/a","n/a","n/a","n/a","19,907","7.80","8.16","7.74 - 8.35","5.44 - 13.20","2.07","Strong Buy","15.00 (+92.31%)","May 14, 2024"],["AFC Gamma, Inc.","AFC Gamma, Inc. originates, structures, underwrites, and invests in senior secured loans, and other various commercial real estate loans and debt securities for established companies operating in the cannabis industry.It primarily originates loans structured as senior loans secured by real estate, equipment, and licenses and/or other assets of the loan parties to the extent permitted by applicable laws and the regulations governing such loan parties.The company has elected and qualified to be taxed as a real estate investment trust for the United States federal income tax purposes under the Internal Revenue Code of 1986.AFC Gamma, Inc. was incorporated in 2020 and is based in West Palm Beach, Florida.","United States","2020","Mar 19, 2021","REIT - Specialty","Real Estate",null,"Daniel  Neville","525 Okeechobee Blvd., Suite 1770West Palm Beach, Florida 33401United States","561.510.2390","afcgamma.com","AFCG","NASDAQ","USD","0001822523",null,"US00109K1051","85-1807125","6500",{"Co-Founder and Executive Chairman":"Leonard Mark Tannenbaum C.F.A.","Co-Founder, Partner and President":"Robyn Tannenbaum","Chief Executive Officer and Partner":"Daniel Neville","Chief Financial Officer and Treasurer":"Brandon Hetzel","Accounting Manager":"Cody Shue","Director of Investor Relations":"Lana Ping","Chief Legal Officer":"Gabriel A. Katz","Chief Marketing Officer":"James F. Velgot","Chief of Staff":"Ian Kirby"},"252.35M","64.18M","20.95M",null,"1.02","11.97","5.89","$1.92 (15.73%)","Mar 27, 2024","82,773","12.36","12.20","12.07 - 12.36","9.91 - 14.60","1.10","Buy","16.25 (+33.09%)","May 9, 2024"],["American Financial Group, Inc.","American Financial Group, Inc., an insurance holding company, provides specialty property and casualty insurance products in the United States.The company offers property and transportation insurance products, such as physical damage and liability coverage for buses and trucks, inland and ocean marine, agricultural-related products, and other commercial property and specialty transportation coverages; specialty casualty insurance, including primarily excess and surplus, executive and professional liability, general liability, umbrella and excess liability, and specialty coverage in targeted markets, as well as customized programs for small to mid-sized businesses and workers' compensation insurance; and specialty financial insurance products comprising risk management insurance programs for lending and leasing institutions, fidelity and surety products, and trade credit insurance.It sells its property and casualty insurance products through independent insurance agents and brokers.The company was founded in 1872 and is headquartered in Cincinnati, Ohio.","United States","1872",null,"Insurance - Property & Casualty","Financials","8,500","Stephen Craig Lindner","Great American Insurance Group Tower, 301 E. 4th StreetCincinnati, Ohio 45202United States","(513) 579-2121","afginc.com","AFG","NYSE","USD","0001042046",null,"US0259321042","31-1544320","6331",{"Co-Chief Executive Officer and Director":"Carl Henry Lindner III","President and Director":"John Bernard Berding C.P.A.","Senior Vice President and Chief Financial Officer":"Brian Scott Hertzman","Senior Vice President, General Counsel and Chief Compliance Officer":"Mark Andrew Weiss","Executive Consultant and Director":"James E. Evans","President and Chief Operating Officer of Property and Casualty Insurance Group":"David Lawrence Thompson Jr.","Chief Information Security Officer and Divisional Vice President":"John R. Rogers","Senior Vice President, Chief Human Resources Officer and Chief Administrative Officer":"Michelle Ann Gillis SPHR","Vice President of Investor and Media Relations":"Diane P. Weidner"},"10.68B","7.99B","882.00M",null,"10.44","12.20","11.13","$2.76 (2.17%)","Apr 12, 2024","238,481","127.42","127.68","125.49 - 128.14","105.22 - 137.72","0.77","Buy","128.00 (+0.46%)","May 1, 2024"],["Affinity Bancshares, Inc.","Affinity Bancshares, Inc. operates as the holding company for Affinity Bank that provides various banking products and services in Georgia.The company offers various deposit accounts, including savings accounts, checking accounts, certificates of deposit, and individual retirement accounts, as well as Kasasa (rewards) deposit program for checking accounts with interest rates or cash-back rewards.It offers commercial and residential real estate, commercial and industrial, residential mortgage, construction and land, and consumer loans, as well as balloon and adjustable-rate loans.In addition, the company invests in U.S. treasury securities; securities issued by the U.S. government and its agencies, or government sponsored enterprises, including mortgage-backed securities and collateralized mortgage obligations; corporate and municipal bonds; certificates of deposit in other financial institutions; and federal and money market funds.Further, it operates a virtual bank under the name FitnessBank, which accepts deposits and provides higher interest rates based on customers meeting certain fitness goals.Affinity Bancshares, Inc. was founded in 1928 and is headquartered in Covington, Georgia.","United States","1928",null,"Banks - Regional","Financials","91","Edward J. Cooney CPA, CPA","3175 Highway 278Covington, Georgia 30014United States","(770) 786-7088","myaffinitybank.com","AFBI","NASDAQ","USD","0001823406",null,"US00832E1038","82-1147778","6036",{"Chief Executive Officer and Director":"Edward J. Cooney CPA, CPA","Executive Vice President and Chief Credit Officer":"Clark N. Nelson Jr.","Executive Vice President of Lending":"Elizabeth M. Galazka","Senior Vice President, Chief Financial Officer, Chief Treasury, Corporate Secretary and Risk Officer":"Brandi C. Pajot CPA, CPA","Senior Vice President and Operations Officer":"Robert A. Vickers","Vice President of Compliance":"Jacqueline Lyle"},"107.16M","29.71M","6.45M",null,"0.98","17.14","n/a","n/a","n/a","1,325","16.91","16.85","16.62 - 16.91","11.56 - 17.15","0.45","n/a","n/a","Apr 26, 2024"],["AudioEye, Inc.","AudioEye, Inc. provides patented, internet content publication, distribution software, and related services to Internet and other media to people regardless of their device, location, or disabilities in the United States.Its software and services enable conversion of digital content into accessible formats and allows for real time distribution to end users on any Internet connected device.The company offers AudioEye, an always-on testing, remediation, and monitoring solution that improves conformance with web content accessibility guidelines; identifies and fixes the accessibility errors and addresses a range of disabilities, including dyslexia, color blindness, epilepsy, and others; and provides additional solutions to provide for enhanced compliance and accessibility, including periodic auditing, human assisted technological remediations, and legal support services, as well as PDF remediation services, Native Mobile App and audit reports to help customers with their digital accessibility needs.The company serves small- and medium-sized businesses, corporate enterprises, non-profit organizations, and federal government agencies, as well as federal, state, and local governments and agencies through content management system partners, platform and agency partners, authorized resellers, and the marketplace.AudioEye, Inc. was incorporated in 2005 and is based in Tucson, Arizona.","United States","2005",null,"Software - Application","Technology","114","David D. Moradi","5210 E. Williams Circle, Suite 750Tucson, Arizona 85711United States","866-331-5324","audioeye.com","AEYE","NASDAQ","USD","0001362190",null,"US0507342014",null,"7372",{"Executive Chairman":"Dr. Carr Bettis Ph.D.","Chief Executive Officer and Director":"David D. Moradi","Chief Financial Officer, Principal Financial Officer and Principal Accounting Officer":"Kelly Georgevich","General Counsel and Secretary":"James Spolar","Senior Vice President of Customer Advocacy":"Sean D. Bradley","Chief Strategy Officer":"Mase Graye","Chief Accessibility Officer":"Michael Paciello"},"214.74M","31.63M","-4.69M",null,"-0.39","n/a","n/a","n/a","n/a","402,343","17.74","17.37","17.51 - 19.70","3.75 - 19.70","1.38","Strong Buy","18.50 (+0.27%)","Apr 23, 2024"],["Aura FAT Projects Acquisition Corp","Aura FAT Projects Acquisition Corp does not have significant operations.The company intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses.It focuses on acquiring technology companies with Web 3.0, blockchain, cryptocurrency, digital ledger, e-gaming, and other new financial technology and services applications in Southeast Asia, Australia, and New Zealand.The company was incorporated in 2021 and is based in Singapore.","Singapore","2021","Apr 13, 2022","Shell Companies","Financials","2","Tristan  Lo","27 Bukit Manis RoadSingapore, U0 099892Singapore","61 452 670 069","aurafatprojects.com","AFAR","NASDAQ","USD","0001901886",null,"KYG063621000",null,"7822",{"Co-Chief Executive Officer and Chairman of the Board":"Tristan Lo","Co-Chief Executive Officer, Chief Financial Officer and Director":"David Andrada","President, Chief Operating Officer, Head of Mergers and Acquisition & Director":"Nils Michaelis","Non-Executive Director and Chief Advisor":"Kar Wing Ng B.Com., L.L.B."},"64.87M","n/a","2.75M",null,"0.21","53.38","n/a","n/a","n/a","1,028","11.22","11.20","11.21 - 11.22","10.55 - 11.64","n/a","n/a","n/a","n/a"],["Aimei Health Technology Co., Ltd Ordinary Share","Aimei Health Technology Co Ltd is a blank check company.","NY","2023","Dec 4, 2023","Shell Companies","Financials",null,"Heung Ming  Wong","10 East 53rd Street, Suite 3001New York, New York 10022United States","34 678 035200",null,"AFJK","NASDAQ","USD","0001979005",null,null,null,"6770",{"8-K":"Jan 18, 2024","SC 13G":"Jan 31, 2024","10-K":"Mar 25, 2024","SC 13G/A":"Feb 14, 2024"},"92.74M","n/a","n/a",null,"n/a","n/a","n/a","n/a","n/a","6","10.27","10.32","10.27 - 10.32","10.15 - 10.30","n/a","n/a","n/a","n/a"],["Acutus Medical, Inc.","Acutus Medical, Inc. designs, manufactures, and markets various tools for catheter-based ablation procedures to treat various arrhythmias in the United States and internationally.Its product portfolio includes novel access sheaths, transseptal crossing tools, diagnostic and mapping catheters, conventional and contact ablation catheters, and mapping and imaging consoles and accessories, as well as supporting algorithms and software programs.Acutus Medical, Inc. was incorporated in 2011 and is headquartered in Carlsbad, California.","United States","2011","Aug 6, 2020","Medical Devices","Healthcare","230","Takeo  Mukai","2210 Faraday Ave, Suite 100Carlsbad, California 92008United States","442-232-6080","acutusmedical.com","AFIB","NASDAQ","USD","0001522860",null,"US0051111096","45-1306615","3841",{"Chief Executive Officer and Chief Financial Officer":"Takeo Mukai","Senior Vice President of Finance":"Gary W. Doherty"},"4.30M","7.16M","-81.66M",null,"-2.81","n/a","n/a","n/a","n/a","395,372","0.154","0.153","0.144 - 0.155","0.144 - 1.000","0.20","n/a","n/a","May 17, 2024"],["Aflac Incorporated","Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products.The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.The Aflac U.S. segment provides cancer, accident, short-term disability, critical illness, hospital indemnity, dental, vision, long-term care and disability, and term and whole life insurance products in the United States.It sells its products through sales associates, brokers, independent corporate agencies, individual agencies, and affiliated corporate agencies.Aflac Incorporated was founded in 1955 and is headquartered in Columbus, Georgia.","United States","1955",null,"Insurance - Life","Financials","12,785","Daniel Paul Amos","1932 Wynnton RdColumbus, Georgia 31999United States","(706) 323-3431","aflac.com","AFL","NYSE","USD","0000004977",null,"US0010551028","58-1167100","6321",{"President, Chairman and Chief Executive Officer":"Daniel Paul Amos","Executive Vice President and Chief Financial Officer":"Max Kristian Broden","Executive Vice President, Global Chief Investment Officer and President of Aflac Global Investments":"Bradley Eugene Dyslin C.F.A.","Executive Vice President and General Counsel":"Audrey Boone Tillman Esq.","Executive Vice President":"Frederick John Crawford","SVice President of Financial Services and Chief Accounting Officer":"Robin L. Blackmon CPA, CGMA","Senior Vice President and Counsel of Federal Relations":"Bradley L. Knox","Executive Vice President and Chief Financial Officer of Aflac Japan":"Steven Kent Beaver","Senior Vice President and Chief Information Security Officer":"Timothy L. Callahan CISM, CISSP, CRISC","Senior Vice President and Global Chief Risk Officer":"Albert Angelo Riggieri Jr."},"48.01B","19.34B","5.35B",null,"9.10","9.14","12.78","$2.00 (2.40%)","May 21, 2024","2,852,353","83.97","84.04","81.96 - 84.27","64.10 - 86.26","0.91","Hold","81.62 (-1.91%)","May 1, 2024"],["Affimed N.V.","Affimed N.V., a clinical-stage biopharmaceutical company, focuses on discovering and developing cancer immunotherapies in the United States and Germany.The company's lead product candidates include AFM13 that has completed Phase 2 clinical trial for CD30-positive lymphoma, Phase Ib clinical trial for hodgkin lymphoma, and completed Phase IIb clinical study for peripheral T-cell lymphoma; AFM24, a tetravalent, bispecific epidermal growth factor receptor, and CD16A-binding innate cell engager, which is in Phase IIa clinical trial for the treatment of advanced cancers; and AFM28, an innate cell engager (ICE), which is in preclinical development for the treatment acute myeloid.It develops AFM32, an ICE candidate that is in preclinical development for the treatment of solid tumors.It has collaboration with Artiva Biotherapeutics to develop the combination of acimtamig and AlloNK; license and strategic collaboration agreement with Roivant Sciences Ltd. to develop and commercialize novel ICE molecules, including AFM32, in oncology; and strategic collaboration agreement with Genentech for the development of certain product candidates, which includes novel NK cell engager-based immunotherapeutics to treat multiple cancers.The company was formerly known as Affimed Therapeutics B.V. and changed its name to Affimed N.V. in October 2014.Affimed N.V. was founded in 2000 and is headquartered in Mannheim, Germany.","Germany","2000","Sep 12, 2014","Biotechnology","Healthcare","76","Dr. Andreas  Harstrick M.D.","Gottlieb-daimler-strasse 2Mannheim, 2M 68165Germany","49-621-560030","affimed.com","AFMD","NASDAQ","USD","0001608390",null,"NL0015001ZQ0",null,"2834",{"Interim Chief Executive Officer, Chief Medical Officer and Member of Management Board":"Dr. Andreas Harstrick M.D.","MD, Chief Operating Officer and Member of Management Board":"Dr. Wolfgang Fischer Ph.D.","Chief Business Officer and Member of Management Board":"Denise Mueller","Founder and Consultant":"Prof. Melvyn Little","Head of Finance and Administration":"Michael Wolf","Head of Investor Relations and Director of Investor Relations":"Alexander Fudukidis","Vice President of Marketing and Communications":"Mary Beth Sandin"},"82.53M","9.19M","-117.71M",null,"-7.63","n/a","n/a","n/a","n/a","82,234","5.42","5.31","5.10 - 5.51","2.24 - 11.10","2.09","Strong Buy","32.00 (+503.77%)","May 21, 2024"],["Affirm Holdings, Inc.","Affirm Holdings, Inc. operates a platform for digital and mobile-first commerce in the United States, Canada, and internationally.The company's platform includes point-of-sale payment solution for consumers, merchant commerce solutions, and a consumer-focused app.Its commerce platform, agreements with originating banks, and capital markets partners enables consumers to pay for a purchase over time with terms ranging up to 60 months.The company has active merchants covering small businesses, large enterprises, direct-to-consumer brands, brick-and-mortar stores, and companies with an omni-channel presence.Its merchants represent a range of industries, including sporting goods and outdoors, furniture and homewares, travel and ticketing, apparel, accessories, consumer electronics, and jewelry.Affirm Holdings, Inc. was founded in 2012 and is headquartered in San Francisco, California.","United States","2012","Jan 13, 2021","Software - Infrastructure","Technology","2,171","Max Roth Levchin","650 California StreetSan Francisco, California 94108United States","(415) 960-1518","affirm.com","AFRM","NASDAQ","USD","0001820953",null,"US00827B1061","84-2224323","6141",{"Founder, Chief Executive Officer and Chairman":"Max Roth Levchin","President and Director":"Libor Michalek","Chief Financial Officer":"Michael A. Linford","Chief Legal Officer and Secretary":"Katherine Adkins Esq.","Senior Vice President of Operations":"Katrina Holt","Vice President of Investor Relations":"Ronald Clark","Chief Capital Officer":"Brooke E. Major-Reid","Senior Vice President of Finance":"Robert W. O'Hare","Head of International":"Dr. Wayne Pommen Ph.D.","Senior Vice President of Revenue":"Pat Suh"},"10.72B","1.91B","-750.32M",null,"-2.49","n/a","n/a","n/a","n/a","5,397,092","36.34","34.44","34.62 - 36.70","9.28 - 52.48","3.58","Hold","27.03 (-22.62%)","May 8, 2024"],["AGBA Acquisition Limited","AGBA Group Holding Limited together with its subsidiaries provides wealth management and healthcare institution services in Hong Kong.The company operates through Platform Business, Distribution Business, Healthcare Business, and Fintech Business segments.The Platform Business segment operates as a financial supermarket that offers financial products, such as life insurance, pensions, property-casualty insurance, stock brokerage, mutual funds, money lending, and real estate agency services.This segment serves banks, financial institutions, family offices, brokers, and individual independent financial advisors.The Distribution Business segment provides personal financial advisory services; and financial services and products, including long-term life insurance, savings, and mortgages.The Healthcare Business segment operates self-operated medical centers and a network of healthcare service providers in the Hong Kong and Macau region.The Fintech Business segment provides assets and businesses in Europe and Hong Kong. The Fintech Business segment manages financial technology investments with a spectrum of services and value-added information in health, insurance, investments, and social sharing.The company was formerly known as AGBA Acquisition Limited and changed its name to AGBA Group Holding Limited.AGBA Group Holding Limited was founded in 1993 and is headquartered in Wan Chai, Hong Kong.","Hong Kong","2018","May 14, 2019","Capital Markets","Financials","176","Wing Fai  Ng","Agba Tower, 68 Johnston RoadWan Chai, K3 00000Hong Kong","852 3601 8000","agba.com","AGBA","NASDAQ","USD","0001769624",null,"VGG012121023",null,"6282",{"Executive Chairman":"Robert Edward Diamond Jr.","Chief Executive Officer and Executive Director":"Wing Fai Ng","Acting Group Chief Financial Officer and Director of Corporate Development":"Pei Huang Shu","Group Chief Operating Officer":"Suet Fai Wong","Group Chief Strategy Officer":"Jeroen Nieuwkoop","Deputy Chief Financial Officer and Company Secretary":"Richard Kong"},"242.52M","54.19M","-49.21M",null,"-0.75","n/a","n/a","n/a","n/a","3,899,761","3.220","3.340","3.130 - 3.550","0.320 - 4.290","0.38","n/a","n/a","May 15, 2024"],["Forafric Global PLC","Forafric Global PLC engages in the purchase, storage, transport, processing, and sale of agricultural commodities and commodity products in Morocco, Burkina, Mali, Angola, and internationally.The company offers flour and semolina; and secondary processing products, such as pasta and couscous under the Tria and MayMouna brands.It serves wholesale foods manufacturers and distributors The company also exports its products to approximately 45 countries.Forafric Global PLC is headquartered in Gibraltar.","Gibraltar","1943",null,"Farm Products","Consumer Staples","600","Mustapha  Jamaleddine","Unit 5.3, Madison Building, Midtown, QueenswayGibraltar, J1 GX111AAGibraltar","011 350 20072505","forafric.com","AFRI","NASDAQ","USD","0001903870",null,"GI000A3DNK69",null,"2040",{"Executive Chairman":"Saâd Bendidi","Chief Executive Officer":"Mustapha Jamaleddine","Chief Financial Officer and Director":"Julien David Benitah","Chief Technology Officer":"Mustapha Ghazali"},"281.69M","305.48M","-12.68M",null,"-0.47","n/a","n/a","n/a","n/a","3,135","10.50","10.30","10.30 - 10.50","9.35 - 12.00","0.38","n/a","n/a","May 14, 2024"],["Afya Limited","Afya Limited operates as a medical education group in Brazil.The company operates through three segments: Undergrad, Continuing Education, and Digital Services. It offers educational products and services, including medical schools, medical residency preparatory courses, graduate courses, and other programs to lifelong medical learners enrolled across its distribution network, as well as to third-party medical schools.The company provides digital health services, such as subscription-based mobile app and website portal that focuses on assisting health professionals and students with clinical decision-making through tools, such as medical calculators, charts, and updated content, as well as prescriptions, clinical scores, medical procedures and laboratory exams, and others.It offers health sciences courses, which comprise medicine, dentistry, nursing, radiology, psychology, pharmacy, physical education, physiotherapy, nutrition, and biomedicine; and degree programs and courses in other subjects and disciplines, including undergraduate and post graduate courses in business administration, accounting, law, civil engineering, industrial engineering, and pedagogy.In addition, the company provides medical postgraduate specialization programs; printed and digital content; and an online medical education platform and practical medical training services.Further, it offers iClinic, a practice management software; educational health and medical imaging solutions through an interactive platform; Cliquefarma, a free-to-use website that tracks prescription drugs, cosmetics and personal hygiene product prices; Shosp, a clinical management software; RX PRO, a solution that connects physicians with the pharmaceutical industry; and Glic, a free diabetes care and management app solution for physicians and patients.The company was founded in 1999 and is headquartered in Nova Lima, Brazil.","Brazil","1999","Jul 19, 2019","Education & Training Services","Consumer Staples","9,680","Virgilio Deloy Capobianco Gibbon","Alameda Oscar Niemeyer, No. 119, 15th Floor, Vila Da SerraNova Lima, Minas Gerais, D5 34006-056Brazil","55 (31) 3515 7500","afya.com.br","AFYA","NASDAQ","USD","0001771007",null,"KYG011251066",null,"8200",{"Chief Executive Officer":"Virgilio Deloy Capobianco Gibbon","Chief Financial Officer":"Luis Andre Carpintero Blanco","Investor Relations Executive Manager":"Renata Couto","Vice President of Continuing Education and Innovation":"Julio Eduardo Razente de Angeli"},"1.68B","590.54M","79.33M",null,"0.84","21.91","10.04","n/a","n/a","75,714","17.72","17.42","17.58 - 17.99","10.87 - 22.48","0.97","Hold","23.00 (+27.99%)","May 22, 2024"],["First Majestic Silver Corp.","First Majestic Silver Corp. engages in the acquisition, exploration, development, and production of mineral properties with a focus on silver and gold production in North America.Its projects include the San Dimas mine covering an area of approximately 71,867 hectares located in Durango State, Mexico; the Santa Elena that covers an area of approximately 102,244 hectares located in Sonora State, México; and the La Encantada covering an area of approximately 4,076 hectares located in Coahuila State, México.The company was formerly known as First Majestic Resource Corp. and changed its name to First Majestic Silver Corp. in November 2006.First Majestic Silver Corp. was incorporated in 1979 and is headquartered in Vancouver, Canada.","Canada",null,null,"Silver","Materials","4,634","Keith N. Neumeyer","925 West Georgia Street, Suite 1800Vancouver, A1 V6C 3L2British Columbia, Canada","604-688-3033","firstmajestic.com","AG","NYSE","USD","0001308648",null,"CA32076V1031",null,"1040",{"Founder, President, Chief Executive Officer and Director":"Keith N. Neumeyer","Chief Financial Officer":"David Soares C.A., CPA, M.B.A.","Chief Operating Officer":"Steven C. Holmes B.Sc., M.B.A.","Vice President of Operations-Mexico":"Colin Bradford Bower","Vice President of Exploration and Technical Services":"Gonzalo Ariel Mercado","Vice President of Corporate Development and Investor Relations":"Mani Alkhafaji","General Counsel and Corporate Secretary":"Samir Devendra Patel L.L.B., LL.B. (Hons)","Vice President of Corporate Communications and Marketing":"Jill Anne Arias","Vice President of Human Resources":"David Smith","Vice President of Treasury":"Karen Liu CMA"},"1.92B","573.80M","-135.11M",null,"-0.48","n/a","454.55","$0.02 (0.29%)","Mar 13, 2024","4,972,512","6.81","6.72","6.61 - 6.93","4.17 - 8.44","1.37","Strong Buy","8.50 (+26.87%)","May 14, 2024"],["Allied Gaming & Entertainment Inc.","Allied Gaming & Entertainment Inc., together with its subsidiaries, operates as a public esports and entertainment company worldwide.It operates esports properties to connect players and fans through a network of connected arenas; and creates original esports content.The company also operates a flagship gaming arena located at the Luxor Hotel in Las Vegas, Nevada, as well as focuses on exploring opportunities in the mobile games markets.In addition, it focuses on orchestrating live entertainment events and offers management and consultation service to experiential entertainment venue operation.Further, the company operates a mobile esports truck that serves as a battleground and content generation hub, as well as a studio for recording and streaming gaming events.The company is based in New York, New York.","United States","2017",null,"Entertainment","Communication Services","73","Ms. Yinghua  Chen","745 Fifth Avenue, Suite 500New York, New York 10151United States","(646) 768-4240","alliedesports.gg","AGAE","NASDAQ","USD","0001708341",null,"US0191701095","82-1659427","7900",{"Chief Executive Officer, President and Executive Director":"Yinghua Chen","Chief Financial Officer and Secretary":"Roy L. Anderson"},"35.98M","7.66M","-3.60M",null,"-0.10","n/a","n/a","n/a","n/a","6,859","0.808","0.820","0.808 - 0.839","0.760 - 1.500","1.28","n/a","n/a","May 13, 2024"],["Agenus Inc.","Agenus Inc., a clinical-stage biotechnology company, discovers and develops immuno-oncology products in the United States and internationally.The company offers Retrocyte Display, an antibody expression platform for the identification of fully human and humanized monoclonal antibodies; and display technologies.It develops QS-21 Stimulon adjuvant, a saponin-based vaccine adjuvant. The company also develops Balstilimab, an anti-PD-1 antagonist that has completed Phase II clinical trial to treat second line cervical cancer; AGEN1181, an antigen 4 (CTLA-4) blocking antibody that is in Phase 2 clinical trial for the treatment of pancreatic cancer and and melanoma; AGEN2373, a CD137 monospecific antibody that is in Phase 1b clinical trial; AGEN1423, a CD73/TGFß TRAP antibody; AGEN1571, an ILT2 monospecific antibody that is in Phase 1 clinical trial; and BMS-986442, a TIGIT bispecific antibodies.In addition, it develops INCAGN1876, a GITR agonist; INCAGN2390, a TIM-3 monospecific antibody; INCAGN2385, a LAG-3 monospecific antibody; MK-4830, a monospecific antibody targeting ILT4 that is in Phase 2 clinical trial; UGN-301, a zalifrelimab intravesical solution for the treatment of cancers of the urinary tract that is in a Phase 1 clinical trial; and AGEN1884, a first-generation anti-CTLA-4 monospecific antibody.The company operates under Agenus, MiNK, Prophage, Retrocyte Display, and Stimulon trademarks. It has collaborations with Bristol-Myers Squibb Company, Betta Pharmaceuticals Co., Ltd., Incyte Corporation, Merck Sharpe & Dohme, and Gilead Sciences, Inc. The company was formerly known as Antigenics Inc. and changed its name to Agenus Inc. in January 2011.Agenus Inc. was founded in 1994 and is headquartered in Lexington, Massachusetts.","United States","1994","Feb 4, 2000","Biotechnology","Healthcare","389","Dr. Garo H. Armen Ph.D.","3 Forbes RoadLexington, Massachusetts 02421United States","781-674-4410","agenusbio.com","AGEN","NASDAQ","USD","0001098972",null,"US00847G7051","06-1562417","2836",{"Founder, Executive Chairman and Chief Executive Officer":"Dr. Garo H. Armen Ph.D.","Vice President of Finance, Principal Financial Officer and Principal Accounting Officer":"Christine M. Klaskin","Chief Medical Officer":"Dr. Steven J. O'Day M.D., Ph.D.","Chief Information Officer":"Craig Winter","Head of Investor Relations":"Zack Armen","Chief People Officer":"Tracy Mazza Clemente","Scientific Director and Head of Drug Discovery":"Dhan Chand","Chief Manufacturing Officer":"Alfred Dadson","Chief Quality Officer":"Eric Humes","Member of Advisory Board and Chief Strategic Advisor":"Dr. Todd Jude Yancey M.D."},"265.12M","156.31M","-245.97M",null,"-13.80","n/a","n/a","n/a","n/a","642,612","12.75","12.52","12.55 - 13.58","4.78 - 42.60","1.28","Strong Buy","146.50 (+1,020.89%)","May 7, 2024"],["Agrify Corporation","Agrify Corporation offers hardware and software cultivation and extraction solutions for the cannabis and hemp industry in the United States.It offers vertical farming units and Agrify Insights Software-as-a-Service software; integrated grow racks and LED grow lights; and non-proprietary products designed, engineered, and manufactured by third parties, such as air cleaning systems and pesticide-free surface protection products.The company also provides associated services comprising consulting, engineering, and construction. In addition, the company offers hydrocarbon, alcohol, solventless, post-processing, and lab equipment, as well as provides indoor farming solutions.In addition, it offers equipment and services in a contract and purchase order. The company was formerly known as Agrinamics, Inc. and changed its name to Agrify Corporation in September 2019.Agrify Corporation was incorporated in 2016 and is headquartered in Troy, Michigan.","United States","2016","Jan 28, 2021","Farm & Heavy Construction Machinery","Industrials","39","Ms. Sheryl  Elliott","2468 Industrial Row DriveTroy, Michigan 48084United States","855-420-0020","agrify.com","AGFY","NASDAQ","USD","0001800637",null,"US00853E3053","30-0943453","0700",{"Chief Executive Officer, Chairman of the Board and Corporate Secretary":"Raymond Nobu Chang Jr.","Chief Scientific Officer":"David Kessler","Senior Vice President of Human Resources":"Sheryl Elliott","Executive Vice President and GM of Extraction Division":"Brian Towns"},"4.24M","16.87M","-18.65M",null,"-12.51","n/a","n/a","n/a","n/a","54,489","0.298","0.300","0.293 - 0.305","0.250 - 4.920","1.92","n/a","n/a","Apr 15, 2024"],["Alamos Gold Inc.","Alamos Gold Inc. engages in the acquisition, exploration, development, and extraction of precious metals in Canada and Mexico.The company primarily explores for gold deposits. It holds 100% interest in the Young-Davidson mine and Island Gold mine located in the Ontario, Canada; Mulatos mine located in the Sonora, Mexico; and Lynn Lake project situated in the Manitoba, Canada.The company also holds interest in the Quartz Mountain project located in the Oregon United states. Alamos Gold Inc. was founded in 2003 and is based in Toronto, Canada.","Canada",null,"Sep 2, 1999","Gold","Materials","1,918","John A. McCluskey","181 Bay Street, Suite 3910Toronto, A6 M5J 2T3Ontario, Canada","416-368-9932","alamosgold.com","AGI","NYSE","USD","0001178819",null,"CA0115321089",null,"1040",{"President, Chief Executive Officer and Director":"John A. McCluskey","Senior Vice President of Mexico":"Dr. Luis Chavez-Martinez B.A., M.Sc., Ph.D.","Senior Vice President of Technical Services":"Christopher Bostwick B.Sc., FAusIMM","Chief Financial Officer":"Greg Fisher B.Comm, CPA, CA","Chief Operating Officer":"Luc Guimond B.Sc., P.Eng.","Senior Vice President of Investor Relations":"Scott Parsons CFA","Senior Vice President and General Counsel":"Nils Frederik Jonas Engelstad BA, LL.B, LL.M, M.A.","Vice President of Public Affairs":"Rebecca Thompson B.A.","Vice President of Human Resources":"Nicole Lichowit M.B.A., M.S.W.","Vice President of Sustainability and External Affairs":"Colin Webster B.Sc., P.Eng."},"5.97B","1.05B","203.70M",null,"0.52","28.90","24.53","$0.10 (0.67%)","Mar 13, 2024","1,483,158","15.01","14.96","14.80 - 15.15","10.78 - 16.01","1.05","Strong Buy","18.81 (+25.15%)","Apr 24, 2024"],["Agios Pharmaceuticals, Inc.","Agios Pharmaceuticals, Inc., a biopharmaceutical company, discovers and develops medicines in the field of cellular metabolism in the United States.Its lead product includes PYRUKYND (mitapivat), an activator of wild-type and mutant pyruvate kinase (PK), enzymes for the treatment of hemolytic anemias.The company develops AG-946, a PK activator for treating lower-risk myelodysplastic syndrome and hemolytic anemias; and AG-181, a phenylalanine hydroxylase stabilizer for the treatment of phenylketonuria.Its preclinical product is siRNA for the treatment of polycythemia vera, a rare blood disorder. Agios Pharmaceuticals, Inc. was incorporated in 2007 and is headquartered in Cambridge, Massachusetts.","United States",null,"Jul 24, 2013","Biotechnology","Healthcare","386","Brian M. Goff M.B.A.","88 Sidney StreetCambridge, Massachusetts 02139United States","617-649-8600","agios.com","AGIO","NASDAQ","USD","0001439222",null,"US00847X1046",null,"2834",{"Chief Executive Officer and Director":"Brian M. Goff M.B.A.","Chief Financial Officer":"Cecilia Jones","Corporate Secretary and Chief Legal Officer":"James William Burns","Chief Medical Officer and Head of Research and Development":"Dr. Sarah Gheuens M.D., Ph.D.","Co-Founder and Member of Scientific Advisory Board":"Dr. Shin-San Su Ph.D.","Co-Founder and Chairman of Scientific Advisory Board":"Dr. Craig B. Thompson M.D.","Principal Accounting Officer":"T. J. Washburn Jr.","Chief Technical Operations Officer":"Dr. Clive Patience Ph.D."},"1.92B","29.40M","-352.62M",null,"-6.32","n/a","2.47","n/a","n/a","785,935","34.90","34.58","33.63 - 35.48","19.80 - 35.50","0.86","Buy","36.75 (+6.4%)","May 2, 2024"],["AGCO Corporation","AGCO Corporation manufactures and distributes agricultural equipment and related replacement parts worldwide.It offers horsepower tractors for row crop production, soil cultivation, planting, land leveling, seeding, and commercial hay operations; utility tractors for small- and medium-sized farms, as well as for dairy, livestock, orchards, and vineyards; and compact tractors for small farms, specialty agricultural industries, landscaping, equestrian, and residential uses.The company also provides grain storage bins and related drying and handling equipment systems; seed-processing systems; swine and poultry feed storage and delivery; ventilation and watering systems; and egg production systems and broiler production equipment.In addition, it offers round and rectangular balers, loader wagons, self-propelled windrowers, forage harvesters, disc mowers, spreaders, rakes, tedders, and mower conditioners for harvesting and packaging vegetative feeds used in the beef cattle, dairy, horse, and renewable fuel industries.Further, the company provides implements, including disc harrows leveling seed beds and mixing chemicals with the soils; heavy tillage to break up soil and mix crop residue into topsoil; field cultivators that prepare smooth seed bed and destroy weeds; drills for small grain seeding; planters and other planting equipment; and loaders.Additionally, it offers combines for harvesting grain crops, such as corn, wheat, soybeans, and rice; and application equipment, such as self-propelled, three- and four-wheeled vehicles, and related equipment for liquid and dry fertilizers and crop protection chemicals, and for after crops emerge from the ground, as well as produces diesel engines, gears, and generating sets.The company markets its products under the Fendt, GSI, Massey Ferguson, Precision Planting, and Valtra brands through a network of independent dealers and distributors.AGCO Corporation was founded in 1990 and is headquartered in Duluth, Georgia.","United States","1990","Apr 16, 1992","Farm & Heavy Construction Machinery","Industrials","27,900","Eric P. Hansotia","4205 River Green PkwayDuluth, Georgia 30096United States","(770) 813-9200","agcocorp.com","AGCO","NYSE","USD","0000880266",null,"US0010841023","58-1960019","3523",{"Chairman, President and Chief Executive Officer":"Eric P. Hansotia","Senior Vice President and Chief Financial Officer":"Damon J. Audia","SVice President and GM of Grain and Protein":"Robert B. Crain","Senior Vice President and GM of Massey Ferguson":"Luis Fernando Sartini Felli","Senior Vice President and GM of Fendt/Valtra":"Torsten Rudolf-Willi Dehner","Vice President and Chief Accounting Officer (Leave of Absence)":"Lara T. Long","Senior Vice President and Chief Digital and Information Officer":"Viren Shah","Vice President of Investor Relations":"Greg Peterson","Senior Vice President, General Counsel, Chief ESG Officer, and Corporate Secretary":"Roger Neil Batkin","Global Corporate Communications Manager":"Cristiane Masina"},"8.34B","14.01B","1.11B",null,"14.78","7.56","8.54","$1.16 (1.04%)","May 17, 2024","1,079,803","110.56","110.63","110.21 - 112.80","105.77 - 140.46","1.33","Strong Buy","144.17 (+28.94%)","May 2, 2024"],["agilon health, inc.","agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States.It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month.The company was formerly known as Agilon Health Topco, Inc. and changed its name to agilon health, inc.in March 2021. agilon health, inc.was founded in 2016 and is based in Austin, Texas.","United States","2016","Apr 15, 2021","Medical Care Facilities","Healthcare","1,117","Steven Jackson Sell","6210 E Hwy 290, Suite 450Austin, Texas 78723United States","562-256-3800","agilonhealth.com","AGL","NYSE","USD","0001831097",null,"US00857U1079","37-1915147","8090",{"President, Chief Executive Officer and Director":"Steven Jackson Sell","Chief Financial Officer":"Timothy S. Bensley","Chief Technology Officer":"Girish Venkatachaliah","Chief Markets Officer":"Ben Shaker","Chief Strategy and Development Officer":"Veeral Desai","Vice President, Controller and Chief Accounting Officer":"Timothy Gertsch","Vice President of Investor Relations":"Matthew Dale Gillmor CFA","Chief Legal Officer and Secretary":"Denise Zamore","Chief Communications and Public Affairs Officer":"Claire Mulhearn","Chief People Officer":"Mat Varghese"},"1.99B","4.32B","-262.60M",null,"-0.64","n/a","204.08","n/a","n/a","3,970,970","4.860","4.830","4.775 - 4.955","4.410 - 26.750","0.50","Hold","9.17 (+89.86%)","May 7, 2024"],["Federal Agricultural Mortgage Corporation","Federal Agricultural Mortgage Corporation provides a secondary market for various loans made to borrowers in the United States.It operates through four segments: Corporate AgFinance, Farm & Ranch, Rural Utilities, and Renewable Energy.The company's Agricultural Finance line of business engages in purchasing and retaining eligible loans and securities; guaranteeing the payment of principal and interest on securities that represent interests in or obligations secured by pools of eligible loans; servicing eligible loans; and issuing LTSPCs for eligible loans.Its Rural Infrastructure Finance line of business is involved in the purchase of rural utilities loans and renewable energy loans and guarantees of securities backed by loans, as well as LTSPCs for pools of eligible rural utilities loans; by loans for electric or telecommunications facilities by lenders organized as cooperatives to borrowers; and other financial institutions that are secured by pools of eligible loans.Federal Agricultural Mortgage Corporation was incorporated in 1987 and is headquartered in Washington, the District of Columbia.","United States","1987",null,"Credit Services","Financials","185","Bradford Todd Nordholm","1999 K Street Nw, 4th FloorWashington, District of Columbia 20006United States","(202) 872-7700","farmermac.com","AGM","NYSE","USD","0000845877",null,"US3131483063","52-1578738","6111",{"President and Chief Executive Officer":"Bradford Todd Nordholm","Executive Vice President, Chief Financial Officer and Treasurer":"Aparna Ramesh","Executive Vice President, General Counsel and Corporate Secretary":"Stephen P. Mullery","Executive Vice President and Chief Business Officer":"Zachary N. Carpenter","Senior Vice President and Chief Credit Officer":"Marc J. Crady","Senior Vice President of Operations":"Robert J. Maines","Vice President, Principal Accounting Officer and Chief Accounting Officer":"Gregory N. Ramsey","Senior Vice President and Chief Information Officer":"Sean T. Datcher","Senior Director of Investor Relations and Finance Strategy":"Jalpa Nazareth","Director of Compliance":"Michelle Nichols"},"2.06B","350.20M","172.84M",null,"15.81","12.28","11.29","$5.60 (2.88%)","Mar 14, 2024","28,243","195.00","193.35","193.19 - 196.83","122.96 - 199.40","1.09","Buy","220.00 (+13.27%)","May 6, 2024"],["Federal Agricultural Mortgage Corporation","Federal Agricultural Mortgage Corporation provides a secondary market for various loans made to borrowers in the United States.It operates through four segments: Corporate AgFinance, Farm & Ranch, Rural Utilities, and Renewable Energy.The company's Agricultural Finance line of business engages in purchasing and retaining eligible loans and securities; guaranteeing the payment of principal and interest on securities that represent interests in or obligations secured by pools of eligible loans; servicing eligible loans; and issuing LTSPCs for eligible loans.Its Rural Infrastructure Finance line of business is involved in the purchase of rural utilities loans and renewable energy loans and guarantees of securities backed by loans, as well as LTSPCs for pools of eligible rural utilities loans; by loans for electric or telecommunications facilities by lenders organized as cooperatives to borrowers; and other financial institutions that are secured by pools of eligible loans.Federal Agricultural Mortgage Corporation was incorporated in 1987 and is headquartered in Washington, the District of Columbia.","United States","1987",null,"Credit Services","Financials","185","Bradford Todd Nordholm","1999 K Street Nw, 4th FloorWashington, District of Columbia 20006United States","(202) 872-7700","farmermac.com","AGM.A","NYSE","USD","0000845877",null,"US3131481083","52-1578738","6111",{"President and Chief Executive Officer":"Bradford Todd Nordholm","Executive Vice President, Chief Financial Officer and Treasurer":"Aparna Ramesh","Executive Vice President, General Counsel and Corporate Secretary":"Stephen P. Mullery","Executive Vice President and Chief Business Officer":"Zachary N. Carpenter","Senior Vice President and Chief Credit Officer":"Marc J. Crady","Senior Vice President of Operations":"Robert J. Maines","Vice President, Principal Accounting Officer and Chief Accounting Officer":"Gregory N. Ramsey","Senior Vice President and Chief Information Officer":"Sean T. Datcher","Senior Director of Investor Relations and Finance Strategy":"Jalpa Nazareth","Director of Compliance":"Michelle Nichols"},"2.05B","350.20M","172.84M",null,"15.81","9.56","8.79","$5.60 (3.70%)","Mar 14, 2024","121","151.20","146.39","146.39 - 151.20","107.50 - 160.48","1.09","Buy","220.00 (+45.5%)","May 6, 2024"],["AGNC Investment Corp.","AGNC Investment Corp. provides private capital to housing market in the United States.It invests in residential mortgage pass-through securities and collateralized mortgage obligations for which the principal and interest payments are guaranteed by the United States government-sponsored enterprise or by the United States government agency.The company qualifies as a real estate investment trust for federal income tax purposes. It generally would not be subject to federal corporate income taxes if it distributes at least 90% of its taxable income to its stockholders.The company was formerly known as American Capital Agency Corp. and changed its name to AGNC Investment Corp. in September 2016.AGNC Investment Corp. was incorporated in 2008 and is headquartered in Bethesda, Maryland.","United States","2008","May 13, 2008","REIT - Mortgage","Real Estate","53","Peter J. Federico","7373 Wisconsin Avenue, 22nd FloorBethesda, Maryland 20814United States","301 968 9300","agnc.com","AGNC","NASDAQ","USD","0001423689",null,"US00123Q1040","26-1701984","6798",{"Executive Chairman":"Gary D. Kain","President, Chief Executive Officer and Director":"Peter J. Federico","Executive Vice President and Chief Financial Officer":"Bernice E. Bell","Executive Vice President and Chief Investment Officer":"Christopher J. Kuehl","Executive Vice President, General Counsel, Chief Compliance Officer and Secretary":"Kenneth L. Pollack","Executive Vice President of Strategy and Corporate Development":"Sean Reid J.D.","Senior Vice President and Chief Technology Officer":"Christopher Erhorn B.S.","Vice President of Investor Relations":"Katie R. Wisecarver","Head of Asset and Liability Management and Senior Vice President":"Jason Campbell","Senior Vice President":"Aaron J. Pas"},"6.54B","251.00M","32.00M",null,"0.05","188.00","4.20","$1.44 (15.32%)","Apr 29, 2024","12,473,969","9.40","9.30","9.36 - 9.49","6.81 - 10.64","1.45","Buy","9.93 (+5.64%)","Apr 22, 2024"],["Assured Guaranty Ltd.","Assured Guaranty Ltd., together with its subsidiaries, provides credit protection products to public finance, infrastructure, and structured finance markets in the United States and internationally.It operates through two segments: Insurance and Asset Management. The company offers financial guaranty insurance that protects holders of debt instruments and other monetary obligations from defaults in scheduled payments.It insures and reinsures various debt obligations, including bonds issued by the United States state governmental authorities; and notes issued to finance infrastructure projects.In addition, the company insures and reinsures various the U.S. public finance obligations, such as general obligation, tax-backed, municipal utility, transportation, healthcare, higher education, infrastructure, housing revenue, investor-owned utility, renewable energy, and other public finance bonds.Further, the company involved in insuring and reinsuring of non-U.S. public finance obligations comprising regulated utilities, infrastructure finance, sovereign and sub-sovereign, renewable energy bonds, pooled infrastructure, and other public finance obligations; and the U.S. and non-U.S. Structured finance obligations, including residential mortgage-backed securities, life insurance transactions, consumer receivables securities, subscription finance facilities, pooled corporate obligations, and financial products.Additionally, it offers specialty business, such as real estate properties, insurance securitizations, and aircraft residual value insurance (RVI) transactions; and asset management services comprising investment advisory services.It markets its financial guaranty insurance directly to issuers and underwriters of public finance and structured finance securities, as well as to investors in such obligations.Assured Guaranty Ltd. was incorporated in 2003 and is headquartered in Hamilton, Bermuda.","Bermuda","2003","Apr 23, 2004","Insurance - Specialty","Financials","350","Dominic John Frederico","30 Woodbourne Ave, 5th FloorHamilton Bermuda, D0 HM08Bermuda","441-279-5700","assuredguaranty.com","AGO","NYSE","USD","0001273813",null,"BMG0585R1060",null,"6351",{"Deputy Chairman, President and Chief Executive Officer":"Dominic John Frederico","Chief Operating Officer":"Robert Adam Bailenson","General Counsel and Secretary":"Gon Ling Chow","Chief Surveillance Officer":"Holly Larie Horn","Chief Credit Officer":"Stephen John Donnarumma","Chief Financial Officer":"Benjamin G. Rosenblum","Chief Accounting Officer and Controller":"Laura Ann Bieling","Chief Technology Officer and Head of Information Technology":"Christopher M. Gibbons","Chief Information Officer":"Kirk Edmunds","Senior Managing Director of Investor Relations and Corporate Communications":"Robert S. Tucker"},"4.32B","1.37B","739.00M",null,"12.30","6.33","13.42","$1.24 (1.59%)","May 14, 2024","435,807","77.38","77.44","76.50 - 78.31","49.84 - 96.60","1.12","Hold","89.67 (+15.15%)","May 7, 2024"],["AGM Group Holdings Inc.","AGM Group Holdings Inc. operates as a technology company, engages in the research and development of blockchain-oriented ASIC chip in Singapore, Hong Kong, and China.The company offers MetaTrader 5, a futures trading solution; and foreign exchange trading system that provides services to financial institutions.It also engages in the research and development, manufacture, and sales of technology hardware. In addition, the company sells cryptocurrency mining machine and standardized computing equipment, and technical support plans, as well as delivers fintech software services.AGM Group Holdings Inc. was incorporated in 2015 and is based in Wan Chai, Hong Kong.","Hong Kong","2015","Apr 18, 2018","Computer Hardware","Technology","25","Dr. Bo  Zhu","Room 1502-3 15/f., Connuaght Commercial, Building, 185 Wanchai RoadWanchai, K3 00000Hong Kong","86 010 65020507","agmprime.com","AGMH","NASDAQ","USD","0001705402",null,"VGG0132V1058",null,"7371",{"Chief Executive Officer, Chief Strategy Officer and Director":"Dr. Bo Zhu","Chief Technology Officer":"Yufeng Mi","Secretary":"Yafang Wang","Investor Relations":"Xuedong Tian C.F.A."},"26.44M","165.45M","13.02M",null,"0.45","2.42","n/a","n/a","n/a","150,525","1.120","1.080","1.080 - 1.150","0.920 - 2.450","1.07","n/a","n/a","May 14, 2024"],["Avangrid, Inc.","Avangrid, Inc., an energy services holding company, engages in the regulated energy transmission and distribution, and renewable energy generation businesses in the United States.The company operates through Networks and Renewables segments. It is involved in the generation, transmission, and distribution of electricity; and distribution, transportation, and sale of natural gas.In addition, the company operates renewable energy generation facilities primarily using onshore wind power, as well as solar, biomass, and thermal power.Further, it delivers natural gas and electricity to residential, commercial, and institutional customers through its regulated utilities in New York, Maine, Connecticut, and Massachusetts; and sells its output to investor-owned utilities, public utilities, and other credit-worthy entities, as well as generates and provides power and other services to federal and state agencies, institutional retail, and joint action agencies.Additionally, the company delivers thermal output to wholesale customers in the Western United States.It owns eight electric and natural gas utilities, serving 3.3 million customers in New York and New England, as well as owns and operates 9.3 gigawatts of electricity capacity primarily through wind power in 22 states.Avangrid, Inc. was incorporated in 1997 and is headquartered in Orange, Connecticut. The company operates as a subsidiary of Iberdrola, S.A.","United States","1847",null,"Utilities - Regulated Electric","Utilities","7,999","Pedro Azagra  Blazquez","180 Marsh Hill RoadOrange, Connecticut 06477United States","207-530-0977","avangrid.com","AGR","NYSE","USD","0001634997",null,"US05351W1036","14-1798693","4911",{"Chief Executive Officer and Director":"Pedro Azagra Blazquez","Senior Vice President, General Counsel and Company Secretary":"R. Scott Mahoney","President and Chief Executive Officer of Avangrid Networks, Inc.":"Catherine S. Stempien","President and Chief Executive Officer of Avangrid Renewables, LLC":"Jose Antonio Miranda Soto","Chief Financial Officer, Senior Vice President and Controller":"Justin B. Lagasse","Vice President of Investor Relations":"Charlotte Ancel","Vice President and Chief Compliance Officer":"German Gonzalez Avecilla","Senior Vice President of State Government Affairs and Corporate Communications":"Kimberly A. Harriman","Senior Vice President of Corporate Development":"Ignacio Estella","Vice President and Chief Human Resources Officer":"Kyra Patterson"},"14.17B","8.26B","892.00M",null,"2.31","15.85","14.99","$1.76 (4.81%)","Jun 3, 2024","491,606","36.82","36.55","36.33 - 36.86","27.46 - 41.22","0.56","Sell","34.50 (-5.79%)","Apr 23, 2024"]]